<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20220802</date><key>pmc.key</key><document><id>9308500</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1007/s40336-022-00513-9</infon><infon key="article-id_pmc">9308500</infon><infon key="article-id_pmid">35910079</infon><infon key="article-id_publisher-id">513</infon><infon key="fpage">1</infon><infon key="kwd">Covid-19 Radiotherapy Oncological practice</infon><infon key="license">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</infon><infon key="lpage">20</infon><infon key="name_0">surname:Piras;given-names:Antonio</infon><infon key="name_1">surname:Venuti;given-names:Valeria</infon><infon key="name_2">surname:D’Aviero;given-names:Andrea</infon><infon key="name_3">surname:Cusumano;given-names:Davide</infon><infon key="name_4">surname:Pergolizzi;given-names:Stefano</infon><infon key="name_5">surname:Daidone;given-names:Antonino</infon><infon key="name_6">surname:Boldrini;given-names:Luca</infon><infon key="section_type">TITLE</infon><infon key="title">Keywords</infon><infon key="type">front</infon><infon key="year">2022</infon><offset>0</offset><text>Covid-19 and radiotherapy: a systematic review after 2 years of pandemic</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>73</offset><text>Introduction</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>86</offset><text>Following the Covid-19 pandemic spread, changes in clinical practice were necessary to limit the pandemic diffusion. Also, oncological practice has undergone changes with radiotherapy (RT) treatments playing a key role.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>306</offset><text>Although several experiences have been published, the aim of this review is to summarize the current evidence after 2 years of pandemic to provide useful conclusions for clinicians.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>489</offset><text>Methods</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>497</offset><text>A Pubmed/MEDLINE and Embase systematic review was conducted. The search strategy was “Covid AND Radiotherapy” and only original articles in the English language were considered.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>679</offset><text>Results</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>687</offset><text>A total of 2.733 papers were obtained using the mentioned search strategy. After the complete selection process, a total of 281 papers were considered eligible for the analysis of the results.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>880</offset><text>Discussion</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>891</offset><text>RT has played a key role in Covid-19 pandemic as it has proved more resilient than surgery and chemotherapy. The impact of the accelerated use of hypofractionated RT and telemedicine will make these strategies central also in the post-pandemic period.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1143</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1156</offset><text>An unexpected series of life threating pneumonias and deaths began in Wuhan, China, starting in December 2019, and soon spread worldwide. On 7 January 2020, the World Health Organization (WHO) announced the official name of the disease as “coronavirus disease 2019” (Covid-19).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1438</offset><text>Analysis of the viral genome revealed that this new coronavirus is phylogenetically close to severe acute respiratory syndrome coronavirus (SARS-CoV).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1589</offset><text>Globally, at 4:00 pm CET, 28 January 2022, 364.191.494 cases of Covid-19 were confirmed, with 5.631.457 deaths as reported to World Health Organization (WHO) by the national authorities.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1777</offset><text>However, thanks to the effectiveness and spread of Covid-19 vaccines around the world, there has been a decrease in mortality rate.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1909</offset><text>As of 28 January 2022, a total of 9.854.237.363 vaccines doses were administered.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1991</offset><text>The symptomatic severity of Covid-19 infection appeared to worsen with increasing age and the presence of comorbidities. In fact, older patients with basic chronic diseases, such as cancer, were more vulnerable to Covid-19 infection.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2225</offset><text>In a recent multicentre study, cancer patients were found to be a highly vulnerable group due to the weakened immune system caused by both tumor growth and anti-cancer treatment. Patients with hematologic cancer, lung cancer, or with metastatic cancer had the highest frequency of severe events. In particular, patients who received surgery had a higher risk of serious events, while patients who received only radiotherapy (RT) showed no significant difference in serious events compared to patients without cancer.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2742</offset><text>RT has played a role in the changes in oncological practice, including an increase in organ-sparing treatment and achieving good local control and improving survival.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2909</offset><text>More than 50% of cancer patients have undergone RT treatment at least one time during their disease.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3010</offset><text>Furthermore, Covid-19 infection had a dramatic impact on cancer diagnosis, prognosis, and therapeutic effects. Serious delays in surgical, chemotherapy and RT treatments due to patients' Covid-19 infection, organizational problems in healthcare facilities and also fear of infection among patients caused a substantial increase in the number of avoidable cancer deaths.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3380</offset><text>Covid-19 has also had a great impact on radiation oncologists, and so several measures have been adopted in patient management beginning with the treatment workflow.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3546</offset><text>Many studies related to RT and Covid-19 have been published in these 2 years of the pandemic. Therefore, the aim of this systematic review is to summarize the current evidences after these 2 years, to provide better and useful conclusions for clinicians.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>3803</offset><text>Materials and methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3825</offset><text>A systematic database search was conducted using definite keywords, according to Preferred Reporting Items for Systematic Reviews and Meta‐analyses (PRISMA) guidelines.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3996</offset><text>The search strategy was performed on PubMed, Medline and Embase using the search terms: “Covid AND Radiotherapy” up to date 31/12/2021.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4136</offset><text>Original studies, editorials, letters to editor, review and case reports focusing on Covid-19 and RT were included in this review.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4267</offset><text>Studies performed not in English and conference abstract were not take into account.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>4352</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4360</offset><text>A total of 2.733 papers were found at the first search, 859 of which were duplicates. Of the 1874 remaining results, 1397 were excluded after a careful screening of abstracts.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4536</offset><text>477 articles were lastly selected for further accurate analysis. Out of these, 196 were excluded, as they did not directly target Covid-19 and RT. The remaining 281 papers were lastly included in this review.</text></passage><passage><infon key="file">40336_2022_513_Fig1_HTML.jpg</infon><infon key="id">Fig1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>4745</offset><text>Prisma diagram</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4760</offset><text>The review workflow was compliant with the PRISMA guidelines, and the relative flowchart is reported in Fig. 1.</text></passage><passage><infon key="file">40336_2022_513_Fig2_HTML.jpg</infon><infon key="id">Fig2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>4873</offset><text>Type of study</text></passage><passage><infon key="file">40336_2022_513_Fig3_HTML.jpg</infon><infon key="id">Fig3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>4887</offset><text>Cluster area</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>4900</offset><text>Summary of main indication for cancer types</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;left&quot;&gt;Site&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;Patient setting&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;RT management&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;RT schedules&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;COVID + (asymptomatic/mild symptomatic)&lt;/th&gt;&lt;th align=&quot;left&quot;&gt;COVID + (symptomatic)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;4&quot;&gt;Lung cancer &lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR72&quot;&gt;72&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR82&quot;&gt;82&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;General&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Increase HFRT&lt;/p&gt;&lt;p&gt;Increase SBRT&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;&gt;Continue RT(CT) with close monitoring of clinical conditions&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Postpone after confirmed healing&lt;/p&gt;&lt;p&gt;Interrupt or preliminarily terminate ongoing treatments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;NSCLC&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Delay post-operative RT&lt;/p&gt;&lt;p&gt;Avoid twice-daily treatments&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;NSLC&lt;/p&gt;&lt;p&gt;(early stage)&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase SBRT&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;50–60 Gy in 5 fr (central tumors)&lt;/p&gt;&lt;p&gt;48 Gy in 4 fr (adjacent/contact with chest wall)&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;SCLC&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Delay PCI&lt;/p&gt;&lt;p&gt;Consider delivering PCI during concurrent RT(CT)&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;5&quot;&gt;Hematological cancer &lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR83&quot;&gt;83&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;General&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Shorten RT course&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Palliative&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Omission RT treatments&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;&gt;–&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Localized low-grade&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Omission RT for completely excised&lt;/p&gt;&lt;p&gt;Delay for asymptomatic patients&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;&gt;Delay RT&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Localized nodular LH&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Omission RT for completely excised&lt;/p&gt;&lt;p&gt;Delay for asymptomatic patients&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Diffuse large B/aggressive LNH&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Omission RT for consolidation&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Head &amp;amp; Neck &lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR72&quot;&gt;72&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR84&quot;&gt;84&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR93&quot;&gt;93&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;General&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase HFRT&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Continue RT(CT) with close monitoring of clinical conditions&lt;/p&gt;&lt;p&gt;Use surgical mask with immobilization setup&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;2&quot;&gt;&lt;p&gt;Prostate&lt;/p&gt;&lt;p&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR94&quot;&gt;94&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR99&quot;&gt;99&lt;/xref&gt;&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;General&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Increase HFRT&lt;/p&gt;&lt;p&gt;Consider starting RT up to 6 months after OT&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Low-risk&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Increase HFRT&lt;/p&gt;&lt;p&gt;Increase SBRT&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;36.25 Gy in 5 fr twice-week&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;6&quot;&gt;Gastrointestinal &lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR98&quot;&gt;98&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR100&quot;&gt;100&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR110&quot;&gt;110&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Esophageal cancer&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;&gt;40 Gy in 15 fr&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Inoperalble Cholangiocarcinoma&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Consider SBRT&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Pancreatic cancer&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Consider SBRT in inoperable LAPC&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Anal cancer&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Increase HFRT&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;36/40 Gy in 20 fr to elective volume;&lt;/p&gt;&lt;p&gt;50 Gy in 20 fr to primary tumor with SIB&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Liver cancer&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Carbon ION RT for unresectable disease&lt;/p&gt;&lt;p&gt;Consider SBRT for Hepato Cellular Carcinomas&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;30–60 Gy in 3–5 fr&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Rectal cancer&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Prefer short course treatments&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Skin &lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR112&quot;&gt;112&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR116&quot;&gt;116&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;General&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Delay or omit adjuvant RT&lt;/p&gt;&lt;p&gt;Consider HFRT&lt;/p&gt;&lt;p&gt;Consider contact skin RT&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Breast &lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR98&quot;&gt;98&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR117&quot;&gt;117&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR121&quot;&gt;121&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;General&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;Delay or omit adjuvant RT in older adult EBC&lt;/p&gt;&lt;p&gt;Consider HFRT&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Soft tissues – Sarcomas &lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR122&quot;&gt;122&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;General&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Consider HFRT&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;&lt;p&gt;30 Gy in 10 fr&lt;/p&gt;&lt;p&gt;30 Gy in 5 fr&lt;/p&gt;&lt;p&gt;28 Gy in 8 fr&lt;/p&gt;&lt;p&gt;25 Gy in 5 fr&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;2&quot;&gt;Gynecological &lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR123&quot;&gt;123&lt;/xref&gt;&lt;xref ref-type=&quot;bibr&quot; rid=&quot;CR124&quot;&gt;124&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;General&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Consider HFRT&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot;&gt;Uterine cancer&lt;/td&gt;&lt;td align=&quot;left&quot;&gt;Do not exceed 6 weeks after surgery for adjuvant RT&lt;/td&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;td align=&quot;left&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>4944</offset><text>Site	Patient setting	RT management	RT schedules	COVID + (asymptomatic/mild symptomatic)	COVID + (symptomatic)	 	Lung cancer 	General	Increase HFRTIncrease SBRT		Continue RT(CT) with close monitoring of clinical conditions	Postpone after confirmed healingInterrupt or preliminarily terminate ongoing treatments	 	NSCLC	Delay post-operative RTAvoid twice-daily treatments				 	NSLC(early stage)	Increase SBRT	50–60 Gy in 5 fr (central tumors)48 Gy in 4 fr (adjacent/contact with chest wall)			 	SCLC	Delay PCIConsider delivering PCI during concurrent RT(CT)				 	Hematological cancer 	General	Shorten RT course				 	Palliative	Omission RT treatments		–		 	Localized low-grade	Omission RT for completely excisedDelay for asymptomatic patients		Delay RT		 	Localized nodular LH	Omission RT for completely excisedDelay for asymptomatic patients				 	Diffuse large B/aggressive LNH	Omission RT for consolidation				 	Head &amp; Neck 	General	Increase HFRT		Continue RT(CT) with close monitoring of clinical conditionsUse surgical mask with immobilization setup		 	Prostate	General	Increase HFRTConsider starting RT up to 6 months after OT				 	Low-risk	Increase HFRTIncrease SBRT	36.25 Gy in 5 fr twice-week			 	Gastrointestinal 	Esophageal cancer		40 Gy in 15 fr			 	Inoperalble Cholangiocarcinoma	Consider SBRT				 	Pancreatic cancer	Consider SBRT in inoperable LAPC				 	Anal cancer	Increase HFRT	36/40 Gy in 20 fr to elective volume;50 Gy in 20 fr to primary tumor with SIB			 	Liver cancer	Carbon ION RT for unresectable diseaseConsider SBRT for Hepato Cellular Carcinomas	30–60 Gy in 3–5 fr			 	Rectal cancer	Prefer short course treatments				 	Skin 	General	Delay or omit adjuvant RTConsider HFRTConsider contact skin RT				 	Breast 	General	Delay or omit adjuvant RT in older adult EBCConsider HFRT				 	Soft tissues – Sarcomas 	General	Consider HFRT	30 Gy in 10 fr30 Gy in 5 fr28 Gy in 8 fr25 Gy in 5 fr			 	Gynecological 	General	Consider HFRT				 	Uterine cancer	Do not exceed 6 weeks after surgery for adjuvant RT				 	</text></passage><passage><infon key="file">Tab1.xml</infon><infon key="id">Tab1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>6997</offset><text>RT radiation therapy, HFRT Hypofractionated radiation therapy, SBRT Stereotactic body radiation therapy, NSCLC Non-small cell lung cancer, SCLC Small cell lung cancer, PCI prophylactic cranial irradiation, LH Hodgkin lymphomas, LNH Non-Hodgkin lymphomas, LAPC Locally advanced pancreatic cancer, SIB simultaneous integrated boost, EBC Early breast cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7352</offset><text>We summarize the main characteristics of the analyzed studies, divided into different cluster areas and study types (Figs. 2, 3). Table 1 resumes the main indications provided for different cancer types.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>7557</offset><text>RT general management</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7579</offset><text>Fifty-four studies focused on the RT general management during Covid-19 pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7661</offset><text>Thirteen studies recommended the use of telemedicine.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7715</offset><text>Telemedicine shows its helpfulness in the RT field, and patients get the supportive care they need minimizing their access to hospitals.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7852</offset><text>In a single academic radiation oncology session, the physicians interviewed indicated that their experience in using telemedicine has been largely positive, and most of them envision telemedicine as part of their radiation oncology practice in the future.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8108</offset><text>Eight studies analyzed the results suggesting the omission or postponement of RT when possible.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8204</offset><text>Indications for RT with limited improvement in oncologic outcomes were viewed critically under conditions of limited health care resources by some expert groups, including RT of low-risk breast cancer in elderly patients and of early-stage Hodgkin’s lymphoma.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8466</offset><text>Twenty-eight studies recommended the use of hypofractionated scheduling and appropriate hypofractionated regimens should be considered during a pandemic to reduce treatment duration and minimize the risk of infection.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8684</offset><text>Six studies discussed organization of work and staff during the pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8758</offset><text>To ensure such continuity of services, the following measures were implemented: patients screening, temperature monitoring, patient and staff education, ensuring adequate medical supplies, continuous use of communication channels, adequate manpower should a staff member fall sick or need to be quarantined as a result of contact with patients with Covid-19, physical segregation of staff across hospitals, physical segregation of patients, formation of separated care teams, remote planning, hygiene and departmental cleaning.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>9286</offset><text>RT management—lung cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9314</offset><text>Eleven studies focused on the RT management of Lung Cancer during Covid-19 pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9399</offset><text>All papers suggested an increase in the use of Hypofractionated radiation therapy (HFRT) and Stereotactic body radiation therapy (SBRT).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9536</offset><text>Liao et al. also suggested the delay of post-operative RT for non-small cell lung cancer, to avoid twice-daily treatments and delay or deliver prophylactic cranial irradiation during radio(chemo)therapy for limited-stage small cell lung cancer.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9781</offset><text>Furthermore, Couñago et al. in their review recommended for non-small-cell lung cancer early-stage central tumors, SBRT with scheme from 10 to 12 Gy/fraction (fr) with a total dose 50–60 Gy. For lesions adjacent or in contact with the chest wall, a dose of up to 48 Gy in 4 fr. For tumors in a safe zone extreme, HFRT with a single fr of 30–34 Gy.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10138</offset><text>The joint European Society for Radiotherapy and Oncology—American Society for Radiation Oncology (ESTRO-ASTRO) established pragmatic and balanced consensus recommendations in common clinical scenarios of RT for lung cancer.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10364</offset><text>In asymptomatic Covid-19 positive patients, radio(chemo)therapy may be continued as planned with precautious measures with caregivers in place to avoid exposure, while in mildly symptomatic Covid-19 positive patients, radio(chemo)therapy may be continued provided the patient is very closely monitored. However, in critically symptomatic Covid-19 positive patients, treatment needs to be postponed, interrupted or even preliminarily terminated.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>10809</offset><text>RT management—hematological cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10846</offset><text>Omission in a palliative setting, for localized low-grade lymphomas if completely excised, for localized nodular lymphocyte-predominant Hodgkin lymphoma if completely excised, in consolidation RT for diffuse large B-cell lymphoma/aggressive non-Hodgkin lymphoma.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11109</offset><text>Delay for asymptomatic localized low-grade lymphomas, for localized nodular lymphocyte-predominant Hodgkin lymphoma, in a palliative setting for low-grade lymphomas in stable patients, or patients who develop Covid-19 infection prior to commencing RT.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11361</offset><text>Shortening the RT course.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11387</offset><text>One study provided practice guidelines on the RT management of hematological cancers. The authors suggested three potential strategies to reduce the demand for RT during the pandemic:</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>11571</offset><text>RT management—head &amp; neck cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11606</offset><text>Eleven studies focused on head and neck cancer (H&amp;N) RT management.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11674</offset><text>Modest HFRT has been recommended by several authors. The most common schedule is 55 Gy in 20 frs. However, no studies recommended extreme HFRT.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11819</offset><text>Thomson et al. recommended not to stop treatment, especially if patients had already completed the first 2 weeks.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11934</offset><text>Three studies investigated surgical mask use in H&amp;N cancer patients.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12003</offset><text>Ding et al. demonstrated in a small prospective study, that the setup error was affected by wearing a surgical mask. They recommended that the immobilization open mask should be used when the patients cannot finish the whole treatment with a surgical mask.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12260</offset><text>Wang et al. in their study revealed that mask wearing for patients undergoing daily RT is feasible and can provide basic protection for patients and staff.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>12416</offset><text>RT management—prostate cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12448</offset><text>Five studies dealt with RT management during the Covid-19 pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12516</offset><text>These studies showed that: ultra HFRT is preferred for localized, oligometastatic, and low-volume M1; while moderate HFRT is preferred for postprostatectomy and clinical node positive disease and salvage is preferred to adjuvant radiation.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12756</offset><text>The trial by Barra et al. recommended SBRT at a dose of 36.25 Gy in 5 frs, twice a week, as the preferred treatment option in medical emergencies in low-risk prostate cancer.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12932</offset><text>As regards hormone therapy in unfavorable intermediate-risk, high-risk, or very high-risk prostate cancer patients, later RT initiation up to 6 months after androgen deprivation therapy initiation was not associated with worse overall survival.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>13178</offset><text>RT management—gastrointestinal cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13218</offset><text>Twelve studies provided recommendations for the use of RT in managing patients with gastrointestinal malignancies in the era of Covid-19:</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13356</offset><text>In esophageal cancer, the Walsh regimen of 40 Gy in 15 frs can be considered, whereas for inoperable cholangiocarcinoma, SBRT is the acceptable option.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13509</offset><text>For cases of pancreatic cancer that remain borderline resectable even after a complete course of six months of neoadjuvant chemotherapy, SBRT in 5 frs can be considered.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13679</offset><text>Patients with anal cancer who are not candidates to receive concurrent chemotherapy (due to comorbidities or poor performance status) can be treated with a hypofractionated regimen of 36–40 Gy in 20 frs to the elective volume with a simultaneous integrated boost to 50 Gy to the primary tumor.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13977</offset><text>Carbon Ion RT is an optimal treatment strategy for unresectable Liver Cancer.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14055</offset><text>SBRT should be considered for patients with Hepato Cellular Carcinoma from the early stage to the most advanced stages with the total dose of 30–60 Gy in 3–5 fr.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14222</offset><text>Short course RT 25 Gy in 5 fr in rectal cancer is preferable to long course RT.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>14303</offset><text>RT management—skin cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14331</offset><text>Five articles discussed RT management in skin cancer patients.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14394</offset><text>Omitting or delaying adjuvant RT should be considered where the benefit is likely to be limited.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14491</offset><text>For Non Melanoma Skin Cancer, Veness et al. in their review, recommended HFRT (2.1–5 Gy fr sizes using 8–20 frs) in both the definitive and post-operative settings. Instead, Lancellotta et al. delivered contact skin RT (brachytherapy) in 8 frs of 5 Gy each, twice a day.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>14768</offset><text>RT management—breast cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14798</offset><text>According to six studies evaluated RT management in breast cancer patients,</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14874</offset><text>HFRT should be the standard of care. Partial breast irradiation and ultra- HFRT regimens could be considered in selected cases due to the pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15022</offset><text>Adjuvant RT might be omitted in a highly selected group of older adult early-stage breast cancer patients with favorable prognostic factors.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>15163</offset><text>RT management—sarcoma</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15187</offset><text>A study investigated the use of preoperative HFRT in sarcomas. The authors suggested that HFRT is a promising treatment option providing satisfactory local control with acceptable toxicity. The recommended regimes are 3 Gy for 10 fr, 3.5 Gy for 8 fr, 5 Gy for 5 fr, 6 Gy for 5 fr.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>15472</offset><text>RT management—gynecological cancer</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15509</offset><text>An expert consensus recommendation provided guidance for delivering radiation therapy during the Covid-19 pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15625</offset><text>HFRT should be used when feasible and recommendations regarding radiation dose, timing, and technique have been provided for external beam and brachytherapy treatments.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15794</offset><text>In a letter to editor, Matsuo et al. examined the association between post-hysterectomy RT wait-time and oncologic outcomes in women with early-stage cervical cancer.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15961</offset><text>They observed a poorer oncologic outcome with longer adjuvant RT wait-time after radical hysterectomy, and suggested the initiation of adjuvant RT within 6 weeks after surgical treatment whenever possible.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>16168</offset><text>Interventional radiotherapy (IRT) management</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16214</offset><text>Nine articles focused on the management of IRT during Covid-19 pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16287</offset><text>The use of shorter IRT fractionation schedules will help minimize patient exposure and conserve resources that are important during Covid-19.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16429</offset><text>Muramaki et al. reported increased number of prostate cancer patients, selecting high dose-rate interstitial brachytherapy in our department.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16571</offset><text>IRT procedure may be a prudent choice used as a first-line treatment in early-stage cervical malignancies. IRT should not be delayed in patients without the Covid-19 symptoms.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16747</offset><text>Practical indications for management of patient candidates for IRT and Intraoperative Radiotherapy (IORT) during Covid-19 pandemic have been provided by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>17008</offset><text>Palliative RT management</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17033</offset><text>Nine articles focused on the management of Palliative RT during Covid-19 pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17116</offset><text>During the Covid-19 pandemic, a short course was recommended to reduce the risk of viral exposure to all patients and staff, without compromising functional outcomes.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17283</offset><text>Also, other studies focusing on the management of different diseases, about palliative RT recommended a single fractionation of 8–10 Gy.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17423</offset><text>The Palliative Care and Supportive Therapies Working Group (AIRO-palliative) provided a comprehensive summary of the literature guideline indications of palliative RT for Metastatic Epidural Spinal Cord Compression, Hemostasis, Mediastinal Syndrome, Painful or no bone metastasis, Oligometastases Suitable for SBRT, Brain metastases.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17757</offset><text>The GEMO (European Study Group of Bone Metastases) recommended the use of monofractionated RT (8 Gy) for painful bone metastases and Metastatic Epidural Spinal Cord Compression; although, RT may be postponed in Adjuvant bone metastasis RT setting.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>18006</offset><text>RT for Covid-19 pneumonia</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18032</offset><text>Forty-three studies investigated treatment of Covid-19 pneumonia with RT. Observations from these studies indicate that Low-dose radiotherapy (LDRT) for Covid-19 pneumonia delivers doses between 0.3 and 1 Gy. LDRT does not decrease the viability of virus directly, but it may increase the effectiveness of antiviral immune responses in the early/medium stages of SARS-CoV‑2 infection.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18420</offset><text>Whole-lung LDRT seems to be a promising approach for avoiding or delaying invasive respiratory support with a low risk of toxicity.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18552</offset><text>LDRT induces an anti-inflammatory phenotype that can potentially give therapeutic benefits against Covid-19-related complications.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>18683</offset><text>RT safety</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18693</offset><text>Thirty-nine studies focused on RT safety during Covid-19 pandemic </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18760</offset><text>In particular, 7 articles discussed RT on Covid-19 positive patients.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18830</offset><text>In the study of Beddok et al. the observed acute and late toxicities were ultimately similar to those observed in a population not infected with Covid-19. However, these results do not prompt the modification of standard RT protocols for irradiation of Covid-19 patients.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19102</offset><text>Covid-19 infected cancer patients in RT practice show similar symptoms and demographic characteristics as the general population infected with SARS-CoV-2 virus.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19263</offset><text>Eight studies addressed the side-effects of LDRT treatment.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19323</offset><text>The prospective trial of Arruda et al. showed that a RT dose ≤ 0.5 Gy provides an acceptable lifetime attributable risk estimate (≤ 1%) for radiation-induced cancer.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19500</offset><text>These studies suggest that RT may have the best benefit-risk balance for older patients with low baseline risk factors.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19620</offset><text>The other studies focused on RT workflow and preventive protection procedures for Covid-19 infection in all patients and healthcare professionals.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>19767</offset><text>Vaccine and RT</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19782</offset><text>Four studies discussed the correlation between Covid-19 vaccine and RT.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19854</offset><text>Three of them were case reports reporting three skin toxicities in treatment fields and one lung toxicity in patients undergoing RT.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19987</offset><text>The prospective study of Scoccianti et al. showed that Moderna mRNA-1273 vaccine produced good results in patients who underwent RT for both early adverse events and late adverse effects.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>20175</offset><text>Diagnosis of Covid-19 in RT</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20203</offset><text>Fifteen studies addressed the diagnosis of Covid-19 in patients during RT or its preparation phases.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20304</offset><text>Five studies confirmed the benefits of the systematic use of chest computed tomography (CT) screening during CT simulation for patients undergoing RT during the Covid-19 pandemic.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20484</offset><text>Cone Beam CT (CBCT) during the treatment also made it possible to diagnose Covid-19.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>20569</offset><text>Impact of Covid-19 in RT</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20594</offset><text>Fifty-eight studies discussed the impact of Covid-19 in RT.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20654</offset><text>These studies were involved in the use of information technologies, RT prioritization, HFRT and protection procedures guarantee between patient care and safety while safeguarding the healthcare staff.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20855</offset><text>In a study published in The Lancet, the authors analyzed data relating to RT delivery for cancer patients in English National Health Service, which showed that RT activity fell significantly, but use of HFRT rapidly increased during the first peak of the Covid-19 pandemic. An increase in treatments for some cancers suggests that RT compensated for reduced surgical activity.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21232</offset><text>Teckie et al. emphasized that RT is more effectual compared to surgery and chemotherapy. During the pandemic, their RT department consistently maintained safe, timely and evidence-based standards of care, with very low staff and patient infection rates. While the surgical option was closed for 2 months, chemotherapy showed an increased risk of death from Covid-19 among patients traditionally receiving more aggressive chemotherapy, including those with haematological cancers, lung cancer and metastatic cancer.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21748</offset><text>The Covid-19 pandemic affected the regular RT delivery to oncologic patients, owing to the delay or cancelation of procedures with the likely effect of observing the worsening of local disease control and reduced survival rates in the future.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21991</offset><text>The RT center of Renmin Hospital of Wuhan University was shut down on January 24, and reopened on March 9, 2020. Thus, many patients had impromptu interruptions of their RT treatment plan during this period and it was detected that stage IV was associated with poor prognosis compared with stage I-III.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>22294</offset><text>A significant increase in the experience of isolation and a decrease in emotional functions and the general quality of life were observed during the Covid-19 lockdown in cancer patients.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>22481</offset><text>A survey among 543 researchers in the field of radiation oncology was carried out during the early weeks of the Covid-19 pandemic, showing a non-negligible impact on both productivity and mental health.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>22684</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22695</offset><text>This is a review of all papers on RT related to the Covid-19 pandemic that have been published in the last 2 years. The search for articles was performed until 31/12/2021, so exactly 2 years after the start of the pandemic.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22921</offset><text>The importance of the topic is demonstrated by the large number of papers found during the review process.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23028</offset><text>These studies were performed all over the world, from Africa to America, from Europe to Asia.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23122</offset><text>RT management (divided into subgroups according to pathology).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23185</offset><text>RT for Covid-19 pneumonia.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23212</offset><text>RT Safety.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23223</offset><text>Vaccine and RT.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23239</offset><text>Diagnosis of Covid-19 in RT.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23268</offset><text>Impact of Covid-19 in RT.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23294</offset><text>We classified the articles into 5 cluster areas:</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23343</offset><text>There was homogeneity in the type of studies published, with a slightly greater tendency for reviews and editorials. This is may be due to the significant attempt to give consensus/guidelines to clinicians during this difficult period.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23579</offset><text>In fact, the largest cluster areas are those of RT management during Covid-19 pandemic and Impact of Covid on RT.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23693</offset><text>Many of the articles included in the review focused on strategies for organizing work and screening for Covid-19 infection to guarantee the safety and efficiency of health services..</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23876</offset><text>There was a large general consensus on the implementation of HFRT and SBRT to reduce access to hospital and the risk of infection.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24007</offset><text>Also, concerning palliative RT, there was great concurrence for single fr treatments of 8–10 Gy.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24107</offset><text>In the era of personalized treatment with research and progressive use of Radiomics and predictive dosimetric parameters, the Covid-19 pandemic has accelerated this process, leading to hypofractionation, postponement and eventually omission of treatment by evaluating risks and benefits for each individual patient.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24423</offset><text>There is a very similar scenario with regards to the digitization of the healthcare system.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24515</offset><text>Telemedicine was crucial during the Covid-19 pandemic allowing clinical activities to continue even during lockdown. The advantages of telemedicine include its cost-effectiveness and its potential to help mitigate any shortage of physicians. Disadvantages include the lack of technological resources available in some parts of the country and problems with the security of patient data.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24902</offset><text>There is great concern in the literature about the effects of the suboptimal delivery of RT (including delays, interruptions or omissions). This may compromise both local control and survival.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25095</offset><text>The pandemic has also led to a great amount of anxiety and fear among both healthcare staff and patients. This is not to be underestimated because it can affect the proper work of healthcare staff and may contribute to interruptions or refusal of treatment by patients </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25365</offset><text>Several studies have been published on LDRT of Covid-19 pneumonia. Although RT has an effective anti-inflammatory action to avoid or delay invasive respiratory disease, the risk of second tumors, though low, exists. With the advent of the vaccine, which is the real cure for Covid-19, LDRT is a limited treatment option.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25686</offset><text>From the analysis of the included studies, except for only 3 case reports of mild toxicity, there was no real risk of interactivity between RT and vaccine. Therefore, the vaccine seems to be safe during RT. The only prospective study by Scoccianti et al. confirms this statement.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25966</offset><text>With regards to safety, just like the vaccine, RT in Covid-19 patients appears to be safe. Although, there seems to be no correlation between Covid-19 infection and RT. Therefore, if the patient has no severe Covid symptoms and is to continue radiation treatment, no adjustments of technique or dose should be made for his safety.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26297</offset><text>A really interesting cluster area was the Diagnosis. Several articles emphasized the usefulness and importance of simulation CT and CBCT in detecting suspicious interstitial pneumonias by Covid-19.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26495</offset><text>The most common observations on CT are ground-glass opacification air bronchograms, crazy-paving patterns, and thickening of the adjacent pleura.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26641</offset><text>CBCT is a medical imaging technique with inferior image quality (compared to diagnostic CT) used routinely for image guided radiotherapy (IGRT) to ensure proper positioning and visualization of any anatomical changes.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26859</offset><text>In conclusion, the Covid-19 pandemic has certainly caused innumerable deaths and injuries in the last two years. The RT world has reacted promptly by developing high quality screening and work safety systems. RT has played a key role in this period as it has proved to be more effective treatment option when compared to surgical procedures and chemotherapy. The accelerated use of HFRT and telemedicine due to the pandemic is already an added value to our discipline and will probably remain so in the years to follow.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>27379</offset><text>Publisher's Note</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>27396</offset><text>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>27515</offset><text>Author contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>27536</offset><text>AP: Content planning, literature review, writing and editing. VV: literature search, literature review and writing. ADA: literature search, literature review and writing. DC: content planning and editing. SP: content planning and editing. AD: content planning and editing. LB: content planning and editing.</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">title</infon><offset>27843</offset><text>Funding</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">paragraph</infon><offset>27851</offset><text>All authors received no specific funding for this work.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>27907</offset><text>Data availability</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>27925</offset><text>The data presented in this study are available on request from the corresponding author.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>28014</offset><text>Declarations</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>28027</offset><text>Conflict of interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>28048</offset><text>All authors declare no conflicts of interests.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>28095</offset><text>Ethical approval and consent to participate</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>28139</offset><text>No Ethical approval was needed due to the design of the study.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>28202</offset><text>Consent for publication</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>28226</offset><text>No consent to publication was needed due to the design of the study.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>28295</offset><text>References</text></passage><passage><infon key="fpage">335</infon><infon key="lpage">337</infon><infon key="name_0">surname:Liang;given-names:W</infon><infon key="name_1">surname:Guan;given-names:W</infon><infon key="name_2">surname:Chen;given-names:R</infon><infon key="pub-id_doi">10.1016/S1470-2045(20)30096-6</infon><infon key="pub-id_pmid">32066541</infon><infon key="section_type">REF</infon><infon key="source">Lancet Oncol</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2020</infon><offset>28306</offset><text>Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China</text></passage><passage><infon key="fpage">313</infon><infon key="lpage">324</infon><infon key="name_0">surname:Ahn;given-names:D-G</infon><infon key="name_1">surname:Shin;given-names:H-J</infon><infon key="name_2">surname:Kim;given-names:M-H</infon><infon key="pub-id_doi">10.4014/jmb.2003.03011</infon><infon key="pub-id_pmid">32238757</infon><infon key="section_type">REF</infon><infon key="source">J Microbiol Biotechnol</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2020</infon><offset>28378</offset><text>Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (Covid-19)</text></passage><passage><infon key="fpage">565</infon><infon key="lpage">574</infon><infon key="name_0">surname:Lu;given-names:R</infon><infon key="name_1">surname:Zhao;given-names:X</infon><infon key="name_2">surname:Li;given-names:J</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30251-8</infon><infon key="pub-id_pmid">32007145</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">395</infon><infon key="year">2020</infon><offset>28494</offset><text>Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28615</offset><text>WHO Coronavirus (Covid-19) Dashboard. https://covid19.who.int. Accessed 30 Jan 2022.</text></passage><passage><infon key="fpage">2603</infon><infon key="lpage">2615</infon><infon key="name_0">surname:Polack;given-names:FP</infon><infon key="name_1">surname:Thomas;given-names:SJ</infon><infon key="name_2">surname:Kitchin;given-names:N</infon><infon key="pub-id_doi">10.1056/NEJMoa2034577</infon><infon key="pub-id_pmid">33301246</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">383</infon><infon key="year">2020</infon><offset>28700</offset><text>Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine</text></passage><passage><infon key="fpage">519</infon><infon key="lpage">527</infon><infon key="name_0">surname:Liu;given-names:C</infon><infon key="name_1">surname:Zhao;given-names:Y</infon><infon key="name_2">surname:Okwan-Duodu;given-names:D</infon><infon key="pub-id_doi">10.20892/j.issn.2095-3941.2020.0289</infon><infon key="pub-id_pmid">32944387</infon><infon key="section_type">REF</infon><infon key="source">Cancer Biol Med</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2020</infon><offset>28758</offset><text>Covid-19 in cancer patients: risk, clinical features, and management</text></passage><passage><infon key="fpage">1239</infon><infon key="lpage">1242</infon><infon key="name_0">surname:Wu;given-names:Z</infon><infon key="name_1">surname:McGoogan;given-names:JM</infon><infon key="pub-id_doi">10.1001/jama.2020.2648</infon><infon key="pub-id_pmid">32091533</infon><infon key="section_type">REF</infon><infon key="source">JAMA</infon><infon key="type">ref</infon><infon key="volume">323</infon><infon key="year">2020</infon><offset>28827</offset><text>Characteristics of and important lessons from the coronavirus disease 2019 (Covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention</text></passage><passage><infon key="fpage">1708</infon><infon key="lpage">1720</infon><infon key="name_0">surname:Guan;given-names:W-J</infon><infon key="name_1">surname:Ni;given-names:Z-Y</infon><infon key="name_2">surname:Hu;given-names:Y</infon><infon key="pub-id_doi">10.1056/NEJMoa2002032</infon><infon key="pub-id_pmid">32109013</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">382</infon><infon key="year">2020</infon><offset>29027</offset><text>Clinical characteristics of coronavirus disease 2019 in China</text></passage><passage><infon key="fpage">507</infon><infon key="lpage">513</infon><infon key="name_0">surname:Chen;given-names:N</infon><infon key="name_1">surname:Zhou;given-names:M</infon><infon key="name_2">surname:Dong;given-names:X</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30211-7</infon><infon key="pub-id_pmid">32007143</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">395</infon><infon key="year">2020</infon><offset>29089</offset><text>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</text></passage><passage><infon key="fpage">363</infon><infon key="lpage">374</infon><infon key="name_0">surname:Tian;given-names:Y</infon><infon key="name_1">surname:Qiu;given-names:X</infon><infon key="name_2">surname:Wang;given-names:C</infon><infon key="pub-id_doi">10.1002/ijc.33213</infon><infon key="pub-id_pmid">32683687</infon><infon key="section_type">REF</infon><infon key="source">Int J Cancer</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2021</infon><offset>29219</offset><text>Cancer associates with risk and severe events of Covid-19: a systematic review and meta-analysis</text></passage><passage><infon key="fpage">783</infon><infon key="lpage">791</infon><infon key="name_0">surname:Dai;given-names:M</infon><infon key="name_1">surname:Liu;given-names:D</infon><infon key="name_2">surname:Liu;given-names:M</infon><infon key="pub-id_doi">10.1158/2159-8290.CD-20-0422</infon><infon key="pub-id_pmid">32345594</infon><infon key="section_type">REF</infon><infon key="source">Cancer Discov</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>29316</offset><text>Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the Covid-19 outbreak</text></passage><passage><infon key="fpage">365</infon><infon key="lpage">376</infon><infon key="name_0">surname:Russell;given-names:NS</infon><infon key="name_1">surname:Bartelink;given-names:H</infon><infon key="pub-id_doi">10.1053/ctrv.1999.0141</infon><infon key="pub-id_pmid">10644502</infon><infon key="section_type">REF</infon><infon key="source">Cancer Treat Rev</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">1999</infon><offset>29424</offset><text>Radiotherapy: the last 25 years</text></passage><passage><infon key="fpage">1268</infon><infon key="lpage">1274</infon><infon key="name_0">surname:Borras;given-names:JM</infon><infon key="name_1">surname:Lievens;given-names:Y</infon><infon key="name_2">surname:Grau;given-names:C</infon><infon key="pub-id_doi">10.3109/0284186X.2015.1062139</infon><infon key="pub-id_pmid">26213310</infon><infon key="section_type">REF</infon><infon key="source">Acta Oncol</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2015</infon><offset>29456</offset><text>The need for radiotherapy in Europe in 2020: not only data but also a cancer plan</text></passage><passage><infon key="fpage">332</infon><infon key="lpage">334</infon><infon key="name_0">surname:Nagar;given-names:H</infon><infon key="name_1">surname:Formenti;given-names:SC</infon><infon key="pub-id_doi">10.1038/s41571-020-0375-1</infon><infon key="pub-id_pmid">32341524</infon><infon key="section_type">REF</infon><infon key="source">Nat Rev Clin Oncol</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2020</infon><offset>29538</offset><text>Cancer and Covid-19 - potentially deleterious effects of delaying radiotherapy</text></passage><passage><infon key="fpage">2763</infon><infon key="lpage">2770</infon><infon key="name_0">surname:Rades;given-names:D</infon><infon key="name_1">surname:Narvaez;given-names:CA</infon><infon key="name_2">surname:Dziggel;given-names:L</infon><infon key="pub-id_doi">10.21873/invivo.12561</infon><infon key="pub-id_pmid">34410966</infon><infon key="section_type">REF</infon><infon key="source">In Vivo</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2021</infon><offset>29617</offset><text>Emotional problems prior to adjuvant radiation therapy for breast cancer</text></passage><passage><infon key="fpage">644</infon><infon key="lpage">650</infon><infon key="name_0">surname:Belkacemi;given-names:Y</infon><infon key="name_1">surname:Loaganadane;given-names:G</infon><infon key="name_2">surname:Grellier;given-names:N</infon><infon key="pub-id_doi">10.1016/j.adro.2020.04.039</infon><infon key="pub-id_pmid">32775775</infon><infon key="section_type">REF</infon><infon key="source">Adv Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2020</infon><offset>29690</offset><text>Radiation therapy department reorganization during the coronavirus disease 2019 (Covid-19) outbreak: keys to securing staff and patients during the first weeks of the crisis and impact on radiation therapy practice from a single institution experience</text></passage><passage><infon key="fpage">1023</infon><infon key="lpage">1034</infon><infon key="name_0">surname:Maringe;given-names:C</infon><infon key="name_1">surname:Spicer;given-names:J</infon><infon key="name_2">surname:Morris;given-names:M</infon><infon key="pub-id_doi">10.1016/S1470-2045(20)30388-0</infon><infon key="pub-id_pmid">32702310</infon><infon key="section_type">REF</infon><infon key="source">Lancet Oncol</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2020</infon><offset>29942</offset><text>The impact of the Covid-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study</text></passage><passage><infon key="fpage">625</infon><infon key="lpage">627</infon><infon key="name_0">surname:Lancia;given-names:A</infon><infon key="name_1">surname:Bonzano;given-names:E</infon><infon key="name_2">surname:Bottero;given-names:M</infon><infon key="pub-id_doi">10.1080/14737140.2020.1785290</infon><infon key="pub-id_pmid">32552073</infon><infon key="section_type">REF</infon><infon key="source">Expert Rev Anticancer Ther</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2020</infon><offset>30084</offset><text>Radiotherapy in the era of Covid-19</text></passage><passage><infon key="fpage">151</infon><infon key="lpage">152</infon><infon key="name_0">surname:Vitullo;given-names:A</infon><infon key="name_1">surname:De Santis;given-names:MC</infon><infon key="name_2">surname:Marchianò;given-names:A</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.028</infon><infon key="pub-id_pmid">32447034</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">2020</infon><offset>30120</offset><text>The simulation-CT: radiotherapy’s useful tool in the race against Covid-19 pandemic. A serendipity approach</text></passage><passage><infon key="fpage">1</infon><infon key="name_0">surname:Moher;given-names:D</infon><infon key="name_1">surname:Shamseer;given-names:L</infon><infon key="name_2">surname:Clarke;given-names:M</infon><infon key="pub-id_doi">10.1186/2046-4053-4-1</infon><infon key="pub-id_pmid">25554246</infon><infon key="section_type">REF</infon><infon key="source">Syst Rev</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2015</infon><offset>30230</offset><text>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement</text></passage><passage><infon key="fpage">140</infon><infon key="name_0">surname:Vordermark;given-names:D</infon><infon key="pub-id_doi">10.1186/s13014-020-01579-3</infon><infon key="pub-id_pmid">32493443</infon><infon key="section_type">REF</infon><infon key="source">Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>30332</offset><text>Shift in indications for radiotherapy during the Covid-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups</text></passage><passage><infon key="fpage">12480</infon><infon key="lpage">12489</infon><infon key="name_0">surname:Di Franco;given-names:R</infon><infon key="name_1">surname:Borzillo;given-names:V</infon><infon key="name_2">surname:D’Ippolito;given-names:E</infon><infon key="pub-id_doi">10.26355/eurrev_202012_24044</infon><infon key="pub-id_pmid">33336767</infon><infon key="section_type">REF</infon><infon key="source">Eur Rev Med Pharmacol Sci</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2020</infon><offset>30511</offset><text>Covid-19 and radiotherapy: potential new strategies for patients management with hypofractionation and telemedicine</text></passage><passage><infon key="fpage">216</infon><infon key="lpage">222</infon><infon key="name_0">surname:Janssens;given-names:GO</infon><infon key="name_1">surname:Mandeville;given-names:HC</infon><infon key="name_2">surname:Timmermann;given-names:B</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.035</infon><infon key="pub-id_pmid">32342872</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>30627</offset><text>A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced pediatric radiotherapy capacity during the Covid-19 pandemic or other crises</text></passage><passage><infon key="fpage">24</infon><infon key="lpage">28</infon><infon key="name_0">surname:Horsley;given-names:PJ</infon><infon key="name_1">surname:Back;given-names:M</infon><infon key="name_2">surname:Lamoury;given-names:G</infon><infon key="pub-id_doi">10.1111/ajco.13456</infon><infon key="pub-id_pmid">32894820</infon><infon key="section_type">REF</infon><infon key="source">Asia Pac J Clin Oncol</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2021</infon><offset>30828</offset><text>Radiation oncology during Covid-19: strategies to avoid compromised care</text></passage><passage><infon key="fpage">4892382</infon><infon key="name_0">surname:Franco;given-names:P</infon><infon key="name_1">surname:Kochbati;given-names:L</infon><infon key="name_2">surname:Siano;given-names:M</infon><infon key="name_3">surname:De Bari;given-names:B</infon><infon key="pub-id_doi">10.1155/2020/4892382</infon><infon key="pub-id_pmid">32509860</infon><infon key="section_type">REF</infon><infon key="source">Biomed Res Int</infon><infon key="type">ref</infon><infon key="volume">2020</infon><infon key="year">2020</infon><offset>30901</offset><text>Suggestions for radiation oncologists during the Covid-19 pandemic</text></passage><passage><infon key="fpage">752</infon><infon key="lpage">753</infon><infon key="name_0">surname:Price;given-names:P</infon><infon key="name_1">surname:Barney;given-names:SE</infon><infon key="pub-id_doi">10.1016/S1470-2045(20)30281-3</infon><infon key="pub-id_pmid">32502440</infon><infon key="section_type">REF</infon><infon key="source">Lancet Oncol</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2020</infon><offset>30968</offset><text>Initiation of the global coalition for radiotherapy during the Covid-19 pandemic</text></passage><passage><infon key="fpage">40</infon><infon key="lpage">42</infon><infon key="name_0">surname:Slotman;given-names:BJ</infon><infon key="name_1">surname:Lievens;given-names:Y</infon><infon key="name_2">surname:Poortmans;given-names:P</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.06.007</infon><infon key="pub-id_pmid">32544604</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">2020</infon><offset>31049</offset><text>Effect of Covid-19 pandemic on practice in European radiation oncology centers</text></passage><passage><infon key="fpage">e000779</infon><infon key="name_0">surname:Meattini;given-names:I</infon><infon key="name_1">surname:Franco;given-names:P</infon><infon key="name_2">surname:Belgioia;given-names:L</infon><infon key="pub-id_doi">10.1136/esmoopen-2020-000779</infon><infon key="pub-id_pmid">32295769</infon><infon key="section_type">REF</infon><infon key="source">ESMO Open</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2020</infon><offset>31128</offset><text>Radiation therapy during the coronavirus disease 2019 (Covid-19) pandemic in Italy: a view of the nation’s young oncologists</text></passage><passage><infon key="fpage">251</infon><infon key="lpage">255</infon><infon key="name_0">surname:Upadhyay;given-names:R</infon><infon key="name_1">surname:Shankar;given-names:A</infon><infon key="pub-id_doi">10.1080/14737140.2021.1860761</infon><infon key="pub-id_pmid">33287614</infon><infon key="section_type">REF</infon><infon key="source">Expert Rev Anticancer Ther</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2021</infon><offset>31255</offset><text>Implementing continued radiation therapy for cancer management in low resource countries during and after the Covid-19 crisis</text></passage><passage><infon key="fpage">124</infon><infon key="lpage">127</infon><infon key="name_0">surname:Rathod;given-names:S</infon><infon key="name_1">surname:Dubey;given-names:A</infon><infon key="name_2">surname:Bashir;given-names:B</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.03.045</infon><infon key="pub-id_pmid">32342864</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>31381</offset><text>Bracing for impact with new 4R’s in the Covid-19 pandemic—a provincial thoracic radiation oncology consensus</text></passage><passage><infon key="fpage">359</infon><infon key="issue">66</infon><infon key="lpage">365</infon><infon key="name_0">surname:Starling;given-names:MTM</infon><infon key="name_1">surname:de Silva;given-names:ARN</infon><infon key="name_2">surname:SE, Pereira APA,</infon><infon key="pub-id_doi">10.1590/1806-9282.66.3.359</infon><infon key="section_type">REF</infon><infon key="source">Rev Assoc Med Bras</infon><infon key="type">ref</infon><infon key="volume">1992</infon><infon key="year">2020</infon><offset>31494</offset><text>Recommendations for radiotherapy during the novel coronavirus pandemic</text></passage><passage><infon key="fpage">1177</infon><infon key="name_0">surname:Barik;given-names:SK</infon><infon key="name_1">surname:Dhar;given-names:SS</infon><infon key="name_2">surname:Majumdar;given-names:SKD</infon><infon key="name_3">surname:Parida;given-names:DK</infon><infon key="pub-id_doi">10.3332/ecancer.2021.1177</infon><infon key="pub-id_pmid">33680091</infon><infon key="section_type">REF</infon><infon key="source">Ecancermedicalscience</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2021</infon><offset>31565</offset><text>Tweaking of radiation and chemotherapy schedules is the new normal during the Covid-19 crisis: perspective from oncologists at a tertiary care health institute</text></passage><passage><infon key="fpage">e155</infon><infon key="lpage">e159</infon><infon key="name_0">surname:Tan;given-names:BF</infon><infon key="name_1">surname:Tuan;given-names:JKL</infon><infon key="name_2">surname:Yap;given-names:SP</infon><infon key="pub-id_doi">10.1016/j.clon.2020.04.006</infon><infon key="pub-id_pmid">32359846</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>31725</offset><text>Managing the Covid-19 pandemic as a national radiation oncology center in Singapore</text></passage><passage><infon key="fpage">74</infon><infon key="name_0">surname:Combs;given-names:SE</infon><infon key="name_1">surname:Belka;given-names:C</infon><infon key="name_2">surname:Niyazi;given-names:M</infon><infon key="pub-id_doi">10.1186/s13014-020-01527-1</infon><infon key="pub-id_pmid">32264908</infon><infon key="section_type">REF</infon><infon key="source">Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>31809</offset><text>First statement on preparation for the Covid-19 pandemic in large German speaking university-based radiation oncology departments</text></passage><passage><infon key="fpage">641</infon><infon key="name_0">surname:Al-Shamsi;given-names:HO</infon><infon key="name_1">surname:Abu-Gheida;given-names:I</infon><infon key="name_2">surname:Rana;given-names:SK</infon><infon key="pub-id_doi">10.1186/s12885-020-07115-6</infon><infon key="pub-id_pmid">32650756</infon><infon key="section_type">REF</infon><infon key="source">BMC Cancer</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2020</infon><offset>31939</offset><text>Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism—a consensus report by the emirates oncology task force</text></passage><passage><infon key="fpage">279</infon><infon key="lpage">280</infon><infon key="name_0">surname:Odei;given-names:B</infon><infon key="name_1">surname:Quick;given-names:A</infon><infon key="pub-id_doi">10.3747/co.27.7095</infon><infon key="pub-id_pmid">33173381</infon><infon key="section_type">REF</infon><infon key="source">Curr Oncol</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2020</infon><offset>32092</offset><text>The implications of Covid-19 in radiation oncology in the United States</text></passage><passage><infon key="fpage">70</infon><infon key="lpage">71</infon><infon key="name_0">surname:Aghili;given-names:M</infon><infon key="name_1">surname:Ghalehtaki;given-names:R</infon><infon key="name_2">surname:Mousavi Darzikolaee;given-names:N</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.051</infon><infon key="pub-id_pmid">32387545</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>32164</offset><text>Radiotherapy and Covid-19: practical recommendations from Iran</text></passage><passage><infon key="fpage">55</infon><infon key="lpage">68</infon><infon key="name_0">surname:Simcock;given-names:R</infon><infon key="name_1">surname:Thomas;given-names:TV</infon><infon key="name_2">surname:Estes;given-names:C</infon><infon key="pub-id_doi">10.1016/j.ctro.2020.03.009</infon><infon key="pub-id_pmid">32274425</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2020</infon><offset>32227</offset><text>Covid-19: Global radiation oncology’s targeted response for pandemic preparedness</text></passage><passage><infon key="fpage">1518</infon><infon key="lpage">1521</infon><infon key="name_0">surname:Huang;given-names:B</infon><infon key="name_1">surname:Zhu;given-names:J</infon><infon key="name_2">surname:Wu;given-names:X-Y</infon><infon key="name_3">surname:Gao;given-names:X-H</infon><infon key="pub-id_pmid">32509394</infon><infon key="section_type">REF</infon><infon key="source">Am J Cancer Res</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>32311</offset><text>Should patients stop their radiotherapy or chemotherapy during the Covid-19 pandemic</text></passage><passage><infon key="fpage">93</infon><infon key="lpage">98</infon><infon key="name_0">surname:Gupta;given-names:M</infon><infon key="name_1">surname:Ahuja;given-names:R</infon><infon key="name_2">surname:Gupta;given-names:S</infon><infon key="pub-id_doi">10.3857/roj.2020.00199</infon><infon key="pub-id_pmid">33012152</infon><infon key="section_type">REF</infon><infon key="source">Radiat Oncol J</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2020</infon><offset>32396</offset><text>Running of high patient volume radiation oncology department during Covid-19 crisis in India: our institutional strategy</text></passage><passage><infon key="fpage">617302</infon><infon key="name_0">surname:Iorio;given-names:GC</infon><infon key="name_1">surname:Ricardi;given-names:U</infon><infon key="name_2">surname:Dal Pra;given-names:A</infon><infon key="pub-id_doi">10.3389/fonc.2020.617302</infon><infon key="pub-id_pmid">33312960</infon><infon key="section_type">REF</infon><infon key="source">Front Oncol</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>32517</offset><text>Radiation-induced lymphopenia beyond the Covid-19 pandemic</text></passage><passage><infon key="fpage">103402</infon><infon key="name_0">surname:Siavashpour;given-names:Z</infon><infon key="name_1">surname:Goharpey;given-names:N</infon><infon key="name_2">surname:Mobasheri;given-names:M</infon><infon key="pub-id_doi">10.1016/j.critrevonc.2021.103402</infon><infon key="pub-id_pmid">34214608</infon><infon key="section_type">REF</infon><infon key="source">Crit Rev Oncol Hematol</infon><infon key="type">ref</infon><infon key="volume">164</infon><infon key="year">2021</infon><offset>32576</offset><text>Radiotherapy based management during Covid-19 pandemic—a systematic review of presented consensus and guidelines</text></passage><passage><infon key="fpage">1144</infon><infon key="name_0">surname:Kochbati;given-names:L</infon><infon key="name_1">surname:Vanderpuye;given-names:V</infon><infon key="name_2">surname:Moujahed;given-names:R</infon><infon key="pub-id_doi">10.3332/ecancer.2020.1144</infon><infon key="pub-id_pmid">33343703</infon><infon key="section_type">REF</infon><infon key="source">Ecancermedicalscience</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2020</infon><offset>32691</offset><text>Cancer care and Covid-19: tailoring recommendations for the African radiation oncology context</text></passage><passage><infon key="fpage">556334</infon><infon key="name_0">surname:Sun;given-names:R</infon><infon key="name_1">surname:Ammari;given-names:S</infon><infon key="name_2">surname:Bockel;given-names:S</infon><infon key="pub-id_doi">10.3389/fonc.2020.556334</infon><infon key="pub-id_pmid">33312944</infon><infon key="section_type">REF</infon><infon key="source">Front Oncol</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>32786</offset><text>Optimization of patient management during the Covid-19 pandemic: chest CT scan and PCR as gatekeepers of the radiation therapy workflow</text></passage><passage><infon key="fpage">23</infon><infon key="lpage">26</infon><infon key="name_0">surname:Price;given-names:P</infon><infon key="name_1">surname:Fleurent;given-names:B</infon><infon key="name_2">surname:Barney;given-names:SE</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2021.04.010</infon><infon key="pub-id_pmid">34348109</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">111</infon><infon key="year">2021</infon><offset>32922</offset><text>The role of the global coalition for radiotherapy in political advocacy for radiation therapy as a cost-effective and underfunded modality around the world</text></passage><passage><infon key="fpage">7292</infon><infon key="lpage">7296</infon><infon key="name_0">surname:Abuhijla;given-names:F</infon><infon key="name_1">surname:Abuhijlih;given-names:R</infon><infon key="name_2">surname:Mohamad;given-names:I</infon><infon key="pub-id_doi">10.12998/wjcc.v9.i25.7292</infon><infon key="pub-id_pmid">34616794</infon><infon key="section_type">REF</infon><infon key="source">World J Clin Cases</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2021</infon><offset>33078</offset><text>Radiation oncology practice during Covid-19 pandemic in developing countries</text></passage><passage><infon key="fpage">189</infon><infon key="lpage">193</infon><infon key="name_0">surname:Tey;given-names:J</infon><infon key="name_1">surname:Ho;given-names:S</infon><infon key="name_2">surname:Choo;given-names:BA</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.03.030</infon><infon key="pub-id_pmid">32342873</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>33155</offset><text>Navigating the challenges of the Covid-19 outbreak: perspectives from the radiation oncology service in Singapore</text></passage><passage><infon key="fpage">e312</infon><infon key="lpage">e314</infon><infon key="name_0">surname:Amaoui;given-names:B</infon><infon key="name_1">surname:Semghouli;given-names:S</infon><infon key="name_2">surname:Benjaafar;given-names:N</infon><infon key="pub-id_doi">10.1016/j.radi.2020.06.008</infon><infon key="pub-id_pmid">32586678</infon><infon key="section_type">REF</infon><infon key="source">Radiography (Lond)</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2020</infon><offset>33269</offset><text>Organization of a radiotherapy service during the Covid-19 epidemic: experience of regional center of oncology of Agadir, Morocco</text></passage><passage><infon key="fpage">267</infon><infon key="lpage">269</infon><infon key="name_0">surname:Suárez-Gironzini;given-names:V</infon><infon key="name_1">surname:Moreno-Olmedo;given-names:E</infon><infon key="name_2">surname:Pérez;given-names:M</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.041</infon><infon key="pub-id_pmid">32479777</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>33399</offset><text>Spanish risk management framework across 17 radiation oncology centers during Covid-19 pandemic</text></passage><passage><infon key="fpage">243</infon><infon key="lpage">244</infon><infon key="name_0">surname:Bi;given-names:N</infon><infon key="name_1">surname:Yi;given-names:J</infon><infon key="name_2">surname:Dai;given-names:J</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.031</infon><infon key="pub-id_pmid">32479778</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>33495</offset><text>Managing a radiotherapy center safely and efficiently using risk-adaptive strategies during coronavirus disease pandemic: experience from national cancer center of China</text></passage><passage><infon key="fpage">421</infon><infon key="lpage">429</infon><infon key="name_0">surname:Zhang;given-names:H</infon><infon key="name_1">surname:Cha;given-names:EE</infon><infon key="name_2">surname:Lynch;given-names:K</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.07.007</infon><infon key="pub-id_pmid">32890525</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>33665</offset><text>Radiation oncologist perceptions of telemedicine from consultation to treatment planning: a mixed-methods study</text></passage><passage><infon key="fpage">E1287</infon><infon key="name_0">surname:Nguyen;given-names:NP</infon><infon key="name_1">surname:Vinh-Hung;given-names:V</infon><infon key="name_2">surname:Baumert;given-names:B</infon><infon key="pub-id_doi">10.3390/cancers12051287</infon><infon key="pub-id_pmid">32438703</infon><infon key="section_type">REF</infon><infon key="source">Cancers (Basel)</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2020</infon><offset>33777</offset><text>Older cancer patients during the Covid-19 epidemic: practice proposal of the international geriatric radiotherapy group</text></passage><passage><infon key="fpage">79</infon><infon key="lpage">85</infon><infon key="name_0">surname:Jensen;given-names:K</infon><infon key="name_1">surname:Dalby;given-names:RB</infon><infon key="name_2">surname:Bouchelouche;given-names:K</infon><infon key="pub-id_doi">10.1053/j.semnuclmed.2021.06.002</infon><infon key="pub-id_pmid">34217435</infon><infon key="section_type">REF</infon><infon key="source">Semin Nucl Med</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">2022</infon><offset>33897</offset><text>Telehealth in multidisciplinary target delineation for radiotherapy during the Covid-19 pandemic. a review and a case</text></passage><passage><infon key="fpage">486</infon><infon key="lpage">488</infon><infon key="name_0">surname:Hall;given-names:E</infon><infon key="name_1">surname:Lewis;given-names:R</infon><infon key="name_2">surname:Snowdon;given-names:C</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.07.004</infon><infon key="pub-id_pmid">32890540</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>34015</offset><text>Life after Covid-19 for cancer clinical trials</text></passage><passage><infon key="fpage">379</infon><infon key="lpage">389</infon><infon key="name_0">surname:Thomson;given-names:DJ</infon><infon key="name_1">surname:Yom;given-names:SS</infon><infon key="name_2">surname:Saeed;given-names:H</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.06.054</infon><infon key="pub-id_pmid">32798063</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>34062</offset><text>Radiation fractionation schedules published during the Covid-19 pandemic: a systematic review of the quality of evidence and recommendations for future development</text></passage><passage><infon key="fpage">41</infon><infon key="lpage">44</infon><infon key="name_0">surname:Mukundan;given-names:H</infon><infon key="name_1">surname:Vats;given-names:P</infon><infon key="pub-id_doi">10.4103/ijc.IJC_1345_20</infon><infon key="pub-id_pmid">33762485</infon><infon key="section_type">REF</infon><infon key="source">Indian J Cancer</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">2021</infon><offset>34226</offset><text>Advances in radiotherapy in 2020: hypofractionation - less is more in times of Covid-19</text></passage><passage><infon key="fpage">e213304</infon><infon key="name_0">surname:Tabrizi;given-names:S</infon><infon key="name_1">surname:Trippa;given-names:L</infon><infon key="name_2">surname:Cagney;given-names:D</infon><infon key="pub-id_doi">10.1001/jamanetworkopen.2021.3304</infon><infon key="pub-id_pmid">33779742</infon><infon key="section_type">REF</infon><infon key="source">JAMA Netw Open</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2021</infon><offset>34314</offset><text>Assessment of simulated SARS-CoV-2 infection and mortality risk associated with radiation therapy among patients in 8 randomized clinical trials</text></passage><passage><infon key="fpage">191</infon><infon key="lpage">194</infon><infon key="name_0">surname:Portaluri;given-names:M</infon><infon key="name_1">surname:Barba;given-names:MC</infon><infon key="name_2">surname:Musio;given-names:D</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.06.036</infon><infon key="pub-id_pmid">32621832</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">2020</infon><offset>34459</offset><text>Hypofractionation in Covid-19 radiotherapy: a mix of evidence based medicine and of opportunities</text></passage><passage><infon key="fpage">1052</infon><infon key="name_0">surname:Larrea;given-names:L</infon><infon key="name_1">surname:López;given-names:E</infon><infon key="name_2">surname:Antonini;given-names:P</infon><infon key="pub-id_doi">10.3332/ecancer.2020.1052</infon><infon key="pub-id_pmid">32565905</infon><infon key="section_type">REF</infon><infon key="source">Ecancermedicalscience</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2020</infon><offset>34557</offset><text>Covid-19: hypofractionation in the radiation oncology department during the “state of alarm”: first 100 patients in a private hospital in Spain</text></passage><passage><infon key="fpage">618641</infon><infon key="name_0">surname:Swanson;given-names:W</infon><infon key="name_1">surname:Kamwa;given-names:F</infon><infon key="name_2">surname:Samba;given-names:R</infon><infon key="pub-id_doi">10.3389/fonc.2020.618641</infon><infon key="pub-id_pmid">33680940</infon><infon key="section_type">REF</infon><infon key="source">Front Oncol</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>34705</offset><text>Hypofractionated Radiotherapy in African cancer centers</text></passage><passage><infon key="fpage">761</infon><infon key="lpage">773</infon><infon key="name_0">surname:Ng;given-names:SSW</infon><infon key="name_1">surname:Ning;given-names:MS</infon><infon key="name_2">surname:Lee;given-names:P</infon><infon key="pub-id_doi">10.1016/j.adro.2020.06.011</infon><infon key="pub-id_pmid">32775790</infon><infon key="section_type">REF</infon><infon key="source">Adv Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2020</infon><offset>34761</offset><text>Single-fraction stereotactic body radiation therapy: a paradigm during the coronavirus disease 2019 (Covid-19) pandemic and beyond?</text></passage><passage><infon key="fpage">1008</infon><infon key="lpage">1011</infon><infon key="name_0">surname:Tripathi;given-names:M</infon><infon key="name_1">surname:Deora;given-names:H</infon><infon key="name_2">surname:Sadashiva;given-names:N</infon><infon key="pub-id_doi">10.4103/0028-3886.299161</infon><infon key="pub-id_pmid">33109842</infon><infon key="section_type">REF</infon><infon key="source">Neurol India</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="year">2020</infon><offset>34893</offset><text>Adaptations in radiosurgery practice during COVID crisis</text></passage><passage><infon key="fpage">259</infon><infon key="lpage">265</infon><infon key="name_0">surname:Riegel;given-names:AC</infon><infon key="name_1">surname:Chou;given-names:H</infon><infon key="name_2">surname:Baker;given-names:J</infon><infon key="pub-id_doi">10.1002/acm2.12971</infon><infon key="pub-id_pmid">32652862</infon><infon key="section_type">REF</infon><infon key="source">J Appl Clin Med Phys</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2020</infon><offset>34950</offset><text>Development and execution of a pandemic preparedness plan: therapeutic medical physics and radiation dosimetry during the Covid-19 crisis</text></passage><passage><infon key="fpage">4</infon><infon key="lpage">7</infon><infon key="name_0">surname:Knutson;given-names:NC</infon><infon key="name_1">surname:Kavanaugh;given-names:JA</infon><infon key="name_2">surname:Li;given-names:HH</infon><infon key="pub-id_doi">10.1002/acm2.13225</infon><infon key="pub-id_pmid">33742538</infon><infon key="section_type">REF</infon><infon key="source">J Appl Clin Med Phys</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2021</infon><offset>35088</offset><text>Radiation oncology physics coverage during the Covid-19 pandemic: successes and lessons learned</text></passage><passage><infon key="name_0">surname:Sezen;given-names:D</infon><infon key="name_1">surname:Selek;given-names:U</infon><infon key="name_2">surname:Akdemir;given-names:EY</infon><infon key="pub-id_doi">10.5505/tjo.2021.3328</infon><infon key="section_type">REF</infon><infon key="source">Turk J Oncol</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>35184</offset><text>Surveying the adaptations during the Covid-19 outbreak in Turkish radiotherapy practice</text></passage><passage><infon key="fpage">140</infon><infon key="lpage">142</infon><infon key="name_0">surname:Mummudi;given-names:N</infon><infon key="name_1">surname:Ghosh-Laskar;given-names:S</infon><infon key="name_2">surname:Tibdewal;given-names:A</infon><infon key="name_3">surname:Agarwal;given-names:JP</infon><infon key="pub-id_doi">10.4103/ijc.IJC_603_20</infon><infon key="pub-id_pmid">33762489</infon><infon key="section_type">REF</infon><infon key="source">Indian J Cancer</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">2021</infon><offset>35272</offset><text>Radiotherapy practice during the Covid-19 pandemic and nation-wide lockdown: the Indian scenario</text></passage><passage><infon key="fpage">120</infon><infon key="lpage">122</infon><infon key="name_0">surname:Jereczek-Fossa;given-names:BA</infon><infon key="name_1">surname:Pepa;given-names:M</infon><infon key="name_2">surname:Zaffaroni;given-names:M</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.09.049</infon><infon key="pub-id_pmid">33065185</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">155</infon><infon key="year">2021</infon><offset>35369</offset><text>Covid-19 safe and fully operational radiotherapy: an AIRO survey depicting the Italian landscape at the dawn of phase 2</text></passage><passage><infon key="fpage">e13288</infon><infon key="name_0">surname:Wei;given-names:S</infon><infon key="name_1">surname:Wang;given-names:J</infon><infon key="pub-id_doi">10.1111/ecc.13288</infon><infon key="pub-id_pmid">32991057</infon><infon key="section_type">REF</infon><infon key="source">Eur J Cancer Care (Engl)</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2020</infon><offset>35489</offset><text>How to manage tumor radiotherapy during Covid-19 pandemic?</text></passage><passage><infon key="fpage">e88</infon><infon key="name_0">surname:Ashcroft;given-names:S</infon><infon key="name_1">surname:Meeking;given-names:K</infon><infon key="name_2">surname:Price;given-names:P</infon><infon key="pub-id_doi">10.1016/j.clon.2020.08.005</infon><infon key="pub-id_pmid">32900587</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2021</infon><offset>35548</offset><text>Flash survey on the effect of Covid-19 on radiotherapy services in the UK - the benefit of social media for rapid information gathering for the radiotherapy community and government</text></passage><passage><infon key="fpage">353</infon><infon key="lpage">354</infon><infon key="name_0">surname:Franzin;given-names:A</infon><infon key="name_1">surname:Spatola;given-names:G</infon><infon key="name_2">surname:Giudice;given-names:L</infon><infon key="pub-id_doi">10.1080/02688697.2020.1758297</infon><infon key="pub-id_pmid">32347128</infon><infon key="section_type">REF</infon><infon key="source">Br J Neurosurg</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2020</infon><offset>35730</offset><text>Maintaining stereotactic radio surgical treatments during Covid-19 outbreak: the case of the gamma knife unit in Brescia - Italy</text></passage><passage><infon key="fpage">e28463</infon><infon key="name_0">surname:Vagelli;given-names:G</infon><infon key="name_1">surname:Garrè;given-names:ML</infon><infon key="name_2">surname:Garaventa;given-names:A</infon><infon key="pub-id_doi">10.1002/pbc.28463</infon><infon key="pub-id_pmid">32543005</infon><infon key="section_type">REF</infon><infon key="source">Pediatr Blood Cancer</infon><infon key="type">ref</infon><infon key="volume">67</infon><infon key="year">2020</infon><offset>35859</offset><text>Specific pathways to prevent SARS-CoV-2 infection in case of repeated hospital admissions for radiotherapy</text></passage><passage><infon key="fpage">223</infon><infon key="lpage">229</infon><infon key="name_0">surname:Guckenberger;given-names:M</infon><infon key="name_1">surname:Belka;given-names:C</infon><infon key="name_2">surname:Bezjak;given-names:A</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.001</infon><infon key="pub-id_pmid">32342863</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">146</infon><infon key="year">2020</infon><offset>35966</offset><text>Practice recommendations for lung cancer radiotherapy during the Covid-19 pandemic: an ESTRO-ASTRO consensus statement</text></passage><passage><infon key="fpage">230</infon><infon key="lpage">235</infon><infon key="name_0">surname:Liao;given-names:Z</infon><infon key="name_1">surname:Rivin Del Campo;given-names:E</infon><infon key="name_2">surname:Salem;given-names:A</infon><infon key="pub-id_doi">10.1016/j.lungcan.2020.05.029</infon><infon key="pub-id_pmid">32585497</infon><infon key="section_type">REF</infon><infon key="source">Lung Cancer</infon><infon key="type">ref</infon><infon key="volume">146</infon><infon key="year">2020</infon><offset>36085</offset><text>Optimizing lung cancer radiation treatment worldwide in Covid-19 outbreak</text></passage><passage><infon key="fpage">481</infon><infon key="lpage">489</infon><infon key="name_0">surname:Faivre-Finn;given-names:C</infon><infon key="name_1">surname:Fenwick;given-names:JD</infon><infon key="name_2">surname:Franks;given-names:KN</infon><infon key="pub-id_doi">10.1016/j.clon.2020.05.001</infon><infon key="pub-id_pmid">32405158</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>36159</offset><text>Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the Covid-19 pandemic</text></passage><passage><infon key="fpage">925</infon><infon key="lpage">929</infon><infon key="name_0">surname:Mayne;given-names:NR</infon><infon key="name_1">surname:Lin;given-names:BK</infon><infon key="name_2">surname:Darling;given-names:AJ</infon><infon key="pub-id_doi">10.1097/SLA.0000000000004363</infon><infon key="pub-id_pmid">33074904</infon><infon key="section_type">REF</infon><infon key="source">Ann Surg</infon><infon key="type">ref</infon><infon key="volume">272</infon><infon key="year">2020</infon><offset>36276</offset><text>Stereotactic body radiotherapy versus delayed surgery for early-stage non-small-cell lung cancer</text></passage><passage><infon key="fpage">510</infon><infon key="lpage">527</infon><infon key="name_0">surname:Couñago;given-names:F</infon><infon key="name_1">surname:Navarro-Martin;given-names:A</infon><infon key="name_2">surname:Luna;given-names:J</infon><infon key="pub-id_doi">10.5306/wjco.v11.i8.510</infon><infon key="pub-id_pmid">32879841</infon><infon key="section_type">REF</infon><infon key="source">World J Clin Oncol</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2020</infon><offset>36373</offset><text>GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the Covid-19 pandemic</text></passage><passage><infon key="fpage">19</infon><infon key="lpage">27</infon><infon key="name_0">surname:Banfill;given-names:K</infon><infon key="name_1">surname:Croxford;given-names:W</infon><infon key="name_2">surname:Fornacon-Wood;given-names:I</infon><infon key="pub-id_doi">10.1016/j.clon.2021.10.009</infon><infon key="pub-id_pmid">34763964</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2022</infon><offset>36467</offset><text>Changes in the management of patients having radical radiotherapy for lung cancer during the first wave of the Covid-19 pandemic in the UK</text></passage><passage><infon key="fpage">e15598</infon><infon key="name_0">surname:Mou;given-names:B</infon><infon key="name_1">surname:Hyde;given-names:D</infon><infon key="name_2">surname:Araujo;given-names:C</infon><infon key="pub-id_doi">10.7759/cureus.15598</infon><infon key="pub-id_pmid">34277219</infon><infon key="section_type">REF</infon><infon key="source">Cureus</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>36606</offset><text>Implementation of single-fraction lung stereotactic ablative radiotherapy in a multicenter provincial cancer program during the Covid-19 pandemic</text></passage><passage><infon key="fpage">580189</infon><infon key="name_0">surname:Kidane;given-names:B</infon><infon key="name_1">surname:Spicer;given-names:J</infon><infon key="name_2">surname:Kim;given-names:JO</infon><infon key="pub-id_doi">10.3389/fonc.2020.580189</infon><infon key="pub-id_pmid">33072612</infon><infon key="section_type">REF</infon><infon key="source">Front Oncol</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>36752</offset><text>SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG cancer or OligomEts during the Covid-19 pandemic</text></passage><passage><infon key="fpage">1174</infon><infon key="lpage">1176</infon><infon key="name_0">surname:Borghetti;given-names:P</infon><infon key="name_1">surname:Toraci;given-names:C</infon><infon key="name_2">surname:Imbrescia;given-names:J</infon><infon key="pub-id_doi">10.1007/s12149-021-01662-z</infon><infon key="pub-id_pmid">34322785</infon><infon key="section_type">REF</infon><infon key="source">Ann Nucl Med</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2021</infon><offset>36902</offset><text>The potential role of SPECT/CT in the clinical management of Covid-19 lung cancer patients undergoing radiotherapy</text></passage><passage><infon key="fpage">229</infon><infon key="lpage">230</infon><infon key="name_0">surname:Magrini;given-names:SM</infon><infon key="name_1">surname:Borghetti;given-names:P</infon><infon key="name_2">surname:Filippi;given-names:AR</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.034</infon><infon key="pub-id_pmid">32342875</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">2020</infon><offset>37017</offset><text>Letter to the editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during Covid-19 pandemic</text></passage><passage><infon key="fpage">227</infon><infon key="lpage">228</infon><infon key="name_0">surname:Troost;given-names:EGC</infon><infon key="name_1">surname:Nestle;given-names:U</infon><infon key="name_2">surname:Putora;given-names:PM</infon><infon key="name_3">surname:Bussink;given-names:J</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.030</infon><infon key="pub-id_pmid">32342862</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">2020</infon><offset>37124</offset><text>Practice recommendations for lung cancer radiotherapy during the Covid-19 pandemic: an ESTRO-ASTRO consensus statement</text></passage><passage><infon key="fpage">1829</infon><infon key="lpage">1832</infon><infon key="name_0">surname:Yahalom;given-names:J</infon><infon key="name_1">surname:Dabaja;given-names:BS</infon><infon key="name_2">surname:Ricardi;given-names:U</infon><infon key="pub-id_doi">10.1182/blood.2020006028</infon><infon key="pub-id_pmid">32275740</infon><infon key="section_type">REF</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="volume">135</infon><infon key="year">2020</infon><offset>37243</offset><text>ILROG emergency guidelines for radiation therapy of hematological malignancies during the Covid-19 pandemic</text></passage><passage><infon key="fpage">3426</infon><infon key="lpage">3437</infon><infon key="name_0">surname:Huang;given-names:SH</infon><infon key="name_1">surname:O’Sullivan;given-names:B</infon><infon key="name_2">surname:Su;given-names:J</infon><infon key="pub-id_doi">10.1002/cncr.32968</infon><infon key="pub-id_pmid">32478895</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2020</infon><offset>37351</offset><text>Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the Covid-19 pandemic: the Princess Margaret experience and proposal</text></passage><passage><infon key="fpage">1482</infon><infon key="lpage">1490</infon><infon key="name_0">surname:Alterio;given-names:D</infon><infon key="name_1">surname:Volpe;given-names:S</infon><infon key="name_2">surname:Marvaso;given-names:G</infon><infon key="pub-id_doi">10.1002/hed.26319</infon><infon key="pub-id_pmid">32557972</infon><infon key="section_type">REF</infon><infon key="source">Head Neck</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="year">2020</infon><offset>37513</offset><text>Head and neck cancer radiotherapy amid Covid-19 pandemic: report from Milan, Italy</text></passage><passage><infon key="fpage">343</infon><infon key="lpage">347</infon><infon key="name_0">surname:De Felice;given-names:F</infon><infon key="name_1">surname:D’Angelo;given-names:E</infon><infon key="name_2">surname:Ingargiola;given-names:R</infon><infon key="pub-id_doi">10.1007/s11547-020-01296-7</infon><infon key="pub-id_pmid">33025304</infon><infon key="section_type">REF</infon><infon key="source">Radiol Med</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2021</infon><offset>37596</offset><text>A snapshot on radiotherapy for head and neck cancer patients during the Covid-19 pandemic: a survey of the Italian association of radiotherapy and clinical oncology (AIRO) head and neck working group</text></passage><passage><infon key="fpage">85</infon><infon key="name_0">surname:Alterio;given-names:D</infon><infon key="name_1">surname:Volpe;given-names:S</infon><infon key="name_2">surname:Bacigalupo;given-names:A</infon><infon key="pub-id_doi">10.1007/s12032-020-01409-2</infon><infon key="pub-id_pmid">32808089</infon><infon key="section_type">REF</infon><infon key="source">Med Oncol</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2020</infon><offset>37796</offset><text>Head and neck radiotherapy amid the Covid-19 pandemic: practice recommendations of the Italian association of radiotherapy and clinical oncology (AIRO)</text></passage><passage><infon key="fpage">105045</infon><infon key="name_0">surname:Gupta;given-names:T</infon><infon key="name_1">surname:Ghosh-Laskar;given-names:S</infon><infon key="name_2">surname:Agarwal;given-names:JP</infon><infon key="pub-id_doi">10.1016/j.oraloncology.2020.105045</infon><infon key="pub-id_pmid">33091846</infon><infon key="section_type">REF</infon><infon key="source">Oral Oncol</infon><infon key="type">ref</infon><infon key="volume">111</infon><infon key="year">2020</infon><offset>37948</offset><text>Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era</text></passage><passage><infon key="fpage">4092</infon><infon key="lpage">4104</infon><infon key="name_0">surname:Kang;given-names:JJ</infon><infon key="name_1">surname:Wong;given-names:RJ</infon><infon key="name_2">surname:Sherman;given-names:EJ</infon><infon key="pub-id_doi">10.1002/cncr.33031</infon><infon key="pub-id_pmid">32639615</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2020</infon><offset>38096</offset><text>The 3 Bs of cancer care amid the Covid-19 pandemic crisis: “be safe, be smart, be kind”-a multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer</text></passage><passage><infon key="fpage">1533033820974021</infon><infon key="name_0">surname:Ding;given-names:Y</infon><infon key="name_1">surname:Ma;given-names:P</infon><infon key="name_2">surname:Li;given-names:W</infon><infon key="pub-id_doi">10.1177/1533033820974021</infon><infon key="pub-id_pmid">33327884</infon><infon key="section_type">REF</infon><infon key="source">Technol Cancer Res Treat</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2020</infon><offset>38301</offset><text>Effect of surgical mask on setup error in head and neck radiotherapy</text></passage><passage><infon key="fpage">651</infon><infon key="lpage">655</infon><infon key="name_0">surname:Yanagihara;given-names:TK</infon><infon key="name_1">surname:Holland;given-names:RE</infon><infon key="name_2">surname:Chera;given-names:B</infon><infon key="pub-id_doi">10.1016/j.adro.2020.05.010</infon><infon key="pub-id_pmid">32775776</infon><infon key="section_type">REF</infon><infon key="source">Adv Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2020</infon><offset>38370</offset><text>Practical Challenges of mask-to-mask encounters with patients with head and neck cancers amid the coronavirus disease 2019 pandemic</text></passage><passage><infon key="fpage">869</infon><infon key="lpage">873</infon><infon key="name_0">surname:Wang;given-names:Y-M</infon><infon key="name_1">surname:Hsieh;given-names:Y-W</infon><infon key="name_2">surname:Huang;given-names:B-S</infon><infon key="pub-id_doi">10.2147/RMHP.S286404</infon><infon key="pub-id_pmid">33688283</infon><infon key="section_type">REF</infon><infon key="source">Risk Manag Healthc Policy</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2021</infon><offset>38502</offset><text>Medical mask wearing during treatment for patients undergoing radiotherapy in Covid-19 pandemic - an experience of protocol setup and dosimetric evaluation for particle/proton beam therapy</text></passage><passage><infon key="fpage">223</infon><infon key="lpage">224</infon><infon key="name_0">surname:Rocha;given-names:BA</infon><infon key="name_1">surname:Mendes;given-names:PA</infon><infon key="name_2">surname:Lima;given-names:LMC</infon><infon key="pub-id_doi">10.1016/j.jormas.2020.07.009</infon><infon key="pub-id_pmid">32777309</infon><infon key="section_type">REF</infon><infon key="source">J Stomatol Oral Maxillofac Surg</infon><infon key="type">ref</infon><infon key="volume">122</infon><infon key="year">2021</infon><offset>38691</offset><text>Why it is crucial to maintain oral care for patients undergoing head and neck radiotherapy during the Covid-19 pandemic</text></passage><passage><infon key="fpage">1630</infon><infon key="lpage">1632</infon><infon key="name_0">surname:Dee;given-names:EC</infon><infon key="name_1">surname:Mahal;given-names:BA</infon><infon key="name_2">surname:Arega;given-names:MA</infon><infon key="pub-id_doi">10.1001/jamaoncol.2020.3545</infon><infon key="pub-id_pmid">32789489</infon><infon key="section_type">REF</infon><infon key="source">JAMA Oncol</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2020</infon><offset>38811</offset><text>Relative timing of radiotherapy and androgen deprivation for prostate cancer and implications for treatment during the Covid-19 pandemic</text></passage><passage><infon key="fpage">100331</infon><infon key="name_0">surname:Detti;given-names:B</infon><infon key="name_1">surname:Ingrosso;given-names:G</infon><infon key="name_2">surname:Becherini;given-names:C</infon><infon key="pub-id_doi">10.1016/j.ctarc.2021.100331</infon><infon key="pub-id_pmid">33581491</infon><infon key="section_type">REF</infon><infon key="source">Cancer Treat Res Commun</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>38948</offset><text>Management of prostate cancer radiotherapy during the Covid-19 pandemic: a necessary paradigm change</text></passage><passage><infon key="fpage">26</infon><infon key="lpage">32</infon><infon key="name_0">surname:Zaorsky;given-names:NG</infon><infon key="name_1">surname:Yu;given-names:JB</infon><infon key="name_2">surname:McBride;given-names:SM</infon><infon key="pub-id_doi">10.1016/j.adro.2020.10.003</infon><infon key="pub-id_pmid">33145460</infon><infon key="section_type">REF</infon><infon key="source">Adv Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2020</infon><offset>39049</offset><text>Prostate cancer radiation therapy recommendations in response to Covid-19</text></passage><passage><infon key="fpage">142</infon><infon key="lpage">146</infon><infon key="name_0">surname:Barra;given-names:S</infon><infon key="name_1">surname:Guarnieri;given-names:A</infon><infon key="name_2">surname:di Monale;given-names:E</infon><infon key="name_3">surname:Bastia;given-names:MB</infon><infon key="pub-id_doi">10.1007/s11547-020-01216-9</infon><infon key="pub-id_pmid">32415472</infon><infon key="section_type">REF</infon><infon key="source">Radiol Med</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2021</infon><offset>39123</offset><text>Short fractionation radiotherapy for early prostate cancer in the time of Covid-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice</text></passage><passage><infon key="fpage">390</infon><infon key="lpage">393</infon><infon key="name_0">surname:Ling;given-names:DC</infon><infon key="name_1">surname:Vargo;given-names:JA</infon><infon key="name_2">surname:Beriwal;given-names:S</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.06.049</infon><infon key="pub-id_pmid">32890517</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>39316</offset><text>Breast, prostate, and rectal cancer: should 5–5-5 be a new standard of care?</text></passage><passage><infon key="fpage">274</infon><infon key="lpage">275</infon><infon key="name_0">surname:Murakami;given-names:N</infon><infon key="name_1">surname:Nakamura;given-names:S</infon><infon key="name_2">surname:Kashihara;given-names:T</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.11.015</infon><infon key="pub-id_pmid">33227353</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">154</infon><infon key="year">2021</infon><offset>39395</offset><text>Increased number of prostate cancer patients selecting high dose-rate interstitial brachytherapy during the Covid-19 pandemic</text></passage><passage><infon key="fpage">e1320</infon><infon key="name_0">surname:Lewis;given-names:S</infon><infon key="name_1">surname:Talapatra;given-names:K</infon><infon key="pub-id_doi">10.1002/cnr2.1320</infon><infon key="pub-id_pmid">33295140</infon><infon key="section_type">REF</infon><infon key="source">Cancer Rep (Hoboken)</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2021</infon><offset>39521</offset><text>Radiotherapy management of rectal cancer in the backdrop of the COVID pandemic</text></passage><passage><infon key="fpage">194</infon><infon key="lpage">200</infon><infon key="name_0">surname:Tchelebi;given-names:LT</infon><infon key="name_1">surname:Haustermans;given-names:K</infon><infon key="name_2">surname:Scorsetti;given-names:M</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.010</infon><infon key="pub-id_pmid">32342878</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>39600</offset><text>Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of Covid-19</text></passage><passage><infon key="fpage">3780</infon><infon key="lpage">3789</infon><infon key="name_0">surname:Inchingolo;given-names:R</infon><infon key="name_1">surname:Acquafredda;given-names:F</infon><infon key="name_2">surname:Tedeschi;given-names:M</infon><infon key="pub-id_doi">10.3748/wjg.v27.i25.3780</infon><infon key="pub-id_pmid">34321843</infon><infon key="section_type">REF</infon><infon key="source">World J Gastroenterol</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>39728</offset><text>Worldwide management of hepatocellular carcinoma during the Covid-19 pandemic</text></passage><passage><infon key="fpage">e15</infon><infon key="lpage">e16</infon><infon key="name_0">surname:Cellini;given-names:F</infon><infon key="name_1">surname:Gambacorta;given-names:MA</infon><infon key="name_2">surname:Mattiucci;given-names:GC</infon><infon key="name_3">surname:Valentini;given-names:V</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.07.005</infon><infon key="pub-id_pmid">32673776</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">154</infon><infon key="year">2021</infon><offset>39806</offset><text>Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of Covid-19 and beyond</text></passage><passage><infon key="fpage">e17</infon><infon key="name_0">surname:Tchelebi;given-names:LT</infon><infon key="name_1">surname:Goodman;given-names:K</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.07.011</infon><infon key="pub-id_pmid">32673775</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">154</infon><infon key="year">2021</infon><offset>39938</offset><text>Response to, “Role of neoadjuvant radiochemotherapy for esophageal cancers over pre/peri-operative chemotherapy in the era of Covid-19 and beyond”</text></passage><passage><infon key="fpage">213</infon><infon key="lpage">215</infon><infon key="name_0">surname:Marijnen;given-names:CAM</infon><infon key="name_1">surname:Peters;given-names:FP</infon><infon key="name_2">surname:Rödel;given-names:C</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.03.039</infon><infon key="pub-id_pmid">32342861</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>40089</offset><text>International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic</text></passage><passage><infon key="fpage">e1249</infon><infon key="lpage">e1250</infon><infon key="name_0">surname:Scorsetti;given-names:M</infon><infon key="name_1">surname:Goodman;given-names:KA</infon><infon key="name_2">surname:Seong;given-names:J</infon><infon key="pub-id_doi">10.1634/theoncologist.2020-0416</infon><infon key="pub-id_pmid">32525607</infon><infon key="section_type">REF</infon><infon key="source">Oncologist</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2020</infon><offset>40218</offset><text>Hepatocellular carcinoma in the Covid-19 era: primetime for stereotactic body radiotherapy and a lesson for the future?</text></passage><passage><infon key="fpage">104801</infon><infon key="name_0">surname:Denaro;given-names:N</infon><infon key="name_1">surname:Merlotti;given-names:AM</infon><infon key="name_2">surname:Merlano;given-names:MC</infon><infon key="name_3">surname:Russi;given-names:E</infon><infon key="pub-id_doi">10.1016/j.oraloncology.2020.104801</infon><infon key="pub-id_pmid">33616062</infon><infon key="section_type">REF</infon><infon key="source">Oral Oncol</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="year">2020</infon><offset>40338</offset><text>Coronavirus disease 19 (Covid-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)</text></passage><passage><infon key="fpage">477</infon><infon key="name_0">surname:Aitken;given-names:K</infon><infon key="name_1">surname:Good;given-names:J</infon><infon key="name_2">surname:Hawkins;given-names:M</infon><infon key="pub-id_doi">10.1016/j.clon.2020.04.012</infon><infon key="pub-id_pmid">32387045</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>40464</offset><text>Liver stereotactic ablative radiotherapy: an effective and feasible alternative to surgery during the Covid-19 pandemic</text></passage><passage><infon key="fpage">1004</infon><infon key="lpage">1005</infon><infon key="name_0">surname:Barcellini;given-names:A</infon><infon key="name_1">surname:Vitolo;given-names:V</infon><infon key="name_2">surname:Cobianchi;given-names:L</infon><infon key="pub-id_doi">10.1016/j.pan.2020.05.007</infon><infon key="pub-id_pmid">32418757</infon><infon key="section_type">REF</infon><infon key="source">Pancreatology</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2020</infon><offset>40584</offset><text>Pancreatic cancer: does a short course of carbon ion radiotherapy worth during Covid-19 outbreak?</text></passage><passage><infon key="fpage">e263</infon><infon key="name_0">surname:Mirnezami;given-names:R</infon><infon key="name_1">surname:Knowles;given-names:J</infon><infon key="name_2">surname:Kar;given-names:A</infon><infon key="name_3">surname:Glynne-Jones;given-names:R</infon><infon key="pub-id_doi">10.1002/bjs.11725</infon><infon key="pub-id_pmid">32463479</infon><infon key="section_type">REF</infon><infon key="source">Br J Surg</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="year">2020</infon><offset>40682</offset><text>Preoperative radiotherapy for locally advanced rectal cancer during and after the Covid-19 pandemic</text></passage><passage><infon key="fpage">767617</infon><infon key="name_0">surname:Li;given-names:Z</infon><infon key="name_1">surname:Li;given-names:Q</infon><infon key="name_2">surname:Wang;given-names:X</infon><infon key="pub-id_doi">10.3389/fpubh.2021.767617</infon><infon key="pub-id_pmid">34957022</infon><infon key="section_type">REF</infon><infon key="source">Front Public Health</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2021</infon><offset>40782</offset><text>Carbon ion radiotherapy acts as the optimal treatment strategy for unresectable liver cancer during the coronavirus disease 2019 crisis</text></passage><passage><infon key="fpage">417</infon><infon key="lpage">419</infon><infon key="name_0">surname:Rembielak;given-names:A</infon><infon key="name_1">surname:Sykes;given-names:AJ</infon><infon key="name_2">surname:Fife;given-names:K</infon><infon key="pub-id_doi">10.1016/j.clon.2020.04.014</infon><infon key="pub-id_pmid">32418675</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>40918</offset><text>Radiotherapy and systemic treatment for non-melanoma skin cancer in the Covid-19 pandemic</text></passage><passage><infon key="fpage">3900</infon><infon key="lpage">3906</infon><infon key="name_0">surname:Baumann;given-names:BC</infon><infon key="name_1">surname:MacArthur;given-names:KM</infon><infon key="name_2">surname:Brewer;given-names:JD</infon><infon key="pub-id_doi">10.1002/cncr.32969</infon><infon key="pub-id_pmid">32478867</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2020</infon><offset>41008</offset><text>Management of primary skin cancer during a pandemic: multidisciplinary recommendations</text></passage><passage><infon key="fpage">591</infon><infon key="lpage">594</infon><infon key="name_0">surname:Veness;given-names:MJ</infon><infon key="pub-id_doi">10.1111/1754-9485.13070</infon><infon key="pub-id_pmid">32460421</infon><infon key="section_type">REF</infon><infon key="source">J Med Imaging Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="year">2020</infon><offset>41095</offset><text>Hypofractionated radiotherapy in patients with non-melanoma skin cancer in the post Covid-19 era: time to reconsider its role for most patients</text></passage><passage><infon key="name_0">surname:Lancellotta;given-names:V</infon><infon key="name_1">surname:D’Aviero;given-names:A</infon><infon key="name_2">surname:Fionda;given-names:B</infon><infon key="pub-id_doi">10.1111/dth.15276</infon><infon key="section_type">REF</infon><infon key="source">Dermatol Ther</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>41239</offset><text>Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during Covid-19 pandemic</text></passage><passage><infon key="name_0">surname:Spigariolo;given-names:CB</infon><infon key="name_1">surname:Piccinno;given-names:R</infon><infon key="pub-id_doi">10.1111/phpp.12762</infon><infon key="section_type">REF</infon><infon key="source">Photodermatol Photoimmunol Photomed</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>41353</offset><text>Phototherapy and dermatologic radiotherapy during the Covid-19 emergency: the experience from the frontline of Milan</text></passage><passage><infon key="fpage">1130</infon><infon key="lpage">1135</infon><infon key="name_0">surname:Palumbo;given-names:I</infon><infon key="name_1">surname:Borghesi;given-names:S</infon><infon key="name_2">surname:Gregucci;given-names:F</infon><infon key="pub-id_doi">10.1016/j.jgo.2021.05.008</infon><infon key="pub-id_pmid">34020908</infon><infon key="section_type">REF</infon><infon key="source">J Geriatr Oncol</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2021</infon><offset>41470</offset><text>Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: a literature review (on the behalf of Italian association of radiotherapy and clinical oncology)</text></passage><passage><infon key="fpage">722</infon><infon key="lpage">726</infon><infon key="name_0">surname:Grellier;given-names:N</infon><infon key="name_1">surname:Hadhri;given-names:A</infon><infon key="name_2">surname:Bendavid;given-names:J</infon><infon key="pub-id_doi">10.1016/j.adro.2020.04.033</infon><infon key="pub-id_pmid">32775782</infon><infon key="section_type">REF</infon><infon key="source">Adv Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2020</infon><offset>41680</offset><text>Regional lymph node irradiation in breast cancer may worsen lung damage in coronavirus disease 2019 positive patients</text></passage><passage><infon key="fpage">e166</infon><infon key="lpage">e171</infon><infon key="name_0">surname:Machiels;given-names:M</infon><infon key="name_1">surname:Weytjens;given-names:R</infon><infon key="name_2">surname:Bauwens;given-names:W</infon><infon key="pub-id_doi">10.1016/j.clon.2020.11.027</infon><infon key="pub-id_pmid">33309183</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2021</infon><offset>41798</offset><text>Accelerated adaptation of ultrahypofractionated radiation therapy for breast cancer at the time of the Covid-19 Pandemic</text></passage><passage><infon key="fpage">e221</infon><infon key="name_0">surname:Hanumanthappa;given-names:N</infon><infon key="name_1">surname:Goldsmith;given-names:C</infon><infon key="name_2">surname:Sawyer;given-names:E</infon><infon key="pub-id_doi">10.1016/j.clon.2020.12.013</infon><infon key="pub-id_pmid">33388225</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2021</infon><offset>41919</offset><text>Adjuvant breast radiotherapy at an academic center during the Covid-19 pandemic: reassuringly safe</text></passage><passage><infon key="fpage">2694</infon><infon key="lpage">2695</infon><infon key="name_0">surname:Montagna;given-names:E</infon><infon key="name_1">surname:Bellerba;given-names:F</infon><infon key="name_2">surname:Sangalli;given-names:C</infon><infon key="pub-id_doi">10.1016/j.ejso.2021.05.037</infon><infon key="pub-id_pmid">34116901</infon><infon key="section_type">REF</infon><infon key="source">Eur J Surg Oncol</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="year">2021</infon><offset>42018</offset><text>Management of breast cancer patients during the peak of the COVID 19 pandemic</text></passage><passage><infon key="fpage">993</infon><infon key="name_0">surname:Spałek;given-names:MJ</infon><infon key="name_1">surname:Rutkowski;given-names:P</infon><infon key="pub-id_doi">10.3389/fonc.2020.00993</infon><infon key="pub-id_pmid">32582558</infon><infon key="section_type">REF</infon><infon key="source">Front Oncol</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>42096</offset><text>Coronavirus disease (Covid-19) outbreak: hypofractionated radiotherapy in soft tissue sarcomas as a valuable option in the environment of limited medical resources and demands for increased protection of patients</text></passage><passage><infon key="fpage">244</infon><infon key="lpage">253</infon><infon key="name_0">surname:Elledge;given-names:CR</infon><infon key="name_1">surname:Beriwal;given-names:S</infon><infon key="name_2">surname:Chargari;given-names:C</infon><infon key="pub-id_doi">10.1016/j.ygyno.2020.06.486</infon><infon key="pub-id_pmid">32563593</infon><infon key="section_type">REF</infon><infon key="source">Gynecol Oncol</infon><infon key="type">ref</infon><infon key="volume">158</infon><infon key="year">2020</infon><offset>42309</offset><text>Radiation therapy for gynecologic malignancies during the Covid-19 pandemic: International expert consensus recommendations</text></passage><passage><infon key="fpage">117</infon><infon key="lpage">120</infon><infon key="name_0">surname:Matsuo;given-names:K</infon><infon key="name_1">surname:Shimada;given-names:M</infon><infon key="name_2">surname:Matsuzaki;given-names:S</infon><infon key="pub-id_doi">10.1016/j.ejca.2021.02.013</infon><infon key="pub-id_pmid">33743479</infon><infon key="section_type">REF</infon><infon key="source">Eur J Cancer</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2021</infon><offset>42433</offset><text>Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: a treatment implication during the coronavirus pandemic</text></passage><passage><infon key="fpage">73</infon><infon key="lpage">77</infon><infon key="name_0">surname:Vavassori;given-names:A</infon><infon key="name_1">surname:Tagliaferri;given-names:L</infon><infon key="name_2">surname:Vicenzi;given-names:L</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.040</infon><infon key="pub-id_pmid">32389752</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>42579</offset><text>Practical indications for management of patients candidate to interventional and intraoperative radiotherapy (brachytherapy, IORT) during Covid-19 pandemic - a document endorsed by AIRO (Italian association of radiotherapy and clinical oncology) interventional radiotherapy working group</text></passage><passage><infon key="fpage">284</infon><infon key="lpage">289</infon><infon key="name_0">surname:Brunnhoelzl;given-names:D</infon><infon key="name_1">surname:Hanania;given-names:AN</infon><infon key="name_2">surname:Echeverria;given-names:A</infon><infon key="pub-id_doi">10.1016/j.brachy.2020.08.002</infon><infon key="pub-id_pmid">32891569</infon><infon key="section_type">REF</infon><infon key="source">Brachytherapy</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2021</infon><offset>42867</offset><text>Paracervical blocks facilitate timely brachytherapy amidst Covid-19</text></passage><passage><infon key="fpage">401</infon><infon key="lpage">411</infon><infon key="name_0">surname:Williams;given-names:VM</infon><infon key="name_1">surname:Kahn;given-names:JM</infon><infon key="name_2">surname:Harkenrider;given-names:MM</infon><infon key="pub-id_doi">10.1016/j.brachy.2020.04.005</infon><infon key="pub-id_pmid">32359937</infon><infon key="section_type">REF</infon><infon key="source">Brachytherapy</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2020</infon><offset>42935</offset><text>Covid-19 impact on timing of brachytherapy treatment and strategies for risk mitigation</text></passage><passage><infon key="fpage">279</infon><infon key="lpage">283</infon><infon key="name_0">surname:Jiang;given-names:Y</infon><infon key="name_1">surname:Li;given-names:G</infon><infon key="name_2">surname:Xing;given-names:B</infon><infon key="pub-id_doi">10.1016/j.brachy.2020.08.005</infon><infon key="pub-id_pmid">32893146</infon><infon key="section_type">REF</infon><infon key="source">Brachytherapy</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2021</infon><offset>43023</offset><text>Brachytherapy care during the Covid-19 pandemic: practice statement from a cancer center in Wuhan, China</text></passage><passage><infon key="fpage">290</infon><infon key="lpage">293</infon><infon key="name_0">surname:Miriyala;given-names:R</infon><infon key="name_1">surname:Mahantshetty;given-names:U</infon><infon key="pub-id_doi">10.5114/jcb.2020.96873</infon><infon key="pub-id_pmid">32695203</infon><infon key="section_type">REF</infon><infon key="source">J Contemp Brachytherapy</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2020</infon><offset>43128</offset><text>Brachytherapy in cervical cancer radiotherapy during Covid-19 pandemic crisis: problems and prospects</text></passage><passage><infon key="fpage">412</infon><infon key="lpage">414</infon><infon key="name_0">surname:Aghili;given-names:M</infon><infon key="name_1">surname:Jafari;given-names:F</infon><infon key="name_2">surname:Vand Rajabpoor;given-names:M</infon><infon key="pub-id_doi">10.1016/j.brachy.2020.05.003</infon><infon key="pub-id_pmid">32410912</infon><infon key="section_type">REF</infon><infon key="source">Brachytherapy</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2020</infon><offset>43230</offset><text>Brachytherapy during the coronavirus disease 2019 - lessons from Iran</text></passage><passage><infon key="fpage">2143</infon><infon key="lpage">2146</infon><infon key="name_0">surname:Kumar;given-names:D</infon><infon key="name_1">surname:Dey;given-names:T</infon><infon key="pub-id_doi">10.2217/fon-2020-0588</infon><infon key="pub-id_pmid">32776790</infon><infon key="section_type">REF</infon><infon key="source">Future Oncol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2020</infon><offset>43300</offset><text>Recapitulating intracavitary brachytherapy in cervical cancer patients during the Covid-19 pandemic: a viewpoint</text></passage><passage><infon key="fpage">649</infon><infon key="lpage">652</infon><infon key="name_0">surname:Nieder;given-names:C</infon><infon key="name_1">surname:Haukland;given-names:EC</infon><infon key="name_2">surname:Mannsaker;given-names:B</infon><infon key="name_3">surname:Yobuta;given-names:R</infon><infon key="pub-id_doi">10.21873/invivo.12304</infon><infon key="pub-id_pmid">33402522</infon><infon key="section_type">REF</infon><infon key="source">In Vivo</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2021</infon><offset>43413</offset><text>Palliative radiotherapy during the last month of life: have Covid-19 recommendations led to reduced utilization?</text></passage><passage><infon key="fpage">1619</infon><infon key="lpage">1656</infon><infon key="name_0">surname:Cellini;given-names:F</infon><infon key="name_1">surname:Di Franco;given-names:R</infon><infon key="name_2">surname:Manfrida;given-names:S</infon><infon key="pub-id_doi">10.1007/s11547-021-01414-z</infon><infon key="pub-id_pmid">34570309</infon><infon key="section_type">REF</infon><infon key="source">Radiol Med</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2021</infon><offset>43526</offset><text>Palliative radiotherapy indications during the Covid-19 pandemic and in future complex logistic settings: the NORMALITY model</text></passage><passage><infon key="fpage">100291</infon><infon key="name_0">surname:Thureau;given-names:S</infon><infon key="name_1">surname:Faivre;given-names:JC</infon><infon key="name_2">surname:Assaker;given-names:R</infon><infon key="pub-id_doi">10.1016/j.jbo.2020.100291</infon><infon key="pub-id_pmid">32292693</infon><infon key="section_type">REF</infon><infon key="source">J Bone Oncol</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2020</infon><offset>43652</offset><text>Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper</text></passage><passage><infon key="fpage">5282</infon><infon key="name_0">surname:Jacobson;given-names:G</infon><infon key="name_1">surname:Kaidar-Person;given-names:O</infon><infon key="name_2">surname:Haisraely;given-names:O</infon><infon key="pub-id_doi">10.1038/s41598-021-84872-9</infon><infon key="pub-id_pmid">33674709</infon><infon key="section_type">REF</infon><infon key="source">Sci Rep</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>43760</offset><text>Palliative radiation therapy for symptomatic advance breast cancer</text></passage><passage><infon key="fpage">589</infon><infon key="lpage">594</infon><infon key="name_0">surname:Yerramilli;given-names:D</infon><infon key="name_1">surname:Xu;given-names:AJ</infon><infon key="name_2">surname:Gillespie;given-names:EF</infon><infon key="pub-id_doi">10.1016/j.adro.2020.04.001</infon><infon key="pub-id_pmid">32363243</infon><infon key="section_type">REF</infon><infon key="source">Adv Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2020</infon><offset>43827</offset><text>Palliative radiation therapy for oncologic emergencies in the setting of Covid-19: approaches to balancing risks and benefits</text></passage><passage><infon key="fpage">319</infon><infon key="lpage">323</infon><infon key="name_0">surname:Crisà;given-names:FM</infon><infon key="name_1">surname:Leocata;given-names:F</infon><infon key="name_2">surname:Arienti;given-names:VM</infon><infon key="pub-id_doi">10.1159/000510271</infon><infon key="pub-id_pmid">32726792</infon><infon key="section_type">REF</infon><infon key="source">Stereotact Funct Neurosurg</infon><infon key="type">ref</infon><infon key="volume">98</infon><infon key="year">2020</infon><offset>43953</offset><text>Gamma knife radiosurgery for treatment of brain metastases during the Covid-19 outbreak</text></passage><passage><infon key="fpage">274</infon><infon key="lpage">280</infon><infon key="name_0">surname:Miura;given-names:H</infon><infon key="name_1">surname:Hioki;given-names:K</infon><infon key="name_2">surname:Ozawa;given-names:S</infon><infon key="pub-id_doi">10.1002/acm2.13279</infon><infon key="pub-id_pmid">34028970</infon><infon key="section_type">REF</infon><infon key="source">J Appl Clin Med Phys</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2021</infon><offset>44041</offset><text>Uncertainty in the positioning of patients receiving treatment for brain metastases and wearing surgical mask underneath thermoplastic mask during Covid-19 crisis</text></passage><passage><infon key="fpage">1211</infon><infon key="lpage">1212</infon><infon key="name_0">surname:Rinaldi;given-names:CG</infon><infon key="name_1">surname:Ippolito;given-names:E</infon><infon key="name_2">surname:Greco;given-names:C</infon><infon key="pub-id_doi">10.1002/ejp.1589</infon><infon key="pub-id_pmid">32418297</infon><infon key="section_type">REF</infon><infon key="source">Eur J Pain</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2020</infon><offset>44204</offset><text>Radiotherapy for pain relief from bone metastases during coronavirus (Covid-19) pandemic</text></passage><passage><infon key="name_0">surname:Chufal;given-names:KS</infon><infon key="name_1">surname:Ahmad;given-names:I</infon><infon key="name_2">surname:Chowdhary;given-names:RL</infon><infon key="pub-id_doi">10.1136/bmjspcare-2020-002758</infon><infon key="pub-id_pmid">33468506</infon><infon key="section_type">REF</infon><infon key="source">BMJ Support Palliat Care</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>44293</offset><text>Palliative stereotactic radiotherapy for metastases during Covid-19: relief when cure is implausible</text></passage><passage><infon key="fpage">679</infon><infon key="lpage">682</infon><infon key="name_0">surname:Rödel;given-names:F</infon><infon key="name_1">surname:Arenas;given-names:M</infon><infon key="name_2">surname:Ott;given-names:OJ</infon><infon key="pub-id_doi">10.1007/s00066-020-01635-7</infon><infon key="pub-id_pmid">32388805</infon><infon key="section_type">REF</infon><infon key="source">Strahlenther Onkol</infon><infon key="type">ref</infon><infon key="volume">196</infon><infon key="year">2020</infon><offset>44394</offset><text>Low-dose radiation therapy for Covid-19 pneumopathy: what is the evidence?</text></passage><passage><infon key="fpage">1086</infon><infon key="lpage">1093</infon><infon key="name_0">surname:Del Castillo;given-names:R</infon><infon key="name_1">surname:Martinez;given-names:D</infon><infon key="name_2">surname:Sarria;given-names:GJ</infon><infon key="pub-id_doi">10.1007/s00066-020-01675-z</infon><infon key="pub-id_pmid">32816059</infon><infon key="section_type">REF</infon><infon key="source">Strahlenther Onkol</infon><infon key="type">ref</infon><infon key="volume">196</infon><infon key="year">2020</infon><offset>44469</offset><text>Low-dose radiotherapy for Covid-19 pneumonia treatment: case report, procedure, and literature review</text></passage><passage><infon key="fpage">212</infon><infon key="lpage">216</infon><infon key="name_0">surname:Dhawan;given-names:G</infon><infon key="name_1">surname:Kapoor;given-names:R</infon><infon key="name_2">surname:Dhawan;given-names:R</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.002</infon><infon key="pub-id_pmid">32437820</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">2020</infon><offset>44571</offset><text>Low dose radiation therapy as a potential lifesaving treatment for Covid-19-induced acute respiratory distress syndrome (ARDS)</text></passage><passage><infon key="fpage">452</infon><infon key="lpage">464</infon><infon key="name_0">surname:Prasanna;given-names:PG</infon><infon key="name_1">surname:Woloschak;given-names:GE</infon><infon key="name_2">surname:DiCarlo;given-names:AL</infon><infon key="pub-id_doi">10.1667/RADE-20-00211.1</infon><infon key="pub-id_pmid">33045077</infon><infon key="section_type">REF</infon><infon key="source">Radiat Res</infon><infon key="type">ref</infon><infon key="volume">194</infon><infon key="year">2020</infon><offset>44698</offset><text>Low-dose radiation therapy (LDRT) for Covid-19: benefits or risks?</text></passage><passage><infon key="fpage">27</infon><infon key="lpage">29</infon><infon key="name_0">surname:Lara;given-names:PC</infon><infon key="name_1">surname:Burgos;given-names:J</infon><infon key="name_2">surname:Macias;given-names:D</infon><infon key="pub-id_doi">10.1016/j.ctro.2020.04.006</infon><infon key="pub-id_pmid">32373721</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2020</infon><offset>44765</offset><text>Low dose lung radiotherapy for Covid-19 pneumonia. the rationale for a cost-effective anti-inflammatory treatment</text></passage><passage><infon key="fpage">1228</infon><infon key="lpage">1235</infon><infon key="name_0">surname:Salomaa;given-names:S</infon><infon key="name_1">surname:Bouffler;given-names:SD</infon><infon key="name_2">surname:Atkinson;given-names:MJ</infon><infon key="pub-id_doi">10.1080/09553002.2020.1786609</infon><infon key="pub-id_pmid">32579043</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Biol</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">2020</infon><offset>44879</offset><text>Is there any supportive evidence for low dose radiotherapy for Covid-19 pneumonia?</text></passage><passage><infon key="fpage">1134</infon><infon key="lpage">1139</infon><infon key="name_0">surname:Ameri;given-names:A</infon><infon key="name_1">surname:Rahnama;given-names:N</infon><infon key="name_2">surname:Bozorgmehr;given-names:R</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.07.026</infon><infon key="pub-id_pmid">32707264</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>44962</offset><text>Low-dose whole-lung irradiation for Covid-19 pneumonia: short course results</text></passage><passage><infon key="fpage">20200581</infon><infon key="name_0">surname:Nasir;given-names:A</infon><infon key="name_1">surname:Agrawal;given-names:D</infon><infon key="name_2">surname:Pathak;given-names:J</infon><infon key="name_3">surname:Theodoulou;given-names:I</infon><infon key="pub-id_doi">10.1259/bjr.20200581</infon><infon key="pub-id_pmid">33252988</infon><infon key="section_type">REF</infon><infon key="source">Br J Radiol</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2021</infon><offset>45039</offset><text>Low-dose X-ray therapy for Covid-19: lessons from the past</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">4</infon><infon key="name_0">surname:Montero;given-names:A</infon><infon key="name_1">surname:Arenas;given-names:M</infon><infon key="name_2">surname:Algara;given-names:M</infon><infon key="pub-id_doi">10.1007/s12094-020-02401-y</infon><infon key="pub-id_pmid">32451973</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Oncol</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2021</infon><offset>45098</offset><text>Low-dose radiation therapy: could it be a game-changer for Covid-19?</text></passage><passage><infon key="fpage">880</infon><infon key="lpage">885</infon><infon key="name_0">surname:Sanmamed;given-names:N</infon><infon key="name_1">surname:Alcantara;given-names:P</infon><infon key="name_2">surname:Cerezo;given-names:E</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.11.049</infon><infon key="pub-id_pmid">33249142</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">109</infon><infon key="year">2021</infon><offset>45167</offset><text>Low-dose radiation therapy in the management of coronavirus disease 2019 (Covid-19) pneumonia (LOWRAD-Cov19): preliminary report</text></passage><passage><infon key="fpage">859</infon><infon key="lpage">866</infon><infon key="name_0">surname:Ameri;given-names:A</infon><infon key="name_1">surname:Ameri;given-names:P</infon><infon key="name_2">surname:Rahnama;given-names:N</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.11.065</infon><infon key="pub-id_pmid">33278503</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">109</infon><infon key="year">2021</infon><offset>45296</offset><text>Low-dose whole-lung irradiation for Covid-19 pneumonia: final results of a pilot study</text></passage><passage><infon key="fpage">886</infon><infon key="lpage">890</infon><infon key="name_0">surname:Hanna;given-names:CR</infon><infon key="name_1">surname:Robb;given-names:KA</infon><infon key="name_2">surname:Blyth;given-names:KG</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.12.003</infon><infon key="pub-id_pmid">33309910</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">109</infon><infon key="year">2021</infon><offset>45383</offset><text>Clinician attitudes to using low-dose radiation therapy to treat Covid-19 lung disease</text></passage><passage><infon key="fpage">302</infon><infon key="lpage">312</infon><infon key="name_0">surname:Koosha;given-names:F</infon><infon key="name_1">surname:Pourbagheri-Sigaroodi;given-names:A</infon><infon key="name_2">surname:Bakhshandeh;given-names:M</infon><infon key="name_3">surname:Bashash;given-names:D</infon><infon key="pub-id_doi">10.1080/09553002.2021.1864049</infon><infon key="pub-id_pmid">33320755</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Biol</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="year">2021</infon><offset>45470</offset><text>Low-dose radiotherapy (LD-RT) for Covid-19-induced pneumopathy: a worth considering approach</text></passage><passage><infon key="fpage">867</infon><infon key="lpage">879</infon><infon key="name_0">surname:Hess;given-names:CB</infon><infon key="name_1">surname:Nasti;given-names:TH</infon><infon key="name_2">surname:Dhere;given-names:VR</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.12.011</infon><infon key="pub-id_pmid">33340603</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">109</infon><infon key="year">2021</infon><offset>45563</offset><text>Immunomodulatory low-dose whole-lung radiation for patients with coronavirus disease 2019-related pneumonia</text></passage><passage><infon key="fpage">1219</infon><infon key="lpage">1223</infon><infon key="name_0">surname:Schaue;given-names:D</infon><infon key="name_1">surname:McBride;given-names:WH</infon><infon key="pub-id_doi">10.1080/09553002.2020.1767314</infon><infon key="pub-id_pmid">32401694</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Biol</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">2020</infon><offset>45671</offset><text>Flying by the seat of our pants: is low dose radiation therapy for Covid-19 an option?</text></passage><passage><infon key="fpage">295</infon><infon key="lpage">302</infon><infon key="name_0">surname:Kumar;given-names:R</infon><infon key="name_1">surname:Haresh;given-names:KP</infon><infon key="name_2">surname:Sharma;given-names:DN</infon><infon key="pub-id_doi">10.4103/jcrt.JCRT_1045_20</infon><infon key="pub-id_pmid">34121671</infon><infon key="section_type">REF</infon><infon key="source">J Cancer Res Ther</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2021</infon><offset>45758</offset><text>Low-dose radiotherapy for COVID 19: a radioimmunological perspective</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">8</infon><infon key="name_0">surname:Wilson;given-names:GD</infon><infon key="name_1">surname:Mehta;given-names:MP</infon><infon key="name_2">surname:Welsh;given-names:JS</infon><infon key="pub-id_doi">10.1667/RADE-20-00108.1</infon><infon key="pub-id_pmid">32845978</infon><infon key="section_type">REF</infon><infon key="source">Radiat Res</infon><infon key="type">ref</infon><infon key="volume">194</infon><infon key="year">2020</infon><offset>45827</offset><text>Investigating low-dose thoracic radiation as a treatment for Covid-19 patients to prevent respiratory failure</text></passage><passage><infon key="fpage">101215</infon><infon key="name_0">surname:Li;given-names:JJ</infon><infon key="pub-id_doi">10.1016/j.isci.2020.101215</infon><infon key="pub-id_pmid">32512383</infon><infon key="section_type">REF</infon><infon key="source">iScience</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2020</infon><offset>45937</offset><text>Mitigating coronavirus-induced acute respiratory distress syndrome by radiotherapy</text></passage><passage><infon key="fpage">429</infon><infon key="lpage">437</infon><infon key="name_0">surname:Moreno-Olmedo;given-names:E</infon><infon key="name_1">surname:Suárez-Gironzini;given-names:V</infon><infon key="name_2">surname:Pérez;given-names:M</infon><infon key="pub-id_doi">10.1007/s00066-020-01743-4</infon><infon key="pub-id_pmid">33502567</infon><infon key="section_type">REF</infon><infon key="source">Strahlenther Onkol</infon><infon key="type">ref</infon><infon key="volume">197</infon><infon key="year">2021</infon><offset>46020</offset><text>Covid-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a single institution report of two cases</text></passage><passage><infon key="fpage">2344</infon><infon key="lpage">2349</infon><infon key="name_0">surname:Bonet;given-names:M</infon><infon key="name_1">surname:Vázquez;given-names:S</infon><infon key="name_2">surname:García;given-names:E</infon><infon key="pub-id_doi">10.1007/s12094-021-02634-5</infon><infon key="pub-id_pmid">34013493</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Oncol</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2021</infon><offset>46146</offset><text>Saving time in the radiotherapy procedures for Covid-19 pneumonia treatment. a single-institution experience</text></passage><passage><infon key="fpage">29</infon><infon key="lpage">33</infon><infon key="name_0">surname:Algara;given-names:M</infon><infon key="name_1">surname:Arenas;given-names:M</infon><infon key="name_2">surname:Marin;given-names:J</infon><infon key="pub-id_doi">10.1016/j.ctro.2020.06.005</infon><infon key="pub-id_pmid">32613089</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2020</infon><offset>46255</offset><text>Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by Covid-19: a proposal for a multi-centric prospective trial</text></passage><passage><infon key="fpage">1559325820956800</infon><infon key="name_0">surname:Hanekamp;given-names:YN</infon><infon key="name_1">surname:Giordano;given-names:J</infon><infon key="name_2">surname:Hanekamp;given-names:JC</infon><infon key="pub-id_doi">10.1177/1559325820956800</infon><infon key="pub-id_pmid">33013251</infon><infon key="section_type">REF</infon><infon key="source">Dose Response</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2020</infon><offset>46388</offset><text>Immunomodulation through low-dose radiation for severe Covid-19: lessons from the past and new developments</text></passage><passage><infon key="fpage">1283</infon><infon key="lpage">1294</infon><infon key="name_0">surname:Meziani;given-names:L</infon><infon key="name_1">surname:Robert;given-names:C</infon><infon key="name_2">surname:Classe;given-names:M</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2021.03.022</infon><infon key="pub-id_pmid">33722770</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">110</infon><infon key="year">2021</infon><offset>46496</offset><text>Low doses of radiation increase the immunosuppressive profile of lung macrophages during viral infection and pneumonia</text></passage><passage><infon key="fpage">106531</infon><infon key="name_0">surname:Gupta;given-names:S</infon><infon key="name_1">surname:Ahuja;given-names:R</infon><infon key="name_2">surname:Sharma;given-names:N</infon><infon key="pub-id_doi">10.1016/j.rmed.2021.106531</infon><infon key="pub-id_pmid">34260977</infon><infon key="section_type">REF</infon><infon key="source">Respir Med</infon><infon key="type">ref</infon><infon key="volume">186</infon><infon key="year">2021</infon><offset>46615</offset><text>Low dose lung radiotherapy for Covid-19 pneumonia: a potential treatment</text></passage><passage><infon key="fpage">387</infon><infon key="lpage">394</infon><infon key="name_0">surname:Abdollahi;given-names:H</infon><infon key="name_1">surname:Shiri;given-names:I</infon><infon key="name_2">surname:Bevelacqua;given-names:JJ</infon><infon key="pub-id_doi">10.31661/jbpe.v0i0.2006-1125</infon><infon key="pub-id_pmid">32802787</infon><infon key="section_type">REF</infon><infon key="source">J Biomed Phys Eng</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>46688</offset><text>Low dose radiation therapy and convalescent plasma: how a hybrid method may maximize benefits for Covid-19 patients</text></passage><passage><infon key="fpage">1274</infon><infon key="lpage">1282</infon><infon key="name_0">surname:Papachristofilou;given-names:A</infon><infon key="name_1">surname:Finazzi;given-names:T</infon><infon key="name_2">surname:Blum;given-names:A</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2021.02.054</infon><infon key="pub-id_pmid">33677049</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">110</infon><infon key="year">2021</infon><offset>46804</offset><text>Low-dose radiation therapy for severe Covid-19 pneumonia: a randomized double-blind study</text></passage><passage><infon key="fpage">489</infon><infon key="lpage">493</infon><infon key="name_0">surname:Lara;given-names:PC</infon><infon key="name_1">surname:Nguyen;given-names:NP</infon><infon key="name_2">surname:Macias-Verde;given-names:D</infon><infon key="pub-id_doi">10.14336/AD.2020.0506</infon><infon key="pub-id_pmid">32489696</infon><infon key="section_type">REF</infon><infon key="source">Aging Dis</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2020</infon><offset>46894</offset><text>Whole-lung low dose irradiation for SARS-Cov2 induced pneumonia in the geriatric population: an old effective treatment for a new disease? Recommendation of the international geriatric radiotherapy group</text></passage><passage><infon key="fpage">1559325820950104</infon><infon key="name_0">surname:Cuttler;given-names:JM</infon><infon key="name_1">surname:Bevelacqua;given-names:JJ</infon><infon key="name_2">surname:Mortazavi;given-names:SMJ</infon><infon key="pub-id_doi">10.1177/1559325820950104</infon><infon key="pub-id_pmid">32868978</infon><infon key="section_type">REF</infon><infon key="source">Dose Response</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2020</infon><offset>47098</offset><text>Unethical not to investigate radiotherapy for Covid-19</text></passage><passage><infon key="fpage">e64</infon><infon key="lpage">e68</infon><infon key="name_0">surname:Hadjiyiannakis;given-names:D</infon><infon key="name_1">surname:Dimitroyannis;given-names:D</infon><infon key="name_2">surname:Eastlake;given-names:L</infon><infon key="pub-id_doi">10.1016/j.clon.2020.08.003</infon><infon key="pub-id_pmid">32829986</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2021</infon><offset>47153</offset><text>Personal view: low-dose lung radiotherapy should be evaluated as a treatment for severe Covid-19 lung disease</text></passage><passage><infon key="fpage">20</infon><infon key="lpage">31</infon><infon key="name_0">surname:Hess;given-names:CB</infon><infon key="name_1">surname:Eng;given-names:TY</infon><infon key="name_2">surname:Nasti;given-names:TH</infon><infon key="pub-id_doi">10.1016/j.radonc.2021.10.003</infon><infon key="pub-id_pmid">34653525</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">165</infon><infon key="year">2021</infon><offset>47263</offset><text>Whole-lung low-dose radiation therapy (LD-RT) for non-intubated oxygen-dependent patients with Covid-19-related pneumonia receiving dexamethasone and/or remdesevir</text></passage><passage><infon key="fpage">2212</infon><infon key="name_0">surname:Yu;given-names:J</infon><infon key="name_1">surname:Azzam;given-names:EI</infon><infon key="name_2">surname:Jadhav;given-names:AB</infon><infon key="name_3">surname:Wang;given-names:Y</infon><infon key="pub-id_doi">10.3390/cells10092212</infon><infon key="pub-id_pmid">34571861</infon><infon key="section_type">REF</infon><infon key="source">Cells</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2021</infon><offset>47427</offset><text>Covid-19: the disease, the immunological challenges, the treatment with pharmaceuticals and low-dose ionizing radiation</text></passage><passage><infon key="fpage">2621</infon><infon key="lpage">2624</infon><infon key="name_0">surname:Ghaznavi;given-names:H</infon><infon key="pub-id_doi">10.1007/s00432-021-03707-2</infon><infon key="pub-id_pmid">34219180</infon><infon key="section_type">REF</infon><infon key="source">J Cancer Res Clin Oncol</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">2021</infon><offset>47547</offset><text>Effectiveness of low-dose radiation therapy to improve mortality of Covid-19</text></passage><passage><infon key="fpage">20210187</infon><infon key="name_0">surname:Sharma;given-names:DN</infon><infon key="name_1">surname:Guleria;given-names:R</infon><infon key="name_2">surname:Wig;given-names:N</infon><infon key="pub-id_doi">10.1259/bjr.20210187</infon><infon key="pub-id_pmid">34545760</infon><infon key="section_type">REF</infon><infon key="source">Br J Radiol</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2021</infon><offset>47624</offset><text>Low-dose radiation therapy for Covid-19 pneumonia: a pilot study</text></passage><passage><infon key="fpage">1010</infon><infon key="lpage">1020</infon><infon key="name_0">surname:Arenas;given-names:M</infon><infon key="name_1">surname:Algara;given-names:M</infon><infon key="name_2">surname:De Febrer;given-names:G</infon><infon key="pub-id_doi">10.1007/s00066-021-01803-3</infon><infon key="pub-id_pmid">34230996</infon><infon key="section_type">REF</infon><infon key="source">Strahlenther Onkol</infon><infon key="type">ref</infon><infon key="volume">197</infon><infon key="year">2021</infon><offset>47689</offset><text>Could pulmonary low-dose radiation therapy be an alternative treatment for patients with Covid-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial)</text></passage><passage><infon key="fpage">3425</infon><infon key="lpage">3432</infon><infon key="name_0">surname:Kapoor;given-names:R</infon><infon key="name_1">surname:Welsh;given-names:JS</infon><infon key="name_2">surname:Dhawan;given-names:V</infon><infon key="pub-id_doi">10.1007/s00204-021-03124-x</infon><infon key="pub-id_pmid">34302492</infon><infon key="section_type">REF</infon><infon key="source">Arch Toxicol</infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="year">2021</infon><offset>47895</offset><text>Low-dose radiation therapy (LDRT) for Covid-19 and its deadlier variants</text></passage><passage><infon key="fpage">83</infon><infon key="lpage">90</infon><infon key="name_0">surname:Ganesan;given-names:G</infon><infon key="name_1">surname:Ponniah;given-names:S</infon><infon key="name_2">surname:Sundaram;given-names:V</infon><infon key="pub-id_doi">10.1016/j.radonc.2021.08.001</infon><infon key="pub-id_pmid">34391759</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">163</infon><infon key="year">2021</infon><offset>47968</offset><text>Whole lung irradiation as a novel treatment for Covid-19: interim results of an ongoing phase 2 trial in India</text></passage><passage><infon key="fpage">139</infon><infon key="lpage">145</infon><infon key="name_0">surname:Dunlap;given-names:NE</infon><infon key="name_1">surname:van Berkel;given-names:V</infon><infon key="name_2">surname:Cai;given-names:L</infon><infon key="pub-id_doi">10.1016/j.radmp.2021.09.004</infon><infon key="pub-id_pmid">34522905</infon><infon key="section_type">REF</infon><infon key="source">Radiat Med Prot</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">2021</infon><offset>48079</offset><text>Covid-19 and low-dose radiation therapy</text></passage><passage><infon key="fpage">396</infon><infon key="lpage">406</infon><infon key="name_0">surname:Mousavi Darzikolaee;given-names:N</infon><infon key="name_1">surname:Kolahdouzan;given-names:K</infon><infon key="name_2">surname:Abtahi;given-names:H</infon><infon key="pub-id_doi">10.1002/jmrs.542</infon><infon key="pub-id_pmid">34416084</infon><infon key="section_type">REF</infon><infon key="source">J Med Radiat Sci</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="year">2021</infon><offset>48119</offset><text>Low-dose whole-lung irradiation in severe Covid-19 pneumonia: a controlled clinical trial</text></passage><passage><infon key="fpage">133</infon><infon key="lpage">142</infon><infon key="name_0">surname:Ganesan;given-names:G</infon><infon key="name_1">surname:Ponniah;given-names:S</infon><infon key="name_2">surname:Sundaram;given-names:V</infon><infon key="pub-id_doi">10.1016/j.radonc.2021.12.024</infon><infon key="pub-id_pmid">34958809</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">167</infon><infon key="year">2021</infon><offset>48209</offset><text>Whole lung irradiation as a novel treatment for Covid-19: final results of the prospective randomized trial (WINCOVID trial)</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">2</infon><infon key="name_0">surname:Roa;given-names:D</infon><infon key="name_1">surname:Moyses;given-names:H</infon><infon key="name_2">surname:Leon;given-names:S</infon><infon key="pub-id_doi">10.1016/j.meddos.2020.07.008</infon><infon key="pub-id_pmid">32878727</infon><infon key="section_type">REF</infon><infon key="source">Med Dosim</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="year">2021</infon><offset>48334</offset><text>Rationale for using a C-arm fluoroscope to deliver a kilo voltage radiotherapy treatment to Covid-19 patients</text></passage><passage><infon key="fpage">736</infon><infon key="lpage">737</infon><infon key="name_0">surname:Chakrabarti;given-names:D</infon><infon key="name_1">surname:Verma;given-names:M</infon><infon key="pub-id_doi">10.1007/s00066-020-01634-8</infon><infon key="pub-id_pmid">32394099</infon><infon key="section_type">REF</infon><infon key="source">Strahlenther Onkol</infon><infon key="type">ref</infon><infon key="volume">196</infon><infon key="year">2020</infon><offset>48444</offset><text>Low-dose radiotherapy for SARS-CoV-2 pneumonia</text></passage><passage><infon key="fpage">505</infon><infon key="name_0">surname:Corry;given-names:PM</infon><infon key="name_1">surname:Griffin;given-names:RJ</infon><infon key="pub-id_doi">10.1667/RADE-20-000PC</infon><infon key="pub-id_pmid">32352871</infon><infon key="section_type">REF</infon><infon key="source">Radiat Res</infon><infon key="type">ref</infon><infon key="volume">193</infon><infon key="year">2020</infon><offset>48491</offset><text>A radiation mitigator as a potential treatment for Covid-19</text></passage><passage><infon key="fpage">224</infon><infon key="lpage">225</infon><infon key="name_0">surname:Kefayat;given-names:A</infon><infon key="name_1">surname:Ghahremani;given-names:F</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.026</infon><infon key="pub-id_pmid">32342874</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">2020</infon><offset>48551</offset><text>Low dose radiation therapy for Covid-19 pneumonia: a double-edged sword</text></passage><passage><infon key="fpage">1436</infon><infon key="lpage">1440</infon><infon key="name_0">surname:Beddok;given-names:A</infon><infon key="name_1">surname:Chevrier;given-names:M</infon><infon key="name_2">surname:Calugaru;given-names:V</infon><infon key="pub-id_doi">10.1080/09553002.2021.1956008</infon><infon key="pub-id_pmid">34269644</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Biol</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="year">2021</infon><offset>48623</offset><text>Acute and late toxicities of patients infected with SARS-CoV-2 and treated for cancer with radiation therapy during the Covid-19 pandemic</text></passage><passage><infon key="fpage">252</infon><infon key="lpage">257</infon><infon key="name_0">surname:Ning;given-names:MS</infon><infon key="name_1">surname:McAleer;given-names:MF</infon><infon key="name_2">surname:Jeter;given-names:MD</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.037</infon><infon key="pub-id_pmid">32474129</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>48761</offset><text>Mitigating the impact of Covid-19 on oncology: clinical and operational lessons from a prospective radiation oncology cohort tested for Covid-19</text></passage><passage><infon key="fpage">1286</infon><infon key="lpage">1292</infon><infon key="name_0">surname:Stepanović;given-names:A</infon><infon key="name_1">surname:Arsenijevic;given-names:T</infon><infon key="name_2">surname:Stankovic;given-names:V</infon><infon key="pub-id_doi">10.3855/jidc.15104</infon><infon key="pub-id_pmid">34669598</infon><infon key="section_type">REF</infon><infon key="source">J Infect Dev Ctries</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2021</infon><offset>48906</offset><text>Clinical analysis of Covid-19 positive cancer inpatients in national cancer center in Serbia</text></passage><passage><infon key="fpage">115</infon><infon key="lpage">117</infon><infon key="name_0">surname:LaPlant;given-names:Q</infon><infon key="name_1">surname:Thor;given-names:M</infon><infon key="name_2">surname:Shaverdian;given-names:N</infon><infon key="pub-id_doi">10.1016/j.radonc.2021.06.002</infon><infon key="pub-id_pmid">34107295</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">161</infon><infon key="year">2021</infon><offset>48999</offset><text>Association of prior radiation dose to the cardiopulmonary system with Covid-19 outcomes in patients with cancer</text></passage><passage><infon key="fpage">824</infon><infon key="lpage">827</infon><infon key="name_0">surname:Allali;given-names:S</infon><infon key="name_1">surname:Servois;given-names:V</infon><infon key="name_2">surname:Beddok;given-names:A</infon><infon key="pub-id_doi">10.1111/tbj.14282</infon><infon key="pub-id_pmid">34435418</infon><infon key="section_type">REF</infon><infon key="source">Breast J</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>49112</offset><text>Evaluation of the early adverse effects of radiotherapy in breast cancer patients with Covid-19: prospective single institutional study</text></passage><passage><infon key="fpage">374</infon><infon key="lpage">376</infon><infon key="name_0">surname:Weltman;given-names:E</infon><infon key="name_1">surname:Kotecha;given-names:R</infon><infon key="pub-id_doi">10.1016/j.meddos.2021.04.002</infon><infon key="pub-id_pmid">33910768</infon><infon key="section_type">REF</infon><infon key="source">Med Dosim</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="year">2021</infon><offset>49248</offset><text>Early-onset symptomatic radiation necrosis after stereotactic radiosurgery in the setting of Covid-19 infection</text></passage><passage><infon key="fpage">289</infon><infon key="lpage">295</infon><infon key="name_0">surname:García-Hernández;given-names:T</infon><infon key="name_1">surname:Romero-Expósito;given-names:M</infon><infon key="name_2">surname:Sánchez-Nieto;given-names:B</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.09.051</infon><infon key="pub-id_pmid">33065184</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">153</infon><infon key="year">2020</infon><offset>49360</offset><text>Low dose radiation therapy for Covid-19: effective dose and estimation of cancer risk</text></passage><passage><infon key="fpage">120</infon><infon key="lpage">125</infon><infon key="name_0">surname:Arruda;given-names:GV</infon><infon key="name_1">surname:Weber;given-names:RRDS</infon><infon key="name_2">surname:Bruno;given-names:AC</infon><infon key="name_3">surname:Pavoni;given-names:JF</infon><infon key="pub-id_doi">10.1080/09553002.2021.1846818</infon><infon key="pub-id_pmid">33164596</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Biol</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="year">2021</infon><offset>49446</offset><text>The risk of induced cancer and ischemic heart disease following low dose lung irradiation for Covid-19: estimation based on a virtual case</text></passage><passage><infon key="fpage">233</infon><infon key="lpage">239</infon><infon key="name_0">surname:Shuryak;given-names:I</infon><infon key="name_1">surname:Kachnic;given-names:LA</infon><infon key="name_2">surname:Brenner;given-names:DJ</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2021.04.018</infon><infon key="pub-id_pmid">33930480</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">111</infon><infon key="year">2021</infon><offset>49585</offset><text>Lung cancer and heart disease risks associated with low-dose pulmonary radiotherapy to Covid-19 patients with different background risks</text></passage><passage><infon key="fpage">849</infon><infon key="lpage">858</infon><infon key="name_0">surname:Little;given-names:MP</infon><infon key="name_1">surname:Zhang;given-names:W</infon><infon key="name_2">surname:van Dusen;given-names:R</infon><infon key="name_3">surname:Hamada;given-names:N</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.09.052</infon><infon key="pub-id_pmid">33011212</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">109</infon><infon key="year">2021</infon><offset>49722</offset><text>Pneumonia after bacterial or viral infection preceded or followed by radiation exposure: a reanalysis of older radio biologic data and implications for low-dose radiation therapy for coronavirus disease 2019 pneumonia</text></passage><passage><infon key="fpage">420</infon><infon key="lpage">422</infon><infon key="name_0">surname:Joseph;given-names:N</infon><infon key="name_1">surname:Choudhury;given-names:A</infon><infon key="pub-id_doi">10.1016/j.clon.2020.04.011</infon><infon key="pub-id_pmid">32362444</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>49940</offset><text>Lymphocytopenia and radiotherapy treatment volumes in the time of Covid-19</text></passage><passage><infon key="fpage">203</infon><infon key="lpage">210</infon><infon key="name_0">surname:Wei;given-names:W</infon><infon key="name_1">surname:Zheng;given-names:D</infon><infon key="name_2">surname:Lei;given-names:Y</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.03.029</infon><infon key="pub-id_pmid">32342870</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>50015</offset><text>Radiotherapy workflow and protection procedures during the coronavirus disease 2019 (Covid-19) outbreak: experience of the Hubei cancer hospital in Wuhan, China</text></passage><passage><infon key="fpage">166</infon><infon key="name_0">surname:Wang;given-names:W</infon><infon key="name_1">surname:Hu;given-names:K</infon><infon key="name_2">surname:Qiu;given-names:J</infon><infon key="name_3">surname:Zhang;given-names:F</infon><infon key="pub-id_doi">10.1186/s13014-020-01612-5</infon><infon key="pub-id_pmid">32646454</infon><infon key="section_type">REF</infon><infon key="source">Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>50176</offset><text>Radiotherapy after the easing of public restrictions during Covid-19 epidemic</text></passage><passage><infon key="fpage">917</infon><infon key="lpage">919</infon><infon key="name_0">surname:Pezzulla;given-names:D</infon><infon key="name_1">surname:Macchia;given-names:G</infon><infon key="name_2">surname:Taccari;given-names:F</infon><infon key="pub-id_doi">10.1136/ijgc-2020-001523</infon><infon key="pub-id_pmid">32448805</infon><infon key="section_type">REF</infon><infon key="source">Int J Gynecol Cancer</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2020</infon><offset>50254</offset><text>Radiotherapy in Southern Italy at the time of Covid-19: options for radiation oncology units</text></passage><passage><infon key="fpage">600</infon><infon key="lpage">603</infon><infon key="name_0">surname:Montesi;given-names:G</infon><infon key="name_1">surname:Di Biase;given-names:S</infon><infon key="name_2">surname:Chierchini;given-names:S</infon><infon key="pub-id_doi">10.1007/s11547-020-01217-8</infon><infon key="pub-id_pmid">32415473</infon><infon key="section_type">REF</infon><infon key="source">Radiol Med</infon><infon key="type">ref</infon><infon key="volume">125</infon><infon key="year">2020</infon><offset>50347</offset><text>Radiotherapy during Covid-19 pandemic. how to create a no fly zone: a Northern Italy experience</text></passage><passage><infon key="fpage">1675</infon><infon key="lpage">1680</infon><infon key="name_0">surname:Wang;given-names:W</infon><infon key="name_1">surname:Liu;given-names:X</infon><infon key="name_2">surname:Zhang;given-names:F</infon><infon key="pub-id_doi">10.21873/invivo.11960</infon><infon key="pub-id_pmid">32503828</infon><infon key="section_type">REF</infon><infon key="source">In Vivo</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2020</infon><offset>50443</offset><text>Radiation therapy during the Covid-19 pandemic: experience from Beijing, China</text></passage><passage><infon key="fpage">6</infon><infon key="lpage">12</infon><infon key="name_0">surname:Mohindra;given-names:P</infon><infon key="name_1">surname:Buckey;given-names:CR</infon><infon key="name_2">surname:Chen;given-names:S</infon><infon key="pub-id_doi">10.1002/acm2.12898</infon><infon key="pub-id_pmid">32324950</infon><infon key="section_type">REF</infon><infon key="source">J Appl Clin Med Phys</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2020</infon><offset>50522</offset><text>Radiation therapy considerations during the Covid-19 pandemic: literature review and expert opinions</text></passage><passage><infon key="fpage">296</infon><infon key="lpage">302</infon><infon key="name_0">surname:Viscariello;given-names:N</infon><infon key="name_1">surname:Evans;given-names:S</infon><infon key="name_2">surname:Parker;given-names:S</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.10.013</infon><infon key="pub-id_pmid">33096163</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">153</infon><infon key="year">2020</infon><offset>50623</offset><text>A multi-institutional assessment of Covid-19-related risk in radiation oncology</text></passage><passage><infon key="fpage">1094</infon><infon key="lpage">1095</infon><infon key="name_0">surname:Deantonio;given-names:L</infon><infon key="name_1">surname:Bosetti;given-names:D</infon><infon key="name_2">surname:Cima;given-names:S</infon><infon key="pub-id_doi">10.1007/s00066-020-01683-z</infon><infon key="pub-id_pmid">32945893</infon><infon key="section_type">REF</infon><infon key="source">Strahlenther Onkol</infon><infon key="type">ref</infon><infon key="volume">196</infon><infon key="year">2020</infon><offset>50703</offset><text>#Stayathome: smart working for radiation oncologists during the corona pandemic</text></passage><passage><infon key="name_0">surname:Hasford;given-names:F</infon><infon key="name_1">surname:Sosu;given-names:EK</infon><infon key="name_2">surname:Awua;given-names:AK</infon><infon key="pub-id_doi">10.1007/s12553-020-00507-5</infon><infon key="section_type">REF</infon><infon key="source">Health Technol (Berl)</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>50783</offset><text>Knowledge and perception on the transmission and control of SARS-COV-2 infection among allied radiation medicine professionals in Ghana</text></passage><passage><infon key="fpage">100</infon><infon key="lpage">102</infon><infon key="name_0">surname:Wei;given-names:W</infon><infon key="name_1">surname:Jiang;given-names:H</infon><infon key="name_2">surname:Chen;given-names:W</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.03.016</infon><infon key="pub-id_pmid">32259751</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">2020</infon><offset>50919</offset><text>How should we implement radiotherapy for cancer patients in China during the endemic period of Covid-19?</text></passage><passage><infon key="fpage">219</infon><infon key="lpage">221</infon><infon key="name_0">surname:Tamari;given-names:K</infon><infon key="name_1">surname:Nagata;given-names:Y</infon><infon key="name_2">surname:Nishiki;given-names:S</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.042</infon><infon key="pub-id_pmid">32474125</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>51024</offset><text>Nationwide survey of Covid-19 prevention measures in Japanese radiotherapy departments via online questionnaire for radiation oncologists</text></passage><passage><infon key="fpage">18</infon><infon key="lpage">24</infon><infon key="name_0">surname:Kearney;given-names:M</infon><infon key="name_1">surname:Coffey;given-names:M</infon><infon key="name_2">surname:Rossi;given-names:M</infon><infon key="pub-id_doi">10.1016/j.tipsro.2021.02.001</infon><infon key="pub-id_pmid">33564723</infon><infon key="section_type">REF</infon><infon key="source">Tech Innov Patient Support Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2021</infon><offset>51162</offset><text>Future-proof Radiation therapist (RTT) practice in a pandemic - lessons learnt from Covid-19</text></passage><passage><infon key="fpage">88</infon><infon key="lpage">91</infon><infon key="name_0">surname:Zhang;given-names:D</infon><infon key="name_1">surname:Li;given-names:T</infon><infon key="name_2">surname:Wang;given-names:P</infon><infon key="pub-id_doi">10.1016/j.ctro.2020.06.010</infon><infon key="pub-id_pmid">32665983</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2020</infon><offset>51255</offset><text>Experts consensus on epidemic prevention and control in radiotherapy centers during the Covid-19 outbreak: experiences from Sichuan Province</text></passage><passage><infon key="name_0">surname:Jereczek-Fossa;given-names:BA</infon><infon key="name_1">surname:Palazzi;given-names:MF</infon><infon key="name_2">surname:Tonoli;given-names:S</infon><infon key="pub-id_doi">10.1177/03008916211009974</infon><infon key="pub-id_pmid">33885350</infon><infon key="section_type">REF</infon><infon key="source">Italy CODRAL/AIRO-L study Tumori</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>51396</offset><text>Almost one year of Covid-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy</text></passage><passage><infon key="fpage">303</infon><infon key="lpage">315</infon><infon key="name_0">surname:Donkor;given-names:A</infon><infon key="name_1">surname:Atuwo-Ampoh;given-names:VD</infon><infon key="name_2">surname:Opie;given-names:C</infon><infon key="pub-id_doi">10.5603/RPOR.a2021.0032</infon><infon key="pub-id_pmid">34211781</infon><infon key="section_type">REF</infon><infon key="source">Rep Pract Oncol Radiother</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2021</infon><offset>51520</offset><text>Novel coronavirus mitigation measures implemented by radiotherapy centers in low and middle-income countries: a systematic review</text></passage><passage><infon key="fpage">104</infon><infon key="lpage">106</infon><infon key="name_0">surname:Zhang;given-names:L</infon><infon key="name_1">surname:Zheng;given-names:Z</infon><infon key="name_2">surname:Hu;given-names:G</infon><infon key="name_3">surname:Yuan;given-names:X</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.011</infon><infon key="pub-id_pmid">32342880</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>51650</offset><text>Prevention and control measure to avoid cross infection during radiotherapy in coronavirus disease 2019 (Covid-19) epidemic in Wuhan, China</text></passage><passage><infon key="fpage">6</infon><infon key="lpage">10</infon><infon key="name_0">surname:Tsang;given-names:Y</infon><infon key="name_1">surname:Duffton;given-names:A</infon><infon key="name_2">surname:Leech;given-names:M</infon><infon key="pub-id_doi">10.1016/j.tipsro.2020.05.003</infon><infon key="pub-id_pmid">32514473</infon><infon key="section_type">REF</infon><infon key="source">Tech Innov Patient Support Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>51790</offset><text>Meeting the challenges imposed by Covid-19: guidance document by the ESTRO radiation therapist committee (RTTC)</text></passage><passage><infon key="fpage">1632</infon><infon key="lpage">1634</infon><infon key="name_0">surname:Jan;given-names:I</infon><infon key="name_1">surname:Chen;given-names:K</infon><infon key="name_2">surname:Sayan;given-names:M</infon><infon key="pub-id_doi">10.1001/jamaoncol.2020.3552</infon><infon key="pub-id_pmid">32852509</infon><infon key="section_type">REF</infon><infon key="source">JAMA Oncol</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2020</infon><offset>51902</offset><text>Prevalence of surface contamination with SARS-CoV-2 in a radiation oncology clinic</text></passage><passage><infon key="fpage">3731</infon><infon key="lpage">3734</infon><infon key="name_0">surname:Gonnelli;given-names:A</infon><infon key="name_1">surname:Montrone;given-names:S</infon><infon key="name_2">surname:Cocuzza;given-names:P</infon><infon key="pub-id_doi">10.21873/invivo.12222</infon><infon key="pub-id_pmid">33144491</infon><infon key="section_type">REF</infon><infon key="source">In Vivo</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="year">2020</infon><offset>51985</offset><text>Radiotherapy in the Covid-19 pandemic era</text></passage><passage><infon key="fpage">1507</infon><infon key="lpage">1517</infon><infon key="name_0">surname:Di Lalla;given-names:V</infon><infon key="name_1">surname:Patrick;given-names:H</infon><infon key="name_2">surname:Siriani-Ayoub;given-names:N</infon><infon key="pub-id_doi">10.3390/curroncol28020142</infon><infon key="pub-id_pmid">33920247</infon><infon key="section_type">REF</infon><infon key="source">Curr Oncol</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2021</infon><offset>52027</offset><text>Satisfaction among cancer patients undergoing radiotherapy during the Covid-19 pandemic: an institutional experience</text></passage><passage><infon key="fpage">15</infon><infon key="lpage">17</infon><infon key="name_0">surname:Lian;given-names:X</infon><infon key="name_1">surname:Shen;given-names:J</infon><infon key="name_2">surname:Sun;given-names:Y</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.049</infon><infon key="pub-id_pmid">32512076</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">2020</infon><offset>52144</offset><text>Under the coronavirus disease 2019 (Covid-19) pandemic circumstance, how to administrate cancer patients with fever during radiotherapy</text></passage><passage><infon key="fpage">403</infon><infon key="lpage">406</infon><infon key="name_0">surname:Sachan;given-names:A</infon><infon key="name_1">surname:Gupta;given-names:S</infon><infon key="name_2">surname:Ghosh;given-names:A</infon><infon key="name_3">surname:Singh;given-names:N</infon><infon key="pub-id_doi">10.31661/jbpe.v0i0.2011-1228</infon><infon key="pub-id_pmid">34189128</infon><infon key="section_type">REF</infon><infon key="source">J Biomed Phys Eng</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>52280</offset><text>Catering the needs of cancer contemporary to this contagious corona catastrophe: institution based changes in cancer management and protection procedures</text></passage><passage><infon key="fpage">1068</infon><infon key="lpage">1079</infon><infon key="name_0">surname:Matuschek;given-names:C</infon><infon key="name_1">surname:Fischer;given-names:JC</infon><infon key="name_2">surname:Combs;given-names:SE</infon><infon key="pub-id_doi">10.1007/s00066-020-01681-1</infon><infon key="pub-id_pmid">32914236</infon><infon key="section_type">REF</infon><infon key="source">Strahlenther Onkol</infon><infon key="type">ref</infon><infon key="volume">196</infon><infon key="year">2020</infon><offset>52434</offset><text>Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland</text></passage><passage><infon key="fpage">e13688</infon><infon key="name_0">surname:Kurosaki;given-names:H</infon><infon key="name_1">surname:Utsumi;given-names:N</infon><infon key="name_2">surname:Miura;given-names:K</infon><infon key="pub-id_doi">10.7759/cureus.13688</infon><infon key="pub-id_pmid">33824832</infon><infon key="section_type">REF</infon><infon key="source">Cureus</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>52585</offset><text>A case of suspected radiation recall pneumonitis After a Covid-19 infection</text></passage><passage><infon key="fpage">394</infon><infon key="lpage">396</infon><infon key="name_0">surname:Cella;given-names:L</infon><infon key="name_1">surname:Gagliardi;given-names:G</infon><infon key="name_2">surname:Hedman;given-names:M</infon><infon key="name_3">surname:Palma;given-names:G</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.06.055</infon><infon key="pub-id_pmid">32890518</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>52661</offset><text>Injuries from asymptomatic Covid-19 disease: new hidden toxicity risk factors in thoracic radiation therapy</text></passage><passage><infon key="fpage">222</infon><infon key="lpage">223</infon><infon key="name_0">surname:Lazzari;given-names:G</infon><infon key="name_1">surname:Silvano;given-names:G</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.027</infon><infon key="pub-id_pmid">32389754</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">147</infon><infon key="year">2020</infon><offset>52769</offset><text>RILI model and the Covid-19 pneumonia: the radiation oncologist point of view</text></passage><passage><infon key="fpage">72</infon><infon key="name_0">surname:Kirkby;given-names:C</infon><infon key="name_1">surname:Mackenzie;given-names:M</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.050</infon><infon key="pub-id_pmid">32387547</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>52847</offset><text>Response to: RILI model and the Covid-19 pneumonia: the radiation oncologist point of view</text></passage><passage><infon key="fpage">236</infon><infon key="lpage">237</infon><infon key="name_0">surname:Boon;given-names:IS</infon><infon key="name_1">surname:Au Yong;given-names:TPT</infon><infon key="name_2">surname:Boon;given-names:CS</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.046</infon><infon key="pub-id_pmid">32505723</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>52938</offset><text>Radiotherapy for Covid-19: primum non nocere</text></passage><passage><infon key="fpage">957</infon><infon key="lpage">961</infon><infon key="name_0">surname:Soyfer;given-names:V</infon><infon key="name_1">surname:Gutfeld;given-names:O</infon><infon key="name_2">surname:Shamai;given-names:S</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2021.02.048</infon><infon key="pub-id_pmid">33677050</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">110</infon><infon key="year">2021</infon><offset>52983</offset><text>Covid-19 vaccine-induced radiation recall phenomenon</text></passage><passage><infon key="fpage">1212</infon><infon key="lpage">1214</infon><infon key="name_0">surname:Scoccianti;given-names:S</infon><infon key="name_1">surname:Delli Paoli;given-names:C</infon><infon key="name_2">surname:Grilli Leonulli;given-names:B</infon><infon key="pub-id_doi">10.1016/S1470-2045(21)00427-7</infon><infon key="pub-id_pmid">34388385</infon><infon key="section_type">REF</infon><infon key="source">Lancet Oncol</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2021</infon><offset>53036</offset><text>Acute tolerance of moderna mRNA-1273 vaccine against Covid-19 in patients with cancer treated with radiotherapy</text></passage><passage><infon key="fpage">e14303</infon><infon key="name_0">surname:Steber;given-names:CR</infon><infon key="name_1">surname:Ponnatapura;given-names:J</infon><infon key="name_2">surname:Hughes;given-names:RT</infon><infon key="name_3">surname:Farris;given-names:MK</infon><infon key="pub-id_doi">10.7759/cureus.14303</infon><infon key="pub-id_pmid">33968515</infon><infon key="section_type">REF</infon><infon key="source">Cureus</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>53148</offset><text>Rapid Development of clinically symptomatic radiation recall pneumonitis immediately following Covid-19 vaccination</text></passage><passage><infon key="fpage">1582</infon><infon key="lpage">1584</infon><infon key="name_0">surname:Afacan;given-names:E</infon><infon key="name_1">surname:Öğüt;given-names:B</infon><infon key="name_2">surname:Üstün;given-names:P</infon><infon key="pub-id_doi">10.1111/ced.14786</infon><infon key="pub-id_pmid">34080223</infon><infon key="section_type">REF</infon><infon key="source">Clin Exp Dermatol</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="year">2021</infon><offset>53264</offset><text>Radiation recall dermatitis triggered by inactivated Covid-19 vaccine</text></passage><passage><infon key="fpage">947</infon><infon key="lpage">956</infon><infon key="name_0">surname:Sun;given-names:R</infon><infon key="name_1">surname:Achkar;given-names:S</infon><infon key="name_2">surname:Ammari;given-names:S</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2021.02.022</infon><infon key="pub-id_pmid">33609591</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">110</infon><infon key="year">2021</infon><offset>53334</offset><text>Systematic screening of Covid-19 disease based on chest CT and RT-PCR for cancer patients undergoing radiation therapy in a coronavirus French hotspot</text></passage><passage><infon key="fpage">1085</infon><infon key="lpage">1087</infon><infon key="name_0">surname:McGinnis;given-names:GJ</infon><infon key="name_1">surname:Ning;given-names:MS</infon><infon key="name_2">surname:Nitsch;given-names:PL</infon><infon key="pub-id_doi">10.1016/j.jtho.2020.04.007</infon><infon key="pub-id_pmid">32311499</infon><infon key="section_type">REF</infon><infon key="source">J Thorac Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>53485</offset><text>Rapid detection of asymptomatic coronavirus disease 2019 by computed tomography image guidance for stereotactic ablative radiotherapy</text></passage><passage><infon key="fpage">1946</infon><infon key="lpage">1951</infon><infon key="name_0">surname:Warren;given-names:GW</infon><infon key="name_1">surname:Lim;given-names:V-S</infon><infon key="name_2">surname:Chowdhary;given-names:M</infon><infon key="pub-id_doi">10.1016/j.jtho.2021.06.005</infon><infon key="pub-id_pmid">34166850</infon><infon key="section_type">REF</infon><infon key="source">J Thorac Oncol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2021</infon><offset>53619</offset><text>New pulmonary infiltrates observed on computed tomography-based image guidance for radiotherapy warrant diagnostic workup for coronavirus disease 2019</text></passage><passage><infon key="fpage">1081</infon><infon key="lpage">1084</infon><infon key="name_0">surname:Suppli;given-names:MH</infon><infon key="name_1">surname:Riisgaard de Blanck;given-names:S</infon><infon key="name_2">surname:Elgaard;given-names:T</infon><infon key="pub-id_doi">10.1016/j.jtho.2020.04.004</infon><infon key="pub-id_pmid">32283316</infon><infon key="section_type">REF</infon><infon key="source">J Thorac Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>53770</offset><text>Early appearance of coronavirus disease 2019 associated pulmonary infiltrates during daily radiotherapy imaging for lung cancer</text></passage><passage><infon key="fpage">28</infon><infon key="name_0">surname:Prabhu;given-names:RS</infon><infon key="name_1">surname:Dhakal;given-names:R</infon><infon key="name_2">surname:Hicks;given-names:AS</infon><infon key="pub-id_doi">10.1186/s13014-021-01760-2</infon><infon key="pub-id_pmid">33541359</infon><infon key="section_type">REF</infon><infon key="source">Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2021</infon><offset>53898</offset><text>Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network</text></passage><passage><infon key="fpage">2561</infon><infon key="lpage">2569</infon><infon key="name_0">surname:Zeng;given-names:Q</infon><infon key="name_1">surname:Tang;given-names:C</infon><infon key="name_2">surname:Deng;given-names:L</infon><infon key="pub-id_doi">10.7150/ijms.46133</infon><infon key="pub-id_pmid">33029098</infon><infon key="section_type">REF</infon><infon key="source">Int J Med Sci</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2020</infon><offset>54059</offset><text>Differential diagnosis of Covid-19 pneumonia in cancer patients received radiotherapy</text></passage><passage><infon key="fpage">17</infon><infon key="lpage">23</infon><infon key="name_0">surname:Clough;given-names:A</infon><infon key="name_1">surname:Sanders;given-names:J</infon><infon key="name_2">surname:Banfill;given-names:K</infon><infon key="pub-id_doi">10.1016/j.radi.2021.07.011</infon><infon key="pub-id_pmid">34332857</infon><infon key="section_type">REF</infon><infon key="source">Radiography (Lond)</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2022</infon><offset>54145</offset><text>A novel use for routine CBCT imaging during radiotherapy to detect Covid-19</text></passage><passage><infon key="name_0">surname:Magrini;given-names:SM</infon><infon key="name_1">surname:Guerini;given-names:AE</infon><infon key="name_2">surname:Borghetti;given-names:P</infon><infon key="pub-id_doi">10.1177/03008916211034917</infon><infon key="pub-id_pmid">34405756</infon><infon key="section_type">REF</infon><infon key="source">Tumori</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>54221</offset><text>Universal testing for Covid-19 in patients undergoing cancer treatment during the second outbreak in Brescia</text></passage><passage><infon key="fpage">876</infon><infon key="lpage">877</infon><infon key="name_0">surname:Warren;given-names:GW</infon><infon key="name_1">surname:Adjei;given-names:AA</infon><infon key="pub-id_doi">10.1016/j.jtho.2020.04.006</infon><infon key="pub-id_pmid">32330542</infon><infon key="section_type">REF</infon><infon key="source">J Thorac Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>54330</offset><text>A call for rapid submission of data for aggregate review: can daily radiotherapy imaging be used as a potential screen for coronavirus disease 2019?</text></passage><passage><infon key="fpage">107</infon><infon key="lpage">111</infon><infon key="name_0">surname:Lazzari;given-names:G</infon><infon key="name_1">surname:Chiara Resta;given-names:E</infon><infon key="name_2">surname:Magli;given-names:M</infon><infon key="pub-id_doi">10.1016/j.ctro.2020.09.007</infon><infon key="pub-id_pmid">33015379</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2020</infon><offset>54479</offset><text>Are there overlapping clinical features between thoracic radiotherapy side effects and Covid-19 pneumonia? Radiation pneumonitis outside the radiation ports: Three case reports</text></passage><passage><infon key="fpage">e38</infon><infon key="lpage">e39</infon><infon key="name_0">surname:Manca;given-names:A</infon><infon key="name_1">surname:Bellizzi;given-names:S</infon><infon key="name_2">surname:Gatti;given-names:M</infon><infon key="pub-id_doi">10.1017/dmp.2020.427</infon><infon key="pub-id_pmid">33687319</infon><infon key="section_type">REF</infon><infon key="source">Disaster Med Public Health Prep</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2021</infon><offset>54656</offset><text>Routine immediate lung assessment during CT conceived for other purposes (thoracic spine CT, simulation CT for radiotherapy, PET-CT): a costless screening and surveillance tool for lung opacities in the Covid-19 era</text></passage><passage><infon key="fpage">223</infon><infon key="lpage">224</infon><infon key="name_0">surname:Boldrini;given-names:L</infon><infon key="name_1">surname:Dinapoli;given-names:N</infon><infon key="name_2">surname:Valentini;given-names:V</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.036</infon><infon key="pub-id_pmid">32342876</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">148</infon><infon key="year">2020</infon><offset>54872</offset><text>Radiotherapy imaging: an unexpected ally in fighting COVID 19 pandemic</text></passage><passage><infon key="fpage">199</infon><infon key="lpage">200</infon><infon key="name_0">surname:Kinj;given-names:R</infon><infon key="name_1">surname:Bennassi;given-names:A</infon><infon key="name_2">surname:Romano;given-names:E</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.12.030</infon><infon key="pub-id_pmid">33400940</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">156</infon><infon key="year">2021</infon><offset>54943</offset><text>Detection of an asymptomatic Covid-19 patient on CBCT-imaging</text></passage><passage><infon key="fpage">89</infon><infon key="lpage">93</infon><infon key="name_0">surname:Jereczek-Fossa;given-names:BA</infon><infon key="name_1">surname:Pepa;given-names:M</infon><infon key="name_2">surname:Marvaso;given-names:G</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.061</infon><infon key="pub-id_pmid">32413527</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>55005</offset><text>Covid-19 outbreak and cancer radiotherapy disruption in Italy: survey endorsed by the Italian association of radiotherapy and clinical oncology (AIRO)</text></passage><passage><infon key="fpage">e2298</infon><infon key="name_0">surname:de Carvalho;given-names:H</infon><infon key="name_1">surname:A, Vasconcelos KGMC, Gomes HC, Salvajoli JV,</infon><infon key="pub-id_doi">10.6061/clinics/2020/e2298</infon><infon key="pub-id_pmid">33174949</infon><infon key="section_type">REF</infon><infon key="source">Clinics (Sao Paulo)</infon><infon key="type">ref</infon><infon key="volume">75</infon><infon key="year">2020</infon><offset>55156</offset><text>Impact of Covid-19 pandemic on a daily-based outpatient treatment routine: experience of a radiotherapy department of a tertiary public/university hospital in Brazil</text></passage><passage><infon key="fpage">1080</infon><infon key="lpage">1085</infon><infon key="name_0">surname:Akuamoa-Boateng;given-names:D</infon><infon key="name_1">surname:Wegen;given-names:S</infon><infon key="name_2">surname:Ferdinandus;given-names:J</infon><infon key="pub-id_doi">10.1007/s00066-020-01698-6</infon><infon key="pub-id_pmid">33123776</infon><infon key="section_type">REF</infon><infon key="source">Strahlenther Onkol</infon><infon key="type">ref</infon><infon key="volume">196</infon><infon key="year">2020</infon><offset>55322</offset><text>Managing patient flows in radiation oncology during the Covid-19 pandemic : reworking existing treatment designs to prevent infections at a German hot spot area university hospital</text></passage><passage><infon key="fpage">374</infon><infon key="lpage">378</infon><infon key="name_0">surname:Martinez;given-names:D</infon><infon key="name_1">surname:Sarria;given-names:GJ</infon><infon key="name_2">surname:Wakefield;given-names:D</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.06.058</infon><infon key="pub-id_pmid">32890516</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>55503</offset><text>COVID’s impact on radiation oncology: a Latin American survey study</text></passage><passage><infon key="fpage">100565</infon><infon key="name_0">surname:Datta;given-names:NR</infon><infon key="name_1">surname:Datta;given-names:S</infon><infon key="name_2">surname:Samiei;given-names:M</infon><infon key="pub-id_doi">10.1016/j.adro.2020.09.005</infon><infon key="pub-id_pmid">32995668</infon><infon key="section_type">REF</infon><infon key="source">Adv Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2021</infon><offset>55573</offset><text>Strategies to maximize available resources with minimum cost escalation for improving radiation therapy accessibility in the post-coronavirus disease 2019 era: an analysis for Asia</text></passage><passage><infon key="fpage">364</infon><infon key="lpage">369</infon><infon key="name_0">surname:Teckie;given-names:S</infon><infon key="name_1">surname:Koffler;given-names:D</infon><infon key="name_2">surname:Potters;given-names:L</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.06.065</infon><infon key="pub-id_pmid">32890514</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>55754</offset><text>The resilience of radiation oncology in the COVID era and beyond</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">7</infon><infon key="name_0">surname:Leonardi;given-names:MC</infon><infon key="name_1">surname:Montagna;given-names:E</infon><infon key="name_2">surname:Galimberti;given-names:VE</infon><infon key="pub-id_doi">10.1159/000513227</infon><infon key="pub-id_pmid">34191930</infon><infon key="section_type">REF</infon><infon key="source">Breast Care (Basel)</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2020</infon><offset>55819</offset><text>Breast adjuvant radiotherapy amid the Covid-19 crisis in a hub cancer center, Lombardy, Italy</text></passage><passage><infon key="fpage">152</infon><infon key="lpage">158</infon><infon key="name_0">surname:Roberge;given-names:D</infon><infon key="name_1">surname:Delouya;given-names:G</infon><infon key="name_2">surname:Bohigas;given-names:A</infon><infon key="name_3">surname:Michalowski;given-names:S</infon><infon key="pub-id_doi">10.3390/curroncol28010018</infon><infon key="pub-id_pmid">33704183</infon><infon key="section_type">REF</infon><infon key="source">Curr Oncol</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2020</infon><offset>55913</offset><text>Catching the wave: quantifying the impact of COVID on radiotherapy delivery</text></passage><passage><infon key="fpage">309</infon><infon key="lpage">320</infon><infon key="name_0">surname:Spencer;given-names:K</infon><infon key="name_1">surname:Jones;given-names:CM</infon><infon key="name_2">surname:Girdler;given-names:R</infon><infon key="pub-id_doi">10.1016/S1470-2045(20)30743-9</infon><infon key="pub-id_pmid">33493433</infon><infon key="section_type">REF</infon><infon key="source">Lancet Oncol</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2021</infon><offset>55989</offset><text>The impact of the Covid-19 pandemic on radiotherapy services in England, UK: a population-based study</text></passage><passage><infon key="fpage">5550536</infon><infon key="name_0">surname:Tramacere;given-names:F</infon><infon key="name_1">surname:Asabella;given-names:AN</infon><infon key="name_2">surname:Portaluri;given-names:M</infon><infon key="pub-id_doi">10.1155/2021/5550536</infon><infon key="pub-id_pmid">34035961</infon><infon key="section_type">REF</infon><infon key="source">Radiol Res Pract</infon><infon key="type">ref</infon><infon key="volume">2021</infon><infon key="year">2021</infon><offset>56091</offset><text>Impact of the Covid-19 pandemic on radiotherapy supply</text></passage><passage><infon key="fpage">226</infon><infon key="name_0">surname:Caravatta;given-names:L</infon><infon key="name_1">surname:Rosa;given-names:C</infon><infon key="name_2">surname:Di Sciascio;given-names:MB</infon><infon key="pub-id_doi">10.1186/s13014-020-01670-9</infon><infon key="pub-id_pmid">32993690</infon><infon key="section_type">REF</infon><infon key="source">Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>56146</offset><text>Covid-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy</text></passage><passage><infon key="fpage">2931</infon><infon key="lpage">2937</infon><infon key="name_0">surname:Desideri;given-names:I</infon><infon key="name_1">surname:Francolini;given-names:G</infon><infon key="name_2">surname:Ciccone;given-names:LP</infon><infon key="pub-id_doi">10.1007/s00520-020-05793-3</infon><infon key="pub-id_pmid">33006676</infon><infon key="section_type">REF</infon><infon key="source">Support Care Cancer</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2021</infon><offset>56259</offset><text>Impact of Covid-19 on patient-doctor interaction in a complex radiation therapy facility</text></passage><passage><infon key="fpage">108</infon><infon key="name_0">surname:Jereczek-Fossa;given-names:BA</infon><infon key="name_1">surname:Pepa;given-names:M</infon><infon key="name_2">surname:Marvaso;given-names:G</infon><infon key="pub-id_doi">10.1007/s12032-020-01434-1</infon><infon key="pub-id_pmid">33150476</infon><infon key="section_type">REF</infon><infon key="source">Med Oncol</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2020</infon><offset>56348</offset><text>Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian Covid-19 phase 2</text></passage><passage><infon key="fpage">1971</infon><infon key="lpage">1974</infon><infon key="name_0">surname:Nieder;given-names:C</infon><infon key="name_1">surname:Johnsen;given-names:SK</infon><infon key="name_2">surname:Winther;given-names:AM</infon><infon key="pub-id_doi">10.21873/anticanres.14964</infon><infon key="pub-id_pmid">33813403</infon><infon key="section_type">REF</infon><infon key="source">Anticancer Res</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">2021</infon><offset>56462</offset><text>Symptom burden in patients treated with palliative radiotherapy before and during the Covid-19 pandemic</text></passage><passage><infon key="fpage">209</infon><infon key="lpage">217</infon><infon key="name_0">surname:Bartels;given-names:MMTJ</infon><infon key="name_1">surname:Gal;given-names:R</infon><infon key="name_2">surname:van der Velden;given-names:JM</infon><infon key="pub-id_doi">10.1007/s10585-021-10079-x</infon><infon key="pub-id_pmid">33634347</infon><infon key="section_type">REF</infon><infon key="source">Clin Exp Metastasis</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2021</infon><offset>56566</offset><text>Impact of the Covid-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study</text></passage><passage><infon key="fpage">717</infon><infon key="lpage">721</infon><infon key="name_0">surname:Francolini;given-names:G</infon><infon key="name_1">surname:Desideri;given-names:I</infon><infon key="name_2">surname:Stocchi;given-names:G</infon><infon key="pub-id_doi">10.1007/s11547-021-01338-8</infon><infon key="pub-id_pmid">33646520</infon><infon key="section_type">REF</infon><infon key="source">Radiol Med</infon><infon key="type">ref</infon><infon key="volume">126</infon><infon key="year">2021</infon><offset>56728</offset><text>Impact of Covid-19 on workload burden of a complex radiotherapy facility</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">3</infon><infon key="name_0">surname:Achard;given-names:V</infon><infon key="name_1">surname:Aebersold;given-names:DM</infon><infon key="name_2">surname:Allal;given-names:AS</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.047</infon><infon key="pub-id_pmid">32512075</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">2020</infon><offset>56801</offset><text>A national survey on radiation oncology patterns of practice in Switzerland during the Covid-19 pandemic: present changes and future perspectives</text></passage><passage><infon key="fpage">1402</infon><infon key="lpage">1403</infon><infon key="name_0">surname:Wakefield;given-names:DV</infon><infon key="name_1">surname:Sanders;given-names:T</infon><infon key="name_2">surname:Wilson;given-names:E</infon><infon key="pub-id_doi">10.1016/j.ijrobp.2020.09.028</infon><infon key="pub-id_pmid">33427664</infon><infon key="section_type">REF</infon><infon key="source">Int J Radiat Oncol Biol Phys</infon><infon key="type">ref</infon><infon key="volume">108</infon><infon key="year">2020</infon><offset>56947</offset><text>Initial impact and operational response of radiation oncology practices to the Covid-19 pandemic in the United States, Europe, and Latin America</text></passage><passage><infon key="fpage">53</infon><infon key="lpage">59</infon><infon key="name_0">surname:Dhont;given-names:J</infon><infon key="name_1">surname:Di Tella;given-names:M</infon><infon key="name_2">surname:Dubois;given-names:L</infon><infon key="pub-id_doi">10.1016/j.ctro.2020.06.006</infon><infon key="pub-id_pmid">32632379</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2020</infon><offset>57092</offset><text>Conducting research in radiation oncology remotely during the Covid-19 pandemic: coping with isolation</text></passage><passage><infon key="fpage">141</infon><infon key="lpage">143</infon><infon key="name_0">surname:Slotman;given-names:BJ</infon><infon key="name_1">surname:Cremades;given-names:V</infon><infon key="name_2">surname:Kirby;given-names:AM</infon><infon key="name_3">surname:Ricardi;given-names:U</infon><infon key="pub-id_doi">10.1016/j.ctro.2021.03.011</infon><infon key="pub-id_pmid">33880421</infon><infon key="section_type">REF</infon><infon key="source">Clin Transl Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2021</infon><offset>57195</offset><text>European radiation oncology after one year of Covid-19 pandemic</text></passage><passage><infon key="fpage">e69</infon><infon key="lpage">e72</infon><infon key="name_0">surname:Lewis;given-names:PJ</infon><infon key="name_1">surname:Morris;given-names:EJA</infon><infon key="name_2">surname:Chan;given-names:CSK</infon><infon key="pub-id_doi">10.1016/j.clon.2020.08.008</infon><infon key="pub-id_pmid">32950351</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2021</infon><offset>57259</offset><text>COVID RT - assessing the impact of Covid-19 on radiotherapy in the UK. A national cancer research institute clinical and translational radiotherapy research working group initiative in partnership with the royal college of radiologists, the society of radiographers and the institute of physics and engineering in medicine</text></passage><passage><infon key="fpage">43</infon><infon key="lpage">45</infon><infon key="name_0">surname:Anacak;given-names:Y</infon><infon key="name_1">surname:Onal;given-names:C</infon><infon key="name_2">surname:Ozyigit;given-names:G</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.06.014</infon><infon key="pub-id_pmid">32544607</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">2020</infon><offset>57582</offset><text>Changes in radiotherapy practice during Covid-19 outbreak in Turkey: a report from the Turkish society for radiation oncology</text></passage><passage><infon key="fpage">1165</infon><infon key="name_0">surname:Selvaraja;given-names:VK</infon><infon key="name_1">surname:Gudipudib;given-names:DK</infon><infon key="pub-id_doi">10.3332/ecancer.2021.1165</infon><infon key="pub-id_pmid">33680079</infon><infon key="section_type">REF</infon><infon key="source">Ecancermedicalscience</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2021</infon><offset>57708</offset><text>Impact of the Covid-19 pandemic on work routine, practice and mental state of radiation oncologists in India: an online survey</text></passage><passage><infon key="fpage">654086</infon><infon key="name_0">surname:Vaandering;given-names:A</infon><infon key="name_1">surname:Ben Mustapha;given-names:S</infon><infon key="name_2">surname:Lambrecht;given-names:M</infon><infon key="pub-id_doi">10.3389/fonc.2021.654086</infon><infon key="pub-id_pmid">33816310</infon><infon key="section_type">REF</infon><infon key="source">Front Oncol</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>57835</offset><text>Impact of the Covid-19 pandemic on patients and staff in radiation oncology departments in Belgium: a national survey</text></passage><passage><infon key="fpage">568839</infon><infon key="name_0">surname:Nardone;given-names:V</infon><infon key="name_1">surname:Reginelli;given-names:A</infon><infon key="name_2">surname:Vinciguerra;given-names:C</infon><infon key="pub-id_doi">10.3389/fpsyg.2021.568839</infon><infon key="pub-id_pmid">33815186</infon><infon key="section_type">REF</infon><infon key="source">Front Psychol</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2021</infon><offset>57953</offset><text>Mood disorder in cancer patients undergoing radiotherapy during the Covid-19 outbreak</text></passage><passage><infon key="fpage">498</infon><infon key="lpage">503</infon><infon key="name_0">surname:Corrao;given-names:G</infon><infon key="name_1">surname:Bergamaschi;given-names:L</infon><infon key="name_2">surname:Zaffaroni;given-names:M</infon><infon key="pub-id_doi">10.1177/0300891620980065</infon><infon key="pub-id_pmid">33327890</infon><infon key="section_type">REF</infon><infon key="source">Tumori</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="year">2021</infon><offset>58039</offset><text>Covid-19 impact in radiotherapy practice in an oncology hub: a screenshot from Lombardy, Italy</text></passage><passage><infon key="fpage">37</infon><infon key="lpage">43</infon><infon key="name_0">surname:He;given-names:J</infon><infon key="name_1">surname:Yang;given-names:L</infon><infon key="name_2">surname:Tao;given-names:Z</infon><infon key="pub-id_doi">10.2147/CMAR.S281323</infon><infon key="pub-id_pmid">33442292</infon><infon key="section_type">REF</infon><infon key="source">Cancer Manag Res</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>58134</offset><text>Impact of the 2019 novel coronavirus disease (Covid-19) epidemic on radiotherapy-treated patients with cancer: a single-center descriptive study</text></passage><passage><infon key="fpage">3859</infon><infon key="lpage">3864</infon><infon key="name_0">surname:Yang;given-names:Y</infon><infon key="name_1">surname:Shen;given-names:C</infon><infon key="name_2">surname:Hu;given-names:C</infon><infon key="pub-id_doi">10.2147/CMAR.S254093</infon><infon key="pub-id_pmid">32547222</infon><infon key="section_type">REF</infon><infon key="source">Cancer Manag Res</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2020</infon><offset>58279</offset><text>Effect of Covid-19 epidemic on delay of diagnosis and treatment path for patients with nasopharyngeal carcinoma</text></passage><passage><infon key="fpage">2253</infon><infon key="lpage">2260</infon><infon key="name_0">surname:Rades;given-names:D</infon><infon key="name_1">surname:Narvaez;given-names:CA</infon><infon key="name_2">surname:Schild;given-names:SE</infon><infon key="pub-id_doi">10.21873/invivo.12498</infon><infon key="pub-id_pmid">34182504</infon><infon key="section_type">REF</infon><infon key="source">In Vivo</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">2021</infon><offset>58391</offset><text>Sleep disorders before and during the Covid-19 pandemic in patients assigned to adjuvant radiotherapy for breast cancer</text></passage><passage><infon key="fpage">91</infon><infon key="lpage">93</infon><infon key="name_0">surname:Herrscher;given-names:H</infon><infon key="name_1">surname:Sauer;given-names:B</infon><infon key="name_2">surname:Truntzer;given-names:P</infon><infon key="name_3">surname:Robert;given-names:C</infon><infon key="pub-id_doi">10.1016/j.ejca.2021.03.003</infon><infon key="pub-id_pmid">33839589</infon><infon key="section_type">REF</infon><infon key="source">Eur J Cancer</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2021</infon><offset>58511</offset><text>Abscopal antitumor effect in a patient with melanoma and coronavirus disease 2019</text></passage><passage><infon key="fpage">3323</infon><infon key="lpage">3330</infon><infon key="name_0">surname:Galofaro;given-names:E</infon><infon key="name_1">surname:Malizia;given-names:C</infon><infon key="name_2">surname:Ammendolia;given-names:I</infon><infon key="pub-id_doi">10.3390/curroncol28050288</infon><infon key="pub-id_pmid">34590595</infon><infon key="section_type">REF</infon><infon key="source">Curr Oncol</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2021</infon><offset>58593</offset><text>Covid-19 pandemic-adapted radiotherapy guidelines: are they really followed?</text></passage><passage><infon key="fpage">650766</infon><infon key="name_0">surname:Xie;given-names:J</infon><infon key="name_1">surname:Qi;given-names:W</infon><infon key="name_2">surname:Cao;given-names:L</infon><infon key="pub-id_doi">10.3389/fonc.2021.650766</infon><infon key="pub-id_pmid">34381703</infon><infon key="section_type">REF</infon><infon key="source">Front Oncol</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>58670</offset><text>Predictors for fear of cancer recurrence in breast cancer patients referred to radiation therapy during the Covid-19 pandemic: a multi-center cross-section survey</text></passage><passage><infon key="fpage">5</infon><infon key="name_0">surname:Lee;given-names:S</infon><infon key="name_1">surname:Heo;given-names:J</infon><infon key="pub-id_doi">10.1007/s12032-021-01604-9</infon><infon key="pub-id_pmid">34739633</infon><infon key="section_type">REF</infon><infon key="source">Med Oncol</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2021</infon><offset>58833</offset><text>Covid-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients</text></passage><passage><infon key="fpage">1004</infon><infon key="lpage">1008</infon><infon key="name_0">surname:Chen;given-names:F</infon><infon key="name_1">surname:Zhan;given-names:W</infon><infon key="name_2">surname:Xu;given-names:H</infon><infon key="pub-id_doi">10.1093/annweh/wxab015</infon><infon key="pub-id_pmid">33907794</infon><infon key="section_type">REF</infon><infon key="source">Ann Work Expo Health</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">2021</infon><offset>58932</offset><text>Changes in the psychological state of medical personnel in the department of radiotherapy at a tertiary care teaching hospital in China during the epidemic</text></passage><passage><infon key="fpage">820</infon><infon key="lpage">827</infon><infon key="name_0">surname:Malicki;given-names:J</infon><infon key="name_1">surname:Martenka;given-names:P</infon><infon key="name_2">surname:Dyzmann-Sroka;given-names:A</infon><infon key="pub-id_doi">10.1016/j.rpor.2020.08.001</infon><infon key="pub-id_pmid">32837336</infon><infon key="section_type">REF</infon><infon key="source">Rep Pract Oncol Radiother</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2020</infon><offset>59088</offset><text>Impact of Covid-19 on the performance of a radiation oncology department at a major comprehensive cancer center in Poland during the first ten weeks of the epidemic</text></passage><passage><infon key="fpage">191</infon><infon key="name_0">surname:Buglione;given-names:M</infon><infon key="name_1">surname:Spiazzi;given-names:L</infon><infon key="name_2">surname:Guerini;given-names:AE</infon><infon key="pub-id_doi">10.1186/s13014-020-01631-2</infon><infon key="pub-id_pmid">32778174</infon><infon key="section_type">REF</infon><infon key="source">Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>59253</offset><text>Two months of radiation oncology in the heart of Italian “red zone” during Covid-19 pandemic: paving a safe path over thin ice</text></passage><passage><infon key="fpage">32</infon><infon key="lpage">34</infon><infon key="name_0">surname:Marconi;given-names:E</infon><infon key="name_1">surname:Chiesa;given-names:S</infon><infon key="name_2">surname:Dinapoli;given-names:L</infon><infon key="pub-id_doi">10.1016/j.tipsro.2021.04.002</infon><infon key="pub-id_pmid">33969234</infon><infon key="section_type">REF</infon><infon key="source">Tech Innov Patient Support Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2021</infon><offset>59384</offset><text>A radiotherapy staff experience of gratitude during Covid-19 pandemic</text></passage><passage><infon key="fpage">407</infon><infon key="lpage">417</infon><infon key="name_0">surname:Morassaei;given-names:S</infon><infon key="name_1">surname:Di Prospero;given-names:L</infon><infon key="name_2">surname:Ringdalen;given-names:E</infon><infon key="pub-id_doi">10.1002/jmrs.557</infon><infon key="pub-id_pmid">34716675</infon><infon key="section_type">REF</infon><infon key="source">J Med Radiat Sci</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="year">2021</infon><offset>59454</offset><text>A survey to explore the psychological impact of the Covid-19 pandemic on radiation therapists in Norway and Canada: a tale of two countries</text></passage><passage><infon key="name_0">surname:Corrao;given-names:G</infon><infon key="name_1">surname:Bergamaschi;given-names:L</infon><infon key="name_2">surname:Zaffaroni;given-names:M</infon><infon key="pub-id_doi">10.1177/03008916211000826</infon><infon key="pub-id_pmid">33730961</infon><infon key="section_type">REF</infon><infon key="source">Tumori</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>59594</offset><text>Covid-19 and radiotherapy: impact on work and personal life of Lombardy residents during first lockdown, survey endorsed by AIRO Young</text></passage><passage><infon key="fpage">e0233330</infon><infon key="name_0">surname:Reuter-Oppermann;given-names:M</infon><infon key="name_1">surname:Müller-Polyzou;given-names:R</infon><infon key="name_2">surname:Wirtz;given-names:H</infon><infon key="name_3">surname:Georgiadis;given-names:A</infon><infon key="pub-id_doi">10.1371/journal.pone.0233330</infon><infon key="pub-id_pmid">32437381</infon><infon key="section_type">REF</infon><infon key="source">PLoS One</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2020</infon><offset>59729</offset><text>Influence of the pandemic dissemination of Covid-19 on radiotherapy practice: a flash survey in Germany, Austria and Switzerland</text></passage><passage><infon key="fpage">57</infon><infon key="lpage">60</infon><infon key="name_0">surname:Handoko</infon><infon key="name_1">surname:Permata;given-names:TBM</infon><infon key="name_2">surname:Giselvania;given-names:A</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.05.044</infon><infon key="pub-id_pmid">32512073</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">150</infon><infon key="year">2020</infon><offset>59858</offset><text>Ensuring safety and sustainability of radiotherapy services during the Covid-19 pandemic in resources constrain country: an Indonesian experience</text></passage><passage><infon key="name_0">surname:Oliveira;given-names:HF</infon><infon key="name_1">surname:Yoshinari;given-names:GH</infon><infon key="name_2">surname:Veras;given-names:IM</infon><infon key="pub-id_doi">10.1016/j.adro.2021.100667</infon><infon key="pub-id_pmid">35036636</infon><infon key="section_type">REF</infon><infon key="source">Adv Radiat Oncol</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>60004</offset><text>Impact of the Covid-19 pandemic on radiation oncology departments in Brazil impact of Covid-19 on Brazilian radiotherapy</text></passage><passage><infon key="fpage">374</infon><infon key="lpage">383</infon><infon key="name_0">surname:Rykers;given-names:K</infon><infon key="name_1">surname:Tacey;given-names:M</infon><infon key="name_2">surname:Bowes;given-names:J</infon><infon key="pub-id_doi">10.1111/1754-9485.13186</infon><infon key="pub-id_pmid">33908186</infon><infon key="section_type">REF</infon><infon key="source">J Med Imaging Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">2021</infon><offset>60125</offset><text>Victoria (Australia) radiotherapy response to working through the first and second wave of Covid-19: strategies and staffing</text></passage><passage><infon key="fpage">1457</infon><infon key="lpage">1459</infon><infon key="name_0">surname:Xie;given-names:C</infon><infon key="name_1">surname:Wang;given-names:X</infon><infon key="name_2">surname:Liu;given-names:H</infon><infon key="pub-id_doi">10.1001/jamaoncol.2020.2783</infon><infon key="pub-id_pmid">32729893</infon><infon key="section_type">REF</infon><infon key="source">JAMA Oncol</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2020</infon><offset>60250</offset><text>Outcomes in radiotherapy-treated patients with cancer during the Covid-19 outbreak in Wuhan, China</text></passage><passage><infon key="fpage">277</infon><infon key="lpage">280</infon><infon key="name_0">surname:Chekhun;given-names:VF</infon><infon key="name_1">surname:Domina;given-names:EA</infon><infon key="pub-id_doi">10.32471/exp-oncology.2312-8852.vol-43-no-3.16554</infon><infon key="pub-id_pmid">34591423</infon><infon key="section_type">REF</infon><infon key="source">Exp Oncol</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2021</infon><offset>60349</offset><text>Can SARS-CoV-2 change individual radiation sensitivity of the patients recovered from Covid-19? (experimental and theoretical background)</text></passage><passage><infon key="fpage">99</infon><infon key="lpage">107</infon><infon key="name_0">surname:Mallick;given-names:I</infon><infon key="name_1">surname:Chakraborty;given-names:S</infon><infon key="name_2">surname:Baral;given-names:S</infon><infon key="pub-id_doi">10.1200/GO.20.00433</infon><infon key="pub-id_pmid">33449800</infon><infon key="section_type">REF</infon><infon key="source">JCO Glob Oncol</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2021</infon><offset>60487</offset><text>Prioritizing delivery of cancer treatment during a Covid-19 lockdown: the experience of a clinical oncology service in India</text></passage><passage><infon key="fpage">e1270</infon><infon key="lpage">e1277</infon><infon key="name_0">surname:Teckie;given-names:S</infon><infon key="name_1">surname:Andrews;given-names:JZ</infon><infon key="name_2">surname:Chen;given-names:WC-Y</infon><infon key="pub-id_doi">10.1200/OP.20.00619</infon><infon key="pub-id_pmid">33529045</infon><infon key="section_type">REF</infon><infon key="source">JCO Oncol Pract</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2021</infon><offset>60612</offset><text>Impact of the Covid-19 pandemic surge on radiation treatment: report from a multicenter New York area institution</text></passage><passage><infon key="fpage">771621</infon><infon key="name_0">surname:Yang;given-names:L</infon><infon key="name_1">surname:Yang;given-names:J</infon><infon key="name_2">surname:He;given-names:J</infon><infon key="pub-id_doi">10.3389/fpsyt.2021.771621</infon><infon key="pub-id_pmid">34955920</infon><infon key="section_type">REF</infon><infon key="source">Front Psychiatry</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2021</infon><offset>60726</offset><text>Analysis of anxiety and depression status in patients undergoing radiotherapy during the Covid-19 epidemic</text></passage><passage><infon key="fpage">5446</infon><infon key="lpage">5447</infon><infon key="name_0">surname:De Felice;given-names:F</infon><infon key="name_1">surname:Moriconi;given-names:F</infon><infon key="pub-id_doi">10.1245/s10434-021-09792-4</infon><infon key="pub-id_pmid">33634388</infon><infon key="section_type">REF</infon><infon key="source">Ann Surg Oncol</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2021</infon><offset>60833</offset><text>Covid-19 and cancer: implications for survival analysis</text></passage><passage><infon key="fpage">312</infon><infon key="lpage">315</infon><infon key="name_0">surname:De;given-names:B</infon><infon key="name_1">surname:Kaiser;given-names:KW</infon><infon key="name_2">surname:Ludmir;given-names:EB</infon><infon key="pub-id_doi">10.1080/0284186X.2020.1865564</infon><infon key="pub-id_pmid">33356801</infon><infon key="section_type">REF</infon><infon key="source">Acta Oncol</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="year">2021</infon><offset>60889</offset><text>Radiotherapy clinical trial enrollment during the Covid-19 pandemic</text></passage><passage><infon key="fpage">e219</infon><infon key="name_0">surname:Mummudi;given-names:N</infon><infon key="name_1">surname:Ghosh-Laskar;given-names:S</infon><infon key="name_2">surname:Tibdewal;given-names:A</infon><infon key="name_3">surname:Agarwal;given-names:JP</infon><infon key="pub-id_doi">10.1016/j.clon.2020.06.004</infon><infon key="pub-id_pmid">32536557</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>60957</offset><text>Covid-19 pandemic and nationwide lockdown - implications of the double trouble on radiotherapy practice in India</text></passage><passage><infon key="fpage">e175</infon><infon key="lpage">e176</infon><infon key="name_0">surname:Orazem;given-names:M</infon><infon key="name_1">surname:Ratosa;given-names:I</infon><infon key="pub-id_doi">10.1016/j.clon.2020.05.006</infon><infon key="pub-id_pmid">32448725</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>61070</offset><text>Covid-19 pandemic as an opportunity for the radiotherapy department</text></passage><passage><infon key="fpage">e217</infon><infon key="name_0">surname:Higgins;given-names:E</infon><infon key="name_1">surname:Walters;given-names:S</infon><infon key="name_2">surname:Powell;given-names:E</infon><infon key="name_3">surname:Staffurth;given-names:J</infon><infon key="pub-id_doi">10.1016/j.clon.2020.05.013</infon><infon key="pub-id_pmid">32487503</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>61138</offset><text>The impact of the acute phase of Covid-19 on radiotherapy demand in South East Wales</text></passage><passage><infon key="fpage">48</infon><infon key="name_0">surname:Sriwijitalai;given-names:W</infon><infon key="name_1">surname:Wiwanitkit;given-names:V</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.04.023</infon><infon key="pub-id_pmid">32342868</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="year">2020</infon><offset>61223</offset><text>Covid-19, radiotherapy and cancer</text></passage><passage><infon key="fpage">e160</infon><infon key="lpage">e161</infon><infon key="name_0">surname:Jereczek-Fossa;given-names:BA</infon><infon key="name_1">surname:Palazzi;given-names:MF</infon><infon key="name_2">surname:Soatti;given-names:CP</infon><infon key="pub-id_doi">10.1016/j.clon.2020.04.007</infon><infon key="pub-id_pmid">32354669</infon><infon key="section_type">REF</infon><infon key="source">Clin Oncol (R Coll Radiol)</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2020</infon><offset>61257</offset><text>Covid-19 outbreak and cancer radiotherapy disruption in Lombardy, Northern Italy</text></passage><passage><infon key="fpage">148</infon><infon key="lpage">151</infon><infon key="name_0">surname:Samper Ots;given-names:PM</infon><infon key="name_1">surname:Zapatero Ortuño;given-names:J</infon><infon key="name_2">surname:Pedraza Fernández;given-names:S</infon><infon key="pub-id_doi">10.1016/j.radonc.2021.06.001</infon><infon key="pub-id_pmid">34118358</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">161</infon><infon key="year">2021</infon><offset>61338</offset><text>Impact of Covid-19 on patients in radiotherapy oncology departments in Spain</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">2</infon><infon key="name_0">surname:Yu;given-names:D</infon><infon key="name_1">surname:Hu;given-names:W</infon><infon key="name_2">surname:Chen;given-names:L</infon><infon key="pub-id_doi">10.1016/j.radonc.2020.09.055</infon><infon key="pub-id_pmid">33053379</infon><infon key="section_type">REF</infon><infon key="source">Radiother Oncol</infon><infon key="type">ref</infon><infon key="volume">155</infon><infon key="year">2021</infon><offset>61415</offset><text>Effect of radiotherapy interruption due to Covid-19 outbreak</text></passage><passage><infon key="fpage">11</infon><infon key="lpage">14</infon><infon key="name_0">surname:Massaccesi;given-names:M</infon><infon key="name_1">surname:Boldrini;given-names:L</infon><infon key="name_2">surname:Piras;given-names:A</infon><infon key="pub-id_doi">10.1016/j.tipsro.2020.02.003</infon><infon key="pub-id_pmid">32154394</infon><infon key="section_type">REF</infon><infon key="source">Tech Innov Patient Support Radiat Oncol</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2020</infon><offset>61476</offset><text>Spatially fractionated radiotherapy (SFRT) targeting the hypoxic tumor segment for the intentional induction of non-targeted effects: an in silico study to exploit a new treatment paradigm</text></passage><passage><infon key="fpage">1023</infon><infon key="lpage">1033</infon><infon key="name_0">surname:Sahgal;given-names:A</infon><infon key="name_1">surname:Myrehaug;given-names:SD</infon><infon key="name_2">surname:Siva;given-names:S</infon><infon key="pub-id_doi">10.1016/S1470-2045(21)00196-0</infon><infon key="pub-id_pmid">34126044</infon><infon key="section_type">REF</infon><infon key="source">Lancet Oncol</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2021</infon><offset>61665</offset><text>Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicenter, randomized, controlled, phase 2/3 trial</text></passage><passage><infon key="fpage">72</infon><infon key="name_0">surname:Cusumano;given-names:D</infon><infon key="name_1">surname:Boldrini;given-names:L</infon><infon key="name_2">surname:Yadav;given-names:P</infon><infon key="pub-id_doi">10.3390/diagnostics11010072</infon><infon key="pub-id_pmid">33466307</infon><infon key="section_type">REF</infon><infon key="source">Diagnostics</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>61855</offset><text>Delta radiomics analysis for local control prediction in pancreatic cancer patients treated using magnetic resonance guided radiotherapy</text></passage><passage><infon key="fpage">e266</infon><infon key="lpage">e273</infon><infon key="name_0">surname:Caudell;given-names:JJ</infon><infon key="name_1">surname:Torres-Roca;given-names:JF</infon><infon key="name_2">surname:Gillies;given-names:RJ</infon><infon key="pub-id_doi">10.1016/S1470-2045(17)30252-8</infon><infon key="pub-id_pmid">28456586</infon><infon key="section_type">REF</infon><infon key="source">Lancet Oncol</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2017</infon><offset>61992</offset><text>The future of personalized radiotherapy for head and neck cancer</text></passage><passage><infon key="fpage">175</infon><infon key="name_0">surname:Catucci;given-names:F</infon><infon key="name_1">surname:Alitto;given-names:AR</infon><infon key="name_2">surname:Masciocchi;given-names:C</infon><infon key="pub-id_doi">10.3390/cancers13020175</infon><infon key="section_type">REF</infon><infon key="source">Cancers (Basel)</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>62057</offset><text>Predicting radiotherapy impact on late bladder toxicity in prostate cancer patients: an observational study</text></passage><passage><infon key="fpage">8001</infon><infon key="name_0">surname:Cusumano;given-names:D</infon><infon key="name_1">surname:Catucci;given-names:F</infon><infon key="name_2">surname:Romano;given-names:A</infon><infon key="pub-id_doi">10.3390/app10228001</infon><infon key="section_type">REF</infon><infon key="source">Appl Sci</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>62165</offset><text>Evaluation of an early regression index (ERITCP) as predictor of pathological complete response in cervical cancer: a pilot-study</text></passage><passage><infon key="fpage">44</infon><infon key="lpage">50</infon><infon key="name_0">surname:Gardin;given-names:I</infon><infon key="name_1">surname:Grégoire;given-names:V</infon><infon key="name_2">surname:Gibon;given-names:D</infon><infon key="pub-id_doi">10.1016/j.critrevonc.2019.03.015</infon><infon key="pub-id_pmid">31092384</infon><infon key="section_type">REF</infon><infon key="source">Crit Rev Oncol Hematol</infon><infon key="type">ref</infon><infon key="volume">138</infon><infon key="year">2019</infon><offset>62295</offset><text>Radiomics: principles and radiotherapy applications</text></passage><passage><infon key="fpage">385</infon><infon key="lpage">395</infon><infon key="name_0">surname:Widmark;given-names:A</infon><infon key="name_1">surname:Gunnlaugsson;given-names:A</infon><infon key="name_2">surname:Beckman;given-names:L</infon><infon key="pub-id_doi">10.1016/S0140-6736(19)31131-6</infon><infon key="pub-id_pmid">31227373</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">394</infon><infon key="year">2019</infon><offset>62347</offset><text>Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomized, non-inferiority, phase 3 trial</text></passage><passage><infon key="fpage">761393</infon><infon key="name_0">surname:Piras;given-names:A</infon><infon key="name_1">surname:Boldrini;given-names:L</infon><infon key="name_2">surname:Menna;given-names:S</infon><infon key="pub-id_doi">10.3389/fonc.2021.761393</infon><infon key="pub-id_pmid">34868976</infon><infon key="section_type">REF</infon><infon key="source">Front Oncol</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>62516</offset><text>Hypofractionated radiotherapy in head and neck cancer elderly patients: a feasibility and safety systematic review for the clinician</text></passage><passage><infon key="fpage">1613</infon><infon key="lpage">1626</infon><infon key="name_0">surname:Brunt;given-names:AM</infon><infon key="name_1">surname:Haviland;given-names:JS</infon><infon key="name_2">surname:Wheatley;given-names:DA</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30932-6</infon><infon key="section_type">REF</infon><infon key="source">The Lancet</infon><infon key="type">ref</infon><infon key="volume">395</infon><infon key="year">2020</infon><offset>62649</offset><text>Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-forward): 5-year efficacy and late normal tissue effects results from a multicenter, non-inferiority, randomized, phase 3 trial</text></passage><passage><infon key="name_0">surname:Piras;given-names:A</infon><infon key="name_1">surname:Menna;given-names:S</infon><infon key="name_2">surname:D’Aviero;given-names:A</infon><infon key="pub-id_doi">10.1002/jmrs.530</infon><infon key="pub-id_pmid">34551211</infon><infon key="section_type">REF</infon><infon key="source">J Med Radiat Sci</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>62846</offset><text>New fractionations in breast cancer: a dosimetric study of 3D-CRT versus VMAT</text></passage><passage><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>62924</offset><text>Fionda B, Alitto AR, Frascino V, et al (2020) PROPHECY: Patient reported outcomes in prostate cancer, a mobile-health experience in radiotherapy.</text></passage><passage><infon key="fpage">2152</infon><infon key="lpage">2153</infon><infon key="name_0">surname:Fionda;given-names:B</infon><infon key="name_1">surname:Piras;given-names:A</infon><infon key="name_2">surname:D’Aviero;given-names:A</infon><infon key="pub-id_doi">10.1016/j.pec.2021.02.014</infon><infon key="pub-id_pmid">33608213</infon><infon key="section_type">REF</infon><infon key="source">Patient Educ Couns</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">2021</infon><offset>63070</offset><text>The “PC-WIRED” study: patient centered evolution of websites of Italian radiotherapy departments</text></passage><passage><infon key="fpage">e000530</infon><infon key="name_0">surname:Kichloo;given-names:A</infon><infon key="name_1">surname:Albosta;given-names:M</infon><infon key="name_2">surname:Dettloff;given-names:K</infon><infon key="pub-id_doi">10.1136/fmch-2020-000530</infon><infon key="pub-id_pmid">32816942</infon><infon key="section_type">REF</infon><infon key="source">Fam Med Community Health</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2020</infon><offset>63171</offset><text>Telemedicine, the current Covid-19 pandemic and the future: a narrative review and perspectives moving forward in the USA</text></passage><passage><infon key="fpage">425</infon><infon key="lpage">434</infon><infon key="name_0">surname:Shi;given-names:H</infon><infon key="name_1">surname:Han;given-names:X</infon><infon key="name_2">surname:Jiang;given-names:N</infon><infon key="pub-id_doi">10.1016/S1473-3099(20)30086-4</infon><infon key="pub-id_pmid">32105637</infon><infon key="section_type">REF</infon><infon key="source">Lancet Infect Dis</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2020</infon><offset>63293</offset><text>Radiological findings from 81 patients with Covid-19 pneumonia in Wuhan, China: a descriptive study</text></passage></document></collection>
